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ABSTRACT
THE CELLULAR AND MOLECULAR DYNAMICS OF THE
QUEUOSINE MODIFICATION IN TRANSFER RNA:
DEFINITION, MODULATION, DEFICIENCIES,
AND EFFECT OF THE QUEUOSINE MODIFICATION SYSTEM
Rana C. Morris
Old DominioQ University and Eastern Virginia Medical School, 1997
Director Dr. Mark S. Elliott
The presence o f the queuosine modification in the wobble position of tRNA“ , tRNA*5*, tRNAhIS,
and tRNA151* is associated with a decrease in cellular growth rate, an increase in the ability to withstand
environmental stress, and differentiation of pleuripotent cells into mature phenotypes. The loss of this
normal modification is strongly correlated with neoplastic transformation and tumor progression o f a wide
variety of cancers.
The “normal” system for formation o f the queuosine modification in tRNA was studied in human
fibroblast cell cultures and in mouse, rat and human liver tissues. The queuosine modification system is
shown to be made up of three distinct mechanisms: uptake of the queuine base across the plasma
membrane; incorporation of this base into cytoplasmic tRNA; and salvage of the base from products of
normal tRNA degradation. The queuine membrane transporter and incorporation enzyme are activated via
phosphorylation by protein kinase C and inactivated by the action o f a phosphatase. This regulation by
phosphorylation integrates the queuosine modification system into a very sensitive eukaryotic cellular
switching mechanism already known to produce phenotypic alterations with strong correlations to changes
in queuosine levels.
A comparative study of two “abnormal” human adenocarcinoma cell-lines (colon and breast) was
performed to assess their queuosine levels and determine the malfunctioning system step(s) for the cause of
the observed deficiencies. The 100% queuosine-deficient colon tumor cell-line possessed a null mutation
for the queuosine incorporation enzyme, while the 50-60% queuosine-deficient breast tumor cell-line
exhibited a strong deficiency in the queuine salvage mechanism. These results demonstrate the potential
for determination of even multiple sites of lesions in the modification sytem that would yield queuosinedeficient tRNA characteristic of tumors.
Computational modeling was utilized to determine the biological function for the queuosine
modification. Steric, electrostatic, and structural differences were observed for queuosine, queuosineanalogues and guanosine, the nucleosides incorporated into tRNA“p anticodon stem/loop structures, and in
triad complexes of tRNA*sp with mRNA and tRNA1*®. The results o f this research identify
indistinguishable energetic parameters for complexes of queuosine-modified anticodon loops when paired
with an mRNA containing cytosine- or a uridine-ending codon. However, guanosine-containing anticodon
loops demonstrate much stronger energetic stability with cytosine-ending codons. The difference in codon
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bias is shown to be due to the restriction of anticodon loop flexibility by a queuosine-induced extended
intraloop hydrogen bonding network and only minimally due to a shift in hydrogen bonding pattern
produced by an intraresidue hydrogen bond.
A key difference in the physiology of normal and neoplastic cells is in the increased expression of
oncodevelopmental genes with respect to those housekeeping genes needed for survival. Sequence
analysis of several oncodevelopmental and housekeeping transcripts suggests the presence o f a contrasting
bias in the usage o f queuosine*related codons which end in cytosine or either cytosine or uridine,
respectively. In combination with the mechanism proposed for tRNA19 decoding preferences, this codon
usage bias suggests a potentially influential role for the queuosine modification system in the translational
control of oncodevelopmental gene expression.
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‘Turns out not where but who you’re with that really matters.
‘Turns out not where but what you think that really matters.
Whatever tears at us, whatever holds us down,
if nothing can be done we’U make the best of what’s around.

paraphrased from “The Best of What’s Around” by the Dave Matthews Band
from their Album Under the Table and Dreaming (1994, The RCA Records Label)
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CHAPTER ONE
MUCH ADO ABOUT Q
Introduction
In 1953 the world o f science changed because o f James D. Watson and Francis H. C. Crick’s
publication on the structure of deoxyribonucleic acid (1). This treatise was not the first to describe the
three-dimensional structure o f a macromolecule, however it was the first attempt to describe the possible
mechanism for a macromolecule’s biological function based on the proposed conformation. Since this
time, molecular biologists, biochemists, physiological chemists, and structural biologists have studied the
impact that the structure of a compound would have on its function. In fact, the quote “structure is
function” has often been regarded as the credo for modem biomolecular research.
For nucleic acids, the three-dimensional structure o f each molecule is largely based on its primary
structure, the nucleotide sequence. In the late 1950s, a primitive mechanism for determining the sequence
of nucleic acids was developed. This procedure was comprised o f a difficult and complicated series of
nuclease digestions and analysis of overlapping fragment lengths. It was not until 1965, after seven years
of work, that the first nucleic acid, yeast alanyl-transfer ribonucleic acid (tRNA11*), was sequenced (2). In
addition to the traditional nucleotide bases o f RNA molecules [adenosine (A), cytosine (C), guanosine (G),
and uridine (U)], the same group discovered that there exist, in tRNA approximately 80 modified forms of
these nucleotides (3). These modified nucleotides comprise up to 25 % of all bases in a given tRNA. Most
of these involve simple methylations of the four basic RNA bases, with a small number o f other types of
minor nucleotide alterations such as the reduction of uridine’s C5-C6 double bond to form dihydrouridine
and the deamination o f adenosine to form inosine. There are a few large modifications that have been
identified solely in tRNA, and these have been shown to exist only in the anticodon region-one of the two
major functional centers o f the molecule (4).
The development of a gas chromatography/mass spectrometry-based method allowed for the
identification of the nucleotide composition o f purified tRNAs (5). However, in 1968 a peak arose in the
profile o f an Escherichia coli tRNAlyr hydrolysate that could not be matched with previously established
standards (6-8). Because this was a new and unknown base, it was given the designation “Q”. In the
vocabulary of biochemistry, the Q base needed to be assigned a name that could more definitively identify
its nucleotidyl form. Since the free form o f G was called guanine, for example, the free form of Q was to
be called queuine. Thus, the written name for the presence of Q in a polynucleotide form was to be
queuosine, again based on the example of guanosine for G. This development o f a naming scheme was
important for the validation of the existence of the Q nucleotide, as Q was eventually found to exist in the
tRNA o f every organism yet studied, with the notable exception of yeast (9-11).
The journal model for this dissertation is Nucleic Acids Research.
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In 1972, the Q modified nucleotide was localized to position 34 of tRNAs specific for aspartate,
asparagine, histidine, and tyrosine (HXFigure 1-1). The structure o f queuosine was later determined by gas
chromatography/mass spectroscopy (S) and elucidated by X-ray crystallography (13) (Figure 1-2).
Queuosine was identified as a strangely modified guanosine analogue. The N-7 position of the purine ring
is a C-7 in queuosine, which is the site o f attachment for an ammomethyl tether to a
dihydroxycyclopentenediol ring. This structure is known to be further modified with the addition of
mannose and galactose residues to the cydopentenediol ring hydroxyl groups o f tRNA*9 and tRNA15'1,
respectively (14). By chemical naming convention, the basic queuosine molecule was defined as 7-(3,4rranr-4,5-cfr-dihydroxy-l-cyclopenten-3-ylaminomethyI)-7-deazaguanosine. Since the early 1970s, focus
on Q research has shied away from structural studies to branch into two main directions: sub-cellular
biochemical research and physiological clinical research.
Biochemical Research
Basic biochemical research has characterized and localized the queuosine modification in the tRNA
of intracellularorganelles (mitochondriaand chIoroplast)and organisms as diverse as monerans (such as
Escherichiacoli, Zymomonasmobilis, Bacillus stearothermophilus, and Salmonella typhimurium), protistans
(Chlamydomonasreinhardtii, Chlorellapyrenoidosa, Acanthamoebacastellaniiand Dictyostelium
discoideum), and plants (Lupinus leuteus, tobacco, and wheat), as well as many animals [from marine life
(lingula, starfish, topminnow, flounder, and hagfish), insects (Bombyx mori, and Drosophila melanogaster),
amphibians (Xenopus laevus), to mammals (mice, rats, opossum, rabbits, cows, and humans)]. Thus far, only
one genus from the kingdom Fungi has been tested. However, several species o f yeast have been identified as
the only organisms currently known that do not contain the queuosine modification in their tRNA (10).
In biological systems, the Q base is known to exist in three forms: free queuine base, free nucleotide
or nucleoside, and nucleoside incorporated in tRNA. The free base form, present in all cells and cell-types,
has only recently been suggested to play a physiological role within a cell—modulationof receptor tyrosine
kinases such as epidermal growth factor receptor and platelet-derivedgrowth factor receptor( 15). The free
nucleoside or nucleotide exists in the cell due to the normal turnover o f tRNA and appears to have no direct
physiological role, although queuosine-S’-phosphatehas been reported to serve as a source of salvaged
queuine base in mammalian cells (16,17). The incorporated form of Q has been demonstrated in aspartyl-,
asparaginy1-, histidy 1-, and tyrosyl-tRNA isoaccepting families o f many organisms (11X These modified
tRNA populations are further separated into queuosine-containingtRNA“p and tRNA1**, and the glycosylated
forms of these queuosine-containingtRNAs; mannosy!atedqueuosine-containingtRNA<spand galactosylated
queuosine-containingtRNAIyr(14,18,19> The purpose ofthese incorporated modification forms is notyet
known.
Originally, it was thought that queuosine modifications in prokaryotic and eukaryotic tRNA were
evolutionary conserved. Thus, the enzyme that catalyzed the formation o f this modification was assigned the
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F igure l - l . Molecular Skeleton, Ribbon Diagram, and Electron Density Surface o f Aminoacylated i'east Aspartyl l/tN/I.The main structure o f the tRNA is
shown in dark blue with the second and third anticodon bases in orange (light color, near the bottom) and the wobble base in red (medium color, at the bottom).
The site for aminoacylation, the ribose o f the adenosine at position 76, is shown in green on top. The Molecular Skeleton (representation on the left) is shown in
ball and stick rendering with the hydrogen bonding sites o f the anticodon and the 2 ’ and 3 ' hydroxyl groups, for covalent attachment to aspartate, as space filling
models. The Ribbon Diagram (center) shows the backbone structure o f the tRNA with the anticodon and aminoacylated residues as ball and stick rendering. The
Electron Density Surface (on the right) is shown with color mapping for the anticodon bases and the aminoacylated residue.
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Figure 1-2. Structures o fGuanine and Queuine Bases. A two dimensional representation o f the
nucleotidyl bases are drawn with an R representing the attachment site for an H for the base form (often
abbreviated as G and Q) or a ribose for the nucleoside form (known as Guanosine and Queuosine). The
classical nucleic acid numbering scheme is shown. Queuine is a modified guanine with the IUPAC
designation 7-(3”,4”-tra/»-4”,5”-cir-dihydroxy-1”-cyclopenten-3”-ylaminomethyl)-7-deazaguanine.
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name tRNA-guaninetransgIycosylase(TGTase; E.C. 2.4.2.29) regardless of the taxonomic classificationof
the host organism. This enzyme was named based on it’s originally measured ability to transfer a guanine
base into the wobble position of these tRNA families (20-22X More recently the Enzyme Commission has
renamed this protein tRNA-guanineribosyitransferase(TGRase), although the original designation is still in
wide use. With the furtherpurificationand identificationofcomponents o f the prokaryoticand eukaryotic
systems, this assumptionof conserved evolution is now in doubt.
The localization,structure, and metabolism of Q have been well studied in prokaryotes, and are now
under scrutiny in eukaryotes with the developmentofnew methods to study the presence or absence o f the
queuosine modification in mammalian tRNA.
Prokaryotes synthesize this nucleotide through a series o f post-transcriptionalsteps catalyzed by
enzymes encoded in the "queuine operon" (23). First, tRNA-guaninetransglycosylase(TGTase—thegene
product o f tgt) inserts preQi (7-aminomethyl-7-deazaguanine)into the cognate tRNAs (24) via a baseexchange reaction without disruptingthe phosphoribosy(backbone (22). Then, a second enzyme, sadenosylmethionine^RNAribosyItransferase-isomerase(gene product of queA), adds the ribosyl group from
an s-adenosylmethionineto the transcriptat the end o f the 7-aminomethylside chain of the inserted preQi and
isomerizes it to form the epoxycyclopentanediolmoiety of what is called oQ (25,26X Finally, the epoxy
group of the oQ is reduced to form queuosine in an as-yet-unknownvitamin B,2-dependent reaction (27).
This completes the prokaryoticqueuosmesynthesis.
It has been suggested that most eukaryotes, including humans, salvage the fully-formedqueuine base
from their diet or through absorption of metabolic turnover products from symbiotic bacteria living in the
intestines o f the host (16,17,28,29). Once inside the circulatory system o f the organism, queuine is efficiently
taken up by a specific cellular transport mechanism (30). Then, a cytosolic enzyme often referred to as either
TGTase or TGRase inserts the pre-formed queuine base into the four queuosine-specifictRNA isoacceptors
(21,31 > Finally, in the case o f eukaryotic tRNA*5’’ and tRNA*1", glycosylatedqueuosine-modifiedtRNA
isotypes have been documented (14X In 1977, a rat liver mannosyltransferasewas identified which places
mannose residues on the hydroxyl groups of the cyclopentenediolring of tRNA*9 (18> It is presumed that
there is a similar galactosyltransferasewhich exists that catalyzes the observed tRNAlyrgIycosylations(19).
Many methods have been developed to detect queuosine-containing tRNAs. Early techniques to
study the nucleotide composition o f tRNAs included the use of infrared analysis and ramen spectroscopy.
However, the most successful method to identify specific nucleotides, including Q, in tRNA samples was
traditional gas chromatography/mass spectrometry (5). Three different methods of analysis have since
been developed that have become the accepted procedures to measure the levels of queuosine-modified
tRNAs. These include high performance liquid chromatography strategies (HPLC), an in vitro enzymatic
radiolabeling assay, and, most recently, in vivo cell culture radiolabeling assays.
(n the early days o f “Q” research, several chromatographic matrices were utilized for the
separation o f queuosine-containing tRNAs including dihydroxyboryl-substitutued cellulose, acetylated-
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dihydroxyborophenyl-succino-aminoethyl cellulose and concavalin A-sepharose affinity chromatography
(3,32,33). Eventually, with the development o f HPLC technology, reversed phase HPLC matrices were
demonstrated to quickly and efficiently separate queuosine-containing from queuosine-deficient tRNAs
based on hydrophobic criteria (3435). Studies on the chromatographic mobility of the queuosine-modified
tRNA (3) and x-ray crystal structure of queuosine (13) have suggested that the physiological state of the
molecule includes a positively-charged quaternary amine in the aminomethyl linker between the base and
the cyclopentenediol ring. Due to the presence of charged amine group and the two hydroxyl groups on
the cyclopentenediol moiety, the queuosine-containing tRNAs can be separated from other non-queuosinecontaining isoforms o f tRNAs using RPC-5 HPLC (34). Thus, the total level o f queuosine-containing
tRNAs can be determined with this method. Recently, a W-Porex C4 HPLC column was shown to resolve
not only queuosine-containing from non-queuosine-containing tRNA isoforms, but also to separate the four
isoaccepting families as well (36,37). Using the W-Porex C4 HPLC method, it is now possible to measure
the queuosine-modification levels for all four families of queuosine-containing tRNAs at once, as is shown
in the Appendix of this document. These HPLC methods require a large amount (1 to 2 mg) o f tRNA and
are, therefore, only suitable for very large cell culture preparations or tissue analysis of substantial organ
biopsies.
A somewhat faster and more sensitive method for measuring queuosine levels was developed
utilizing the cloned Escherichiacoli queuosine-incorporationenzyme, TGTase, in an in vitro assay (38,39}
The modificationoftRNA with queuosine is an irreversibleone, thus enzymatic incorporationof a
radiolabeledqueuine or guanine will “tag” the tRNAs that did not previously contain this modified base. The
amount o f queuosine-containingtRNA will, therefore, be inverselyproportionalto the signal obtained. This
method requires extensive purification of the tRNA fraction from samples, but has been widely used to
measure the levels o f queuosine in biopsy tissues (40-43} organ tissue lysates (40,43,44) and cell culture
lysates (17,30,45)
Cell culture methods were more recently developed to measure cellular activities pertaining to the
queuosine modification system in vivo. In order to measure the permeabilityof or active transport (“uptake”)
mechanism in cells for the queuine base, a culture o f cells is exposed to radiolabeledqueuine for a period of
time and the amount o f radioactivity taken up by the cells is assessed (30). A modificationof this strategy was
made to measure the amount o f radiolabeledqueuine incorporated into cytoplasmictRNA (46). The treatment
of cells with radiolabeledqueuine is the same in this method as with the uptake assay, however the cytosolic
fraction is filtered to retain any radiolabeledqueuine that has been incorporated into large macromolecules
such as tRNA. A method to measure the salvage of queuosine base from tRNA turnover products is similar to
that of the incorporation assay but involves a pulse-chasetype of experimental design (16). Cell cultures are
pre-treated with queuine-free media for varying lengths of time to produce a queuosine-free population of
tRNAs and to induce any cellular salvage mechanisms for the maintenanceof cytosolic queuine levels. Then,
a 24 hour exposure of the cells to radiolabeled-queuineis performed to fully saturate the tRNAs with the
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radiolabeled-base. Two sets o f cultures are assayed for the ability of the ceils to retain the label in
macromolecularform: one is monitored for the rate o f tRNA turnover (total levels o f radiolabeled-tRNA)by
chasing out the radiolabeledsignal with the addition o f an excess o f unlabeled queuine to the media, while the
other is treated with queuine-free media to determine the ability of the cells to maintain the radiolabel after the
initial incorporation. The procedures for analysis o f the timed samples are identical to that of the
incorporation assay. These cell culture methods are highly sensitive (requiring limited ceil culture samples to
run) and, since these are in vivo assays, represent a method able to measure three facets of queuine metabolism
(uptake, incorporation,and salvage) under relatively realisticand controllable physiological conditions.
Despite the years of biochemical research on the Q base and the queuosine modificationof tRNA, a
deflnitivedescriptionof the mammalian queuosine modification system itself, and in relation to the well
characterizedprokaryoticsystem, has not yet been produced. Unfortunately, the established method for
monitoring queuosine modification levels, RPC-5 HPLC, is obsolete due to lack o f availabilityo f the column
matrix and to natural degradation o f the remaining stock. Therefore, alternative methods such as W-Porex C-4
HPLC and the in vitro and in vivo assays must ae utilized in order to study the queuosine modification system
in biochemical and physiologicalcontexts.
Physiological Research
Although the biochemical function o f and purpose for the Q nucleoside has not yet been established,
there are strong correlations between queuosine levels and phenotypic variations in prokaryotic and eukaryotic
organisms. The abilities o f cells to survive stressed conditions, and undergo differentiationor neoplastic
transformationhave been shown to be indicativeof and potentially caused by the presence or absence o f
queuosine-modifiedtRNA.
Studies with a mutant E. coli strain containinga null mutation for the TGTase enzyme suggested that
queuosine-modifiedtRNA protects the organism from stress invoked by suboptimal growth conditions (47)
and is necessary for the proper expression o f nitrate reductase and an increased amount of b-type cytochromes
under anaerobic conditions (48). This modification appears to allow these eubacterial cells to recover quickly
from environmental strains to resume normal growth patterns. Eukaryotic D. discoideum, though able to grow
in the absenceof queuine, is not able to differentiateaftereithera nutritional or metabolic stress without a
source of this base (49). These queuine deficient cells exhibit lower levels o f lactate dehydrogenase (an
anoxic stress protein) and the appearance o f a novel cytochrome b with an absorbance maximum at 559 nm
(50-52) However, with the addition o f queuine to the culture media, the cells rapidly grow in size and
number and are able to differentiate into stalk cells and spores. Thus, queuosine-modifiedtRNA may be
involved with management of nutritional and oxidative stress in both prokaryotic and eukaryotic cells.
Cellular and clinical research has generally focused on establishingand strengtheningthe correlation
between Q-modification levels and development, differentiation,and carcinogenesis in more complex
eukaryotic organisms. In cells o f plants, insects, and mammals a motifhas been described noting the existence
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o f low levels o f Q-modified tRNAs in embryonic and undifferentiatedtissues with a shift towards complete Qmodificadon in mature, differendateddssues (53,54) In A. castellanii, vegetative cells (trophozoites)contain
significantly lower levels of queuosine-modifiedtRNA than mature cysts (55). In D. meianogaster, the levels
o f queuosine-modifiedtRNAs increase dramatically in the first week after “birth” from non-existent to
complete modification, but the rate o f modification varies with genotypic strain and diet (56,57)l The same
pattern is observed during development in the rat, with maximal queuosine-modificationlevels plateauing at
approximately 5 months post-birth(58). Human placental tissue has been shown to be deficient in this
modificationdespite the availabilityo f large amounts o f free queuine within neighboringamniotic fluid (59),
but normal, mature human tissue is completely modified with respect to Q (60). Thus, the level o f queuosinemodified tRNA may be indicative o f the developmental stage o f an organism.
In 1980, a study was initiated to determine the effect o f a “queuine-fred’ diet on conventional and
germ-free mice (6 IX It was discovered that the formation o f queuosine-modifiedtRNA did require the
absorption of the dietary nutrient queuine, in that after one year the queuine-starvedmice became entirely
deficient in the queuosinemodification(29,61X These animals appeared to be physiologicallynormal,
although unchallengedby foreign immunogens. Thus, it was suggested that queuosine is not necessary for
development, it may only be an artifact. However, it was discovered that, even after 4 weeks o f the queuinefree diet, the mice retained 100% o f queuosine in tRNA*sp and tRNAtyr, as well as 88% of the queuosine in
tRNAh“ and 85% o f tRNA*“ <6l). It has since been observed that tRNA“p maintains the modification the
longest of all the isoacceptors(37X Therefore, it is likely that the mice maintained very high levels of the
queuosine modification throughouttheir formative weeks, significantlydecreasing in the levels of the
modification only after the cells became mature and static. Thus, the queuine-free diet study does not appear
to rule out an effect for queuosine-modifiedtRNA in developing mouse embryos—particularlywith
information arising from studies involving cellular differentiationevents both in situ and in cultured cells.
The differentiationoftwo organisms, D. discoideum and the topminnow, exhibit a dramatic increase
in the levels of the queuosine modification from the onset of developments sporulation in the slime mold,
and formation of the melanophoricsystem in this fish (62,63) Without exposures queuine, the pleuripotent
cells fail to differentiateand the organisms become senescentor die.
Cell culture studies examining differentiationpatteras o f mammalian cell-lines have
shown a correlation o f a rise in queuosine modification levels with chemically-induceddifferentiationevents.
While dimethylsulfoxide-inducederythroiddifferentiationof murine erythroleukemiacells occurs with an
early decrease in the level of queuosine-modifiedtRNAs, the actual phenotypic change event concludes with a
concomitant rise in the modification level during the late phases o f differentiation^,65) This experiment
was repeated by another research group, this time with the use of multiple differentiation induction agents
(66 ). Regardless o f the agent added, a sharp increase in the level of the queuosine modification always
preceded the final differentiationof these cells.
Additionally, the study of the differentiationof erythroleukemiacells was performed using a human
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cell-line with several differentiationagents known to exhibit varying difTerentiation-inductioncapabilities
(67). The use of 5-azacytidineonly weakly effected the cells, causing a minor slowing in cell growth and no
change in queuosine levels. Exposure to hemin induced a reversible differentiation event that was quickly
reversed with removal o f the agent by dialysis, and only a transient increase in queuosine-modifiedtRNA was
observed. Sodium butyrate exposure caused a more stable differentiationevent that required forty eight hours
of dialysis for reversal. The initial differentiationcorrelated well with an early increase in the levels o f the
queuosinemodificationwithaconcomitantdecreaseafterthe long-term removal o f the agent 1-{J-Darabinofuranosylcytosinewas exposed to the cultures to induce an ineversibledifferentiationevent in the
cells. The level of queuosine-containingtRNA increased immediatelyand was maintained when growth
became inhibited. These studies firmly establish the linkage between an increase in the level o f queuosinemodified tRNA and the phenotypic alteration toward a more differentiated state.
Unlike the strong evidence o f the reactionary increase in queuosine levels during chemicallyinduced differentiation, there is some dispute about the effect of exposure o f cell cultures to high levels of
queuine. In studies utilizing the HeLa cultured human cervical carcinoma cell-line, the effect o f
supplementary exogenous queuine appeared to vary widely with regard to oxidative state of the cells from
enhancing growth rate to blocking growth altogether (68,69). In specific leukemic and carcinomacell-Iines
and under certain conditions, queuine was shown to prevent differentiationand increase the likelihood of
proliferation. However the addition o f queuine to other cultured cell-lines has shown strong anti-proliferative
potential (70-72} During the early stages o f chemical transfbrmationofChinese hamster embryo cells a
decrease in the level o f queuosine-modifiedtRNA was observed (73} Both the rapid growth seen during the
transformation and the decrease in modification levels were reversed with the exposure of these cells to excess
queuine added to the growth media. In addition, the rapid growth rate of neoplastic cells placed under the skin
of a nude mouse was effectively blocked by the subcutaneousadditionofa large dose of queuine (28,29}
Studies involving phorbolester-inducedtransformadonof normal human fibroblasts identified a
transientdecreaseinqueuosinelevelsjustbeforeaS-to 10-fold increase in saturation density (74} With
prolonged exposure o f phorbol esters to these cultures, an increase in queuosine modification level was shown
to precede a decrease in saturation density. The quantity of queuosine-modifiedtRNAs were comparableto
those in “normal" cultures that had not been exposed to phorbol esters. Simultaneous treatment o f cultures
with both phorbol esters and additional exogenous queuine prevented the increase in cell growth.
A major facet o f the neoplastic transformation(retrograde-differentiation)of cells involves the
acquisition of anchorage-independentstatus. Thus, the ability o f a cell-line to overcome cell density
influences in its growth is a major step in the promotion of cancer. Two-stage initiation-promotion
experiments for the transfbrmationof Chinese hamster embryo cell cultures were undertaken to evaluate the
effectivenessof the queuine analogue 7-methylguanineto promote transformation(75). 7-methylguaninewas
able to increase the formation of type III foci and anchorage-independentgrowth, thus functioning as a tumor
promoter. Since this chemical serves as an inhibitor of the queuine-incorporationenzyme TGRase (76), it was
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suggested that the queuosinemodificationserves as a suppressorof the promotion stage of carcinogenesis.
Additional studies with phorbol ester-inducedtransformationofthe Chinese hamster embryo cells showed a
decrease in the levels of the queuosineinodificationin the early stages of their transformation effects (73).
The addition o f excess exogenous queuine to the culture media resulted in both an increase in queuosine
modification levels and the reattainmentofthe anchorage-dependentphenotype.
It has long been known that cellular transformationcan be induced in cultured ceils when exposed to
methylated purines and other purine analogues (77,78). In tissue culture studies, transformationof Chinese
hamster embryo cells (75,79) and human fibroblasts(30,74,80) have been induced by exposure to either a
classical phorbol ester tumor promoter or the methylated purine 7-methylguanine. These agents both appeared
to promote a reduction o f Q-modification levels in the course o f their transformationeffects.
Many of the studies mentioned with regard to differentiationand transformation and their correlation
with fluctuating queuosine levels involve the treatment of cultured cells with phorbol ester tumor promoters.
Phorbol esters are known to directly bind to and hyper-activateprotein kinase C (PKC), an important
regulatory enzyme in several cellularsignaltransductioncascades(8l,82} Short-term exposure studies
exploiting the ability o f phorbol esters to activate PKC have been used as the classical ceil culture method for
the analysis o f PKC-directedeffects (83). However, under conditions of chronic exposure the cell’s entire
supply o f endogenous PKC is activated. Thispermitstherapidcataiyticdegradationoftheenzymewhich
effectively ends the “burst’ o f metabolic activation induced by the phosphorylationof PKC’s target proteins
(84). Chronic exposure to phorbol esters actually decreases the activity of this enzyme. This deactivation
mechanism has been evolutionarilydevelopedas a feedback-controlloop for PKC, which plays an important
role in cellularsignal transductionpathways. The idiosyncrasyofthis differential effect on PKC by a single
compound has since been exploited 1) in experimentationto more strongly identify a PKC-catalyzed
regulatory mechanism in certain cellular processes and 2) in explanationsof why phorbol ester modulation of
PKC activity has been correlated with both differentiationand retrograde differentiationevents.
As mentioned previously, phosphorylationcontrol mechanisms for the regulation of gene expression
patterns have been strongly tied to phenotypic change events in many mammalian organisms. PKC, in
particular, is an importantregulatory switch in differentiationand neoplastic transformationof many cell types
(85). This enzyme is directly tied to a large number of key metabolic processes within the cell by direct
phosphorylationand activation or inhibitionof the target’s biological activity. PKC’s ability to influence
phenotypic alterations have been used to explain the effect o f phorbol esters on cells, since it was discovered
that these compounds directly hyper-activate PKC. Thus, if control of the queuosine modification system can
be tied to PKC regulation, as suggested in a few studies, it would link tRNA metabolism and it’s function to a
list o f other molecular events known to occur in the signal transduction pathway's control of gene expression
and tumor promotion.
Abnormally low queuosine modification levels in tRNA have been strongly associated with tumor
promotion and carcinogenicity(neoplastic transformation,a.k.a. retrograde-differentiationjboth in vivo and in
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situ. Transfer RNA isolated from neoplastic tissues and transformed cel 1-lines is queuosine-hypomodifiedto
various degrees generally corTespondingto the severity of the disease (38,60,86). In situ studies on multiple
human tumor biopsies have shown a strong correlation between the loss of Q-modificationand the progression
and aggression o f neoplasticdisease. The degree o f hypomodificationhas been used to develop diagnostic
tests for staging o f human neoplasticdisease in lymphomas and leukemias(40X and in lung (4IX ovarian (42)
and brain (43) solid tumors. Explicit levels o f decreasingqueuosine in these cancerous tissues have been
shown to directly correlate to increased aggression o f the associated tumor’s growth and metastasis as
determined by histopathologicalgrading.
Over the last ten years, physiological research has documented many cases describing abnormally
low levels ofthequeuosinemodification in undifferentiatedand neoplastic cells. While addition o f queuine
base to culture media appears to induce differentiationand decrease growth rate in transformed cells, it also
appears to reverse the transformation induced by chronic exposure o f cells to phorbol esters. In addition, it
has been suggested that the queuosine modification system might be in some way induced by PKC-catalyzed
phosphorylation. PKC has been recognized as being adversely effected in many forms of transformed cells
(85). Thus, PKC-modulationofthe queuosine modification system might be deregulated in these cells,
causing a cellular deficiency in the productionof properly modified tRNA populations.
Each o f the three steps o f the queuosine modification system (cellular uptake o f the free base,
incorporationofqueuine into tRNA, and salvage o f the nucleoside) and modulation o f their activity by PKC
are all potential sites for deficienciesthat can occur in neoplasticcells. These are likely to vary based on the
origin of the tumor and may even involve a multiple lesion scheme that is often observed in cancers.
However, only one queuosinedeficient cell-line has so far been studied with respect to the actual
malfunctioningstep in the queuosine modification scheme (87). Thus, the likelihood of breakdown for any
one or more of the steps of the queuosine modificationsystem has yet to be determined. Also, a direct, or
even indirect, causal relationship between queuine and cancer has not yet been established because o f the lack
of knowledge concerning the modified base’s natural biological function and purpose.
Statement and Significance of Thesis Research
There have not yet been any attempts to describe the mammalian queuosine modification system in
depth and only a few to mechanisticallyexplain the effect of this modified nucleotide on cellular physiology.
Thus, a global hypothesis describing the biological function of and purpose for the Q nucleotide has not yet
been accepted.
To establish the foundations for a theory describing the reason for Q’s existence, several preliminary
studies must be completed. 1) A descriptionof the queuosine modificationsystem, in its entirety, in
prokaryotic and eukaryotic hosts must be established. 2) The interrelatednessor connectivity o f the queuosine
modificationsystem with other physiological processes within the cell must be ascertained. 3) Actual sites for
queuosine modification system breakdown in abnormal cells must be demonstrated. 4) A plausible function
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of the queuosine modification system with regard to the stability o f macromoIecularstructures(tRNA) and to
effect on interactionswithin macromolecularcomplexes must be postulated and supported.
All methods utilized in the research described in this treatise are described in Chapter 2 with
literature reviews of the protocols and information concemingthe experimental design strategies.
While the prokaryoticqueuosine modificationsystem in £L colihas been well described (23), various
parts o f the eukaryotic system have been studied in many different organisms and in cell cultures. However,
all of the components o f a single eukaryotic organism’s queuosine modification system have not yet been
described in a single picture. Chapter 3 o f this treatise describes methods used to study the eukaryotic
queuosine modificationsystem. These techniques include in vivo assays that are able to dissect the uptake,
incorporation, and salvage steps within the system in a cell culture model system and an in vitro assay to
measure the presence o f the queuosine incorporation enzyme, TGRase, which is useful for protein isolation
and characterizationprotocols. Cell culture studies were performed on normal human fibroblasts to measure
the abilities of these cells to perform the uptake, incorporation, and salvage components that comprise the
queuosine modificationsystem. To further examine the incorporation step of this system, mammalian
incorporation enzymes from mouse, rat, and human liver were isolated and characterized. Finally, the
eukaryotic and previously characterizedprokaryoticqueuosine modification systems were compared in order
to determine an evolutionaryrelationship. This information is important to lay the framework for the choice
of proper model systems to be used in human disease etiology studies in the future.
In the course o f attempting to study queuine uptake in cultured human cells and to isolate the
mammalian queuosine incorporation enzyme it appeared that these systems may be modulated by phorbol
ester tumor promoters and protein phosphatase inhibitors, respectively. With the known linkage between
phorbol esters and PKC, and phosphatase inhibitors with an antagonist enzyme for PKC, studies were
undertaken to determine if this key secondary messenger system is involved in regulating the modificationof
tRNA with queuine. Chapter4 describes in vivo uptake, incorporation, and salvage assays performed on
human cell cultures in the presence o f multiple kinase and phosphatase modulators. In addition, protein
isolation protocols were altered and in vitro assays were performed with the purified mammalian incorporation
enzymes to assess action o f PKC directly on this enzyme. Thus, the interactionof the queuosine modification
system with PKC, a major cellular regulatory switch, would indicate connectivity o f the queuosine
modificationsystem with other important physiological processes.
It is well known that the queuosine modification is deficient in neoplastic cells, and that progression
of cancer is strongly correlated with staged decreases in modification levels. Chapter 5 describes in vivo cell
culture studies performed on human colon adenocarcinoma(HxGC,) and breast adenocarcinoma(MCF-7)
cel 1-lines to determine the source of their queuosine deficiencies which measure at 100% and 50-60%,
respectively. Uptake, incorporation,and salvage, as well as PKC-modulationassays were performed. These
results would indicate if a single step or multiple lesions of the queuosine modification system are the cause of
the deficiencies in these cell-lines. This information could have implicationson the use of queuosine
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modification levels for the designation of a tumor’s origin and may be important in any future diagnostic
protocol or treatment schemes that might be proposed.
Despite the cellular and clinical evidence o f the importance o f the queuosine modification, there has
not yet been a hypothesis suggested which links the presence o f queuosine to a function that could cause the
observed correlations with wide phenotypic effects, such as differentiationand neoplastic transformation.
Chapter6 describes the results ofcomputationalchemistry studies which attempt to explain potential effects of
the queuosine modification on the rate and efficiency o f protein translation by examining the effect o f this
modified base on the structure and dynamics o f the tRNA. With the advent of molecularmodeling techniques
and comparison to previouslypublishedexperimentalresults, structural studies o f the queuosine base itself, of
tRNA“p with and without the queuosine modification, and in complexation studies within a A-site
tRNA/mRNA/P-sitetRNA ribosomal model were performed. The results were used to assess queuosine’s
effect on tRNA structure and function leading to an explanation o f queuosine’s possible role in translational
control of gene expression.
In the conclusion of this document, codon bias patterns for specific mRNA sequences were analyzed
in orderto correlate the structural effects of the queuosine-modifiedversus unmodified complex with the
sequence of certain gene classes (housekeepingand oncodevelopment-related). Finally, a mechanism for the
queuosine modificationsystem with regard to the regulation o f gene expression is proposed. This hypothesis
attempts to mechanisticallyillustratethe role o f the queuosine modification in normal cellularphysiologyand
explain the effect of the lack of this base on development, differentiationand neoplastic transformation.
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CHAPTER TWO
EXPERIMENTAL DESIGN AND METHODS
Introduction
This chapter describes the use of several in vivo cell culture methods and an in vitro enzymatic
assay to study the queuosine modification system. (A third technique based on high or medium pressure
reverse phase liquid chromatography, is discussed in the Appendix of this document). The protocols have
been optimized for the study of the system in mammalian tissues and cells. The in vivo studies utilized
human foreskin fibroblast cultures to represent a “normal” mammalian tissue or human colon or breast
adenocarcinoma cultures to represent neoplastic cells in assays for queuine uptake, incorporation, and
salvage. In vitro assays were used to purify and further characterize the queuine incorporation enzymes
from several mammalian sources (mouse, rat, and human liver tissues). This protein catalyzes the actual
formation of the queuosine modification in what may be considered as the essential step in the synthesis of
this modification in eukaryotes.
In addition, modified in vivo protocols were performed to identify the involvement o f PKC in the
regulation of queuine uptake, incorporation into tRNA, and salvage mechanisms. These involved exposure
of the human Fibroblast cell cultures to PKC activators (TPA and PDD) and inhibitors (H-7, staurosporine,
sphingosine, and calphostin C) and phosphatase inhibitors (okadaic acid and calyculin A). Protein
phosphatase activators are not commercially available, thus were not used in this study. Chronic exposure
of cell cultures to TPA is known to induce proteolytic degradation and down-regulation of PKC activity.
This phenomenon was exploited to verify the short-term exposure experiments by correlating the PKC and
phosphatase inhibitor results and scrutinizing the PKC activator (TPA) results. PKC-modulation studies
were performed in both cell cultures and in modified in vitro assays with semi-purified and purified
queuine incorporation enzyme samples.
All human cell-lines and mammalian tissues were handled in accordance with Old Dominion
University’s policy regarding bloodbome pathogens.
In the final section of this chapter, computational chemistry methods for structure and property
determination are described for guanosine, queuosine-analogue, and queuosine nucleotides. In addition,
these nucleotides are studied for their effect on the structure and energetics of tRNA“p anticodon stem-loop
molecules; as part o f tRNAs in complexation with a translating mRNA; and located within an A-site
tRNA/mRNA/P-site tRNA complex. The nucleotide analysis is based on a semi-empirical charge
assessment and geometry optimization algorithm. Koilman all-atom force field parameters were employed
for energy minimization and molecular dynamics simulation protocols utilized in tRNA anticodon
stem/loop structure, tRNA/mRNA interactions, and tRNA/mRNA/tRNA complexations. In addition, a
description of the methods used for gene transcript sequence analysis for codon bias patterns is outlined.
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Cell Culture Methods
Eukaryotic cells have been shown to require the primary substrate for queuosine synthesis, the
queuine base, to be imported into individual cells through a specific uptake mechanism. Uptake o f queuine
at the cellular level has been studied using cell culture techniques with mammalian cell-lines. These cells
acquire the queuine base horn serum that supplements the nutrient media (88). In 1985, queuine uptake
studies were performed with diploid human fibroblasts using a tritritiated queuine analogue to observe and
measure queuine membrane transport (30). The cells were exposed to the radiolabeled nucleotide for a
given period of time, then the culture was washed extensively to remove extracellular label. The cells were
lysed and the internal components solubilized with ethanol. Finally, a liquid scintillation analysis of die
radioactivity contained within this lysate indicated the amount o f radiolabeled material transported into the
cell.
An in vivo method for the investigation o f radiolabeled queuine incorporation into tRNAs in
cultured cells was developed by Muralidhar et al. in 1988 (46). The cells were exposed to radiolabeled
queuine for a given period of time, then the culture was washed extensively to remove extracellular label.
The cells were lysed and the internal components solubilized by incubation in a detergent-based lysis
buffer. Then, an acid precipitation step was performed on the solubilized cytosolic solution in order to
precipitate the large nucleotide component of the cytosol. A filter binding step was executed to remove the
small molecular weight compounds, including unincorporated radiolabeled queuine base. Finally, the filter
was analyzed by liquid scintillation. Using this method, the levels o f intracellular queuine incorporation
activity were able to be measured in a few cell lines.
Using a monkey kidney cultured cell-line, the maintenance of queuosine levels during queuine
starvation has been assessed by a radiolabeled queuine pulse-chase methodology (17,31). This protocol
involved the deprivation of queuine by treatment o f cells with charcoal-stripped media, then saturation of
cellular tRNAs with radiolabeled queuine by pre-incubation for 24 hours just prior to the initiation o f the
study. Then, cultures o f cells were either maintained in charcoal-stripped media (to measure the ability of
the cells to maintain the label—salvage the queuine base and reuse it in formation o f the queuosine
modification), or were exposed to media containing high levels of unlabeled queuine to flush out the label
(which would indicate the turnover rate of the tRNAs specifically in the cells being studied). The final
steps of the assay were similar to that utilized for the in vivo queuine incorporation assays.
Materials
The HFF cell-line was established from circumcision tissue by established methods (74). The
HxGC3 human colon adenocarcinoma cell-line was obtained as a gift from Dr. Jon R. Katze (University of
Tennessee, Memphis), and the MCF-7 human breast adenocarcinoma cell-line was obtained from the
American Type Culture Collection (Bethesda, MD). Cell cultures were established and maintained in
either 10% neonatal calf serum supplemented minimum essential media (HFF and HxGC3 cell-lines) or
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10% neonatal calf serum supplemented Delbecco's modified eagle media (MCF-7 cell-line) (GIBCO,
Grand rsland NY). The DNA methylase inhibitor, 5-azacytidine (S-azaC), employed in the generation of
the 5-azaC-treated HxGC3 cultures was purchased from Sigma Chemical Company (St. Louis, MO). 5azaC-treated HxGQ cultures were exposed to S pM 5-azaC for 24 hours, then incubated with minimal
essential media containing 10% neonatal calf serum until confluence. Queuine-deficient cultures for the
incorporation and salvage studies were generated by growing the cells in media supplemented with 10%
charcoal-stripped calf serum (74), for at least three passages before the studies were initiated.
The radiolabeled reduced analog o f queuine, tritiated dOtydroqueuine (rQT3), was a gift from Dr.
Ronald W. Trewyn (Kansas State University). The addition o f a radiolabeled analog o f queuine, tritritiated
dihydroqueuine (rQT3), to cell cultures was employed to monitor cellular uptake of this base, it’s
incorporation into tRNA, or salvage o f the incorporated base during tRNA turn-over. Two lots of
lyophilized rQT3 were dissolved in water to yield stocks concentration o f 1 mM with specific activities of
0.19 pCi/pg and 3 pCi/pmol and stored at -20°C.
Studies involving protein kinase and protein phosphatase modulators were performed after
treatment as specified. They were all received in powder form and dissolved in acetone at 1,000 times the
working concentration to form stock solutions. cGMP- and cAMP-dependent kinase, and PKC activators
were obtained from Sigma Chemical Company (St. Louis, MO). The cGMP and cAMP analogues
(dibutyryl and 8-bromo) were applied to cell cultures at a concentration o f 10 pM. 12-tetradecanoyl
phorbol-13-acetate (TPA) and phorbol-12,13-didecanoate (PDD) were used at concentrations of 20 nM.
The PKC inhibitors sphingosine (used at 20 pM), staurosporine (used at 100 nM), and calphostin C (used
at 100 nM) were purchased from Biomol Research Laboratories o f Plymouth Meeting, PA. The PKC
inhibitor H-7 (l-[5-isoquinoline sulfonyl]-2-methyl piperazine dihydrochloride) (utilized at 10 pM) was
obtained from Seikagaku America, Inc. (S t Petersburg, FL). The protein phosphatase inhibitors okadaic
acid and calyculin A (utilized at varying nM concentrations) were purchased from Biomol Research
Laboratories (Plymouth Meeting, PA).
All culture work was performed in sterile polystyrene plasticware from Coming (Coming, NY).
rQT3 Uptake Assays
Cells were subcultured into 35 mm dishes at a density o f 4xl0 4 cells/mL in a final volume o f 2
mL of media containing 10% serum. When required, 5-azaC treatment o f HxGC3 cultures was performed
at this point At confluence, the media was decanted from the cells and 1 mL of media supplemented with
10% calf serum and 100 nM rQT3 (0.10 pCi) was added. In phosphorylation modulation studies, uptake of
rQT3 was compared between untreated control cultures and with cultures exposed to PKC and protein
phosphatase modulating agents at concentrations listed above. The modulating agents were added to the
culture at the same time as the rQT3 for short-term exposure studies or for 7 days prior to the introduction
of rQT3 for long-term or chronic exposure studies. Incubations for rQT3 uptake analysis were conducted at
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37°C for up to 6 hours and terminated by rinsing the ceil monolayer four times with 5 mL of ice-cold
phosphate buffered saline. Then, the cells were lysed with 1.0 mL of 95% ethanol for five minutes. The
lysate was aspirated and radioactivity determined by liquid scintillation. The amount of radioactivity in the
cell lysate, normalized to the number of picomoles o f rQT3 per 10s cells, was reflective o f rQT3 uptake into
the cultured cells.
rQT} Incorporation Assays
Prior to the initiation o f the incorporation assays, the generation o f queuosine-deficient cultures
was required to form queuosine-deficient tRNAs in order to effectively assess cellular TGRase activity.
These cultures were produced by growing the cells in media supplemented with 10% charcoal-stripped calf
serum for at least three passages before the start o f the experiment. Cells were then subcultured into 35
mm dishes at a density of 4xl0 4 cells/mL in a final volume of 2 mL o f media containing 10% charcoalstripped neonatal calf serum. When required, 5-azaC treatment o f HxGCj cultures was performed at this
point At confluence, the media was decanted from the cells and 1 mL o f media supplemented with 10%
charcoal-stripped neonatal calf serum and 100 nM rQT3 (0.10 pCi) was added. Incorporation o f rQT3 into
the acid precipitable fraction (tRNA) of various control cultures and those treated with PKC and protein
phosphatase modulating agents were compared in phosphorylation modulation studies. PKC and protein
phosphatase modulators were added to the cultures either at the same time as the rQT3 (short-term
exposures) or 7 days prior to the rQT3 addition (long-term or chronic exposures) at concentrations listed
above. Incubations for all rQT3 incorporation analyses were conducted at 37°C for timed intervals of up to
24 hours. Incubations were terminated by rinsing the cell monolayer four times with 5 mL o f ice-cold
phosphate buffered saline, followed by disruption o f the cells with 0.5 mL of lysis buffer (10 mM Tris (pH
7.5), 0.01% SDS, 0.01% Triton X-100) for ten minutes at room temperature. The lysate was transferred to
a small test tube, treated with 0.25 mL of ice-cold 30% trichloroacetic acid (TCA), and placed on ice for
ten minutes. The resulting precipitate was collected by vacuum filtration through GFA 2.4 cm glass fiber
filter disks. Each disk was thoroughly rinsed with 40 mL o f ice-cold 5% TCA and a final rinse o f 5 mL icecold 95% ethanol. The filters were analyzed for bound radioactivity by liquid scintillation. The amount of
radioactivity on the filter disks, normalized to number o f picomoles o f rQT3 per 105 cells, was reflective of
rQT3 incorporation into the acid precipitable fraction (tRNA) from cultured cells.
rQT} Salvage
Fibroblasts and MCF-7 cells were subcultured into 25 mL culture flasks at a density o f IxIO4
celis/mL in a final volume of 5 mL o f media containing 10% calf serum. When the cells reached
confluence, the media was decanted and 5 mL o f media supplemented with 10% charcoal-stripped calf
serum for one day, one week, or three weeks to induce a possible latent queuine salvage mechanism.
Before the beginning of the salvage study, 100 nM rQT3 (0.10 pCi) was added to the cultures ant then
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incubated for 24 hours to fully saturate the tRNAs with radiolabeled queuine. At the beginning o f the
study, the cell monolayer was washed 4 times with sterile phosphate-buffered saline and then incubated in
either media containing 10% serum supplemented with 0.10 A ^ units unlabeled queuine (89) or media
supplemented with 10% charcoal-stripped serum and, if indicated, PKC and phosphatase modulators at
conditions listed above. Incubations for rQT3 salvage analysis were conducted at 37°C at 24 hour intervals
for up to 4 days. Incubations were terminated by rinsing the cell monolayer four times with 5 mL of icecold phosphate buffered saline, followed by disruption of the cells with 0.5 mL o f lysis buffer (10 mM Tris
(pH 7.5), 0.01% SDS, 0.01% Triton X-100) for ten minutes at room temperature. The lysate was
transferred to a small test tube and treated with 0.25 mL of ice-cold 30% trichloroacetic acid (TCA), and
placed on ice for ten minutes. The resulting precipitate was collected by vacuum aspiration through GFA
2.4 cm glass fiber filter disks, and then thoroughly rinsed with 40 mL o f ice-cold 5% TCA and a final rinse
of 5 mL ice-cold 9S% ethanol. The filters were analyzed for bound radioactivity by liquid scintillation.
The level of radioactivity on the filter disks was reflective of the amount o f remaining rQT3 in the acid
precipitable fraction (tRNA) from cultured fibroblast cells over time.
Methods for the Isolation and Characterization of the Mammalian Liver tRNA:Guanine
Ribosyltransferase
In an adaptation of an established in vitro method for the quantification of the queuosine
modification in tRNAs, an enzymatic assay for the incorporation of queuine into tRNA is utilized to
monitor the purification process of the queuine incorporation enzyme (tRNA-guanine ribosyltransferase;
TGRase). This assay is a variation of the one developed by Okada, et ai. in 1978 using the £ coli TGTase
enzyme (38). This method has been used to measure the increasing levels o f queuosine in tRNA during
differentiation and development in different organisms (55,90,91), as well as to measure the decreasing
levels of queuosine in tRNA during progressive stages o f neoplastic transformation and metastatic
progression (40-43).
In the in vitro enzymatic assay, a completely unmodified tRNA population with respect to
queuosine is used as a substrate for the measurement o f tritiated guanine or queuine incorporation
(TGRase) activity of a sample. Since the yeast organisms are known to not synthesize queuosine nor
utilize queuine (10), and since purified brewer's yeast tRNA is commercially available, this was the
substrate of choice for the assay of TGRase activity. In the presence of the enzyme, incorporated
radiolabeled queuine or guanine substrate in tRNA is separated from the free nucleotidyl bases by acid
precipitation of the larger tRNA nucleic acid and filtration to remove the low molecular weight free
queuine base. Since the modification of tRNA with queuosine is irreversible, the ability of the enzyme to
incorporate tritiated guanine or queuine into tRNA is an inverse measure of the levels of queuosinemodified tRNA in a given sample.
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Materials
Yeast tRNA and PKC purified from rat brain were purchased from Boehringer Mannheim
(Atlanta, GA). ATP (biotech grade) was purchased from Fisher Scientific (Indianapolis, IN).
Staurosporine and sphingosine were purchased from Biomol Research Laboratories (Plymouth Meeting,
PA). H-7 (1-[5-isoquinoline sulfonyl]-2-methyl piperazine dihydrochloride) was obtained from Seikagaku
America, Inc. (S t Petersburg, FL). 3H-guanine (1 mCi, 168 Ci/mmol) and [y-32P]ATP (250 pCi, 3000
Ci/mmol) were purchased from Amersham Corporation (Arlington Heights, IL). The Silver Stain kit was
purchased from BioRad, Inc. (Hercules, CA). All other chemicals or reagents were purchased from Sigma
Chemical Company (S t Louis, MO).
Buffers
Homogenization buffo' (20 mM Tris-Cl [pH 7.5], 1 mM MgClj, 1.0 mM EDTA, 0.5 mM
dithiothreitol, 10% glycerol, 0.05% Triton X-100, and 10 pg/mL o f the following protease inhibitors;
aprotinin, calpain inhibitor I, chymostatin, leupeptin, pepstatin, phenylmethylsulfonylfluoride), Phosphate
buffer (20 mM sodium phosphate [pH 7.2], 0J mM dithiothreitol, 1 mM MgClj, and 10% glycerol),
Storage buffer (20 mM Tris-Cl [pH 7.5], 1 mM MgCl^ 0.5 mM dithiothreitol, 1 mM EDTA, and 50%
glycerol), Mono-Q buffer (10 mM Tris-Cl [pH 7.5], 1 mM MgCl^ and 0.5 mM dithiothreitol), Reaction
buffer (10 mM Tris-Cl [pH 7.5], 35 mM KCL 1 mM MgCl^ 0.5 mM dithiothreitol), Denaturing Sample
buffer (10 mM Tris-Cl [pH 7.4], 0.5% SDS, 20% glycerol, and 0.01% bromophenol blue), and Non
denaturing Sample buffer {10 mM Tris-Cl [pH 7.4], 20% glycerol, and 0.01% bromophenol blue).
Isolation o f TGRase From Mammalian Liver
The purification o f TGRase was performed by adaptation o f previously published methods (44).
Livers (42.5 g) were collected from five adult Sprague-Dawley rats that were sacrificed by cervical
dislocation. 50.0 g liver tissue was obtained from adult BALB/c mice that had also been sacrificed by
cervical dislocation. Approximately 43.0 g of human liver was obtained from autopsy o f a 62 year old
man who died of cardiac arrest. The fresh or flash-frozen livers were rinsed in ice-cold Homogenization
buffer. The tissue was homogenized in 100 mL of cold buffer first by Waring blender and then by Dounce
homogenizer, filtered through two layers of sterile gauze, and centrifuged at 10,000 x g for thirty minutes
at 4°C. The resulting supernatant was centrifuged at 100,000 x g for one hour at 4°C. The supernatant was
decanted through sterile gauze, brought to a final volume o f300 mL in Homogenization buffer, and loaded
by gravity feed onto a 13 x 5 cm DE-52 ion exchange column in a 2 liter scintered glass funnel pre
equilibrated with Homogenization buffer. A two liter wash of Homogenization buffer lacking the protease
inhibitors and triton X-100 was drawn through the column by low pressure vacuum using a water-aspirator.
TGRase was eluted from the column with one liter of Homogenization buffer containing 0.2 M KC1.
Protein in the 0.2 M KCI fraction was precipitated by adding ammonium sulfate to a final saturation of
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55%. The solution was stirred on ice for 30 minutes, and then allowed to stand an additional 30 minutes.
The protein precipitate was collected by centrifugation for 20 minutes at 10,000 x g.
The precipitate was redissolved in 25 mL of Phosphate buffer, and dialyzed against 4 liters o f the
buffer overnight at 4°C with at least two changes of buffer. Denatured precipitate in the dialysate was
removed by centrifugation at 10,000 x g for 20 minutes, and the supernatant was collected and applied to a
P-11 phosphocellulose column (2x10 cm) which had been pre-equilibrated at 4°C with Phosphate buffer.
The phosphocellulose column was washed with 100 mL o f Phosphate buffer at a flow rate o f 1.0 mL/min.
The sample was eluted with a 200 mL 0 to 1.0 M KC1 gradient in Phosphate buffer. Fractions (2 mL) were
collected and tested for the capability of 3H-guanine exchange with yeast tRNA. Those fractions that
resulted in 3H-guanine incorporation were judged to contain TGRase activity. The pooled TGRase-active
fractions (10 mL) from the 0.25 to 0.30 M KC1 region of the gradient were either stored at sub-zero
temperatures (-20°C or -70°C), or further purified using a 1 x 10 cm Pharmacia Mono-Q ion exchange
column.
Samples to be stored were dialyzed against storage buffer for at least three hours and then stored
in 1 mL aliquots at either -20°C or -70°C. Samples to be purified further by Mono-Q FPLC ion exchange
chromatography were concentrated to 5 mL in an 50 mL Amicon pressure cell using a YM 10 membrane
(10,000 MWCO) under 40 psi N2 gas. The sample was then diluted to 50 mL with Mono-Q buffer and
reconcentrated to 5 mL.
Five to ten milligrams o f protein (as determined by Bradford assay (92)) in 1.0 mL aliquots o f the
TGRase preparation were injected onto a pre-equilibrated 1 x 10 cm Mono-Q column. The column was
eluted at a flow rate o f 1.0 mL/min with a 100 mL 0 to 0.5 M KC1 linear gradient in Mono-Q buffer. The
fractions collected were assayed for TGRase activity. The protein preparation exhibiting TGRase activity
eluted in the 0.20 to 0.25 M region of the gradient, and corresponded to the major peak of the A2*0 profile
o f the elution gradient The Mono-Q fractions were concentrated to 3.0 mL in an Amicon pressure cell as
before. The 3.0 mL samples were concentrated further using a Centricon 10 concentrator to volumes o f 0.5
mL to 1.0 mL. These preparations were then used as samples in enzyme assays, electrophoresis and
autoradiography, and Superose 6 size-exclusion chromatography.
Reaction Conditionsfo r TGRase Assays
The assay for TGRase activity parallels one described previously(44), and is based on the
enzyme’s ability to reversibly exchange 3H-guanine for guanine in the first position of the anticodon of
yeast tRNA. Yeast tRNA is unique in that it does not contain queuosine(10), therefore it is an excellent
substrate for TGRase. TGRase assays were conducted in a total volume of 0.3 mL Reaction buffer with 20
pM 3H-guanine (1 pCi), 0.1 A260 unit of yeast tRNA (5 pg), and TGRase. Assays were incubated for one
hour at 37°C, terminated by the addition of 100 pL of ice-cold 30% trichloroacetic acid (TCA), and chilled
on ice for 10 minutes. The resulting precipitate was collected by suction filtration through glass fiber
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filters, washed with 45 mL o f ice-cold 5% TCA, and analyzed by liquid scintillation.
Reaction Conditionsfo r PKC Assays
PKC reactions were performed in a total volume of 0J mL Reaction buffer containing I mM
CaCl2, 5.0 pg diolein, 5.0 pg phosphatidyl serine, and 100 pM [y-32P]ATP (1 pCi). Various concentrations
of either histone fraction IV (positive control) or the TGRase preparation and PKC were added, incubated
at 30°C for 30 minutes, and terminated by the addition of 100 pL of ice-cold 30% TCA. The precipitate
was allowed to stand on ice for 10 minutes, collected by suction filtration through glass fiber filters,
washed with 40 mL o f cold 5% TCA and analyzed by liquid scintillation.
Reaction Conditionsfo r the Combined TGRase, PKC and Alkaline Phosphatase Assays
TGRase, PKC, and Alkaline Phosphatase (AP) assays were combined using the aforementioned
assay conditions. Reactions were performed in a total volume o f 0.3 mL o f Reaction buffer containing 1
mM CaCL, 5.0 pg diolein, 5.0 pg phosphatidyl serine, 20 pM 3H-guanine (1 pCi), 100 pM ATP, 0.1 A ^
yeast tRNA (5 pg), and various concentrations o f TGRase, PKC, and/or AP as indicated. The reaction
mixtures were incubated 30°C for 45 minutes. The reaction was terminated and prepared for liquid
scintillation analysis as previously described.
Electrophoretic Analysis
Samples from each stage o f the purification procedure were saved and applied to a denaturing or
non-denaturing polyacrylamide electrophoresis experiment The samples were boiled for five minutes and
allowed to cool to room temperature. The samples were loaded onto parallel 16 x 16 cm SDS- and nondenaturing-PAGE gels prepared by the method o f Laemmli (93). Each gel was run at 50 mA constant
current for approximately 5 hours. The gels were then fixed and silver-stained using the BioRad Silver
Stain kit to reveal banding patterns.
Combination reactions using the TGRase and PKC preparations were performed to assess the
ability of PKC to incorporate 32P from [y- 32P]ATP into TGRase. Reaction conditions were as described
with the PKC assays with the differing reaction mixture samples containing 40 pg histone fraction IV
(positive control), P-l 1 concentrated sample, or 10 pg of Mono-Q fraction samples. The radioactive
reaction mixtures were incubated for 45 minutes at 30°C and terminated by the addition of Denaturing
Sample buffer. The samples were boiled for five minutes and allowed to cool to room temperature. The
samples were loaded onto a 16 x 16 cm SDS-PAGE gel. The gel was run at 50 mA constant current for
approximately 5 hours. The gel was then wrapped in cellophane and exposed to X-ray film at -70°C for 48
hours. The X-ray film was developed by an automated film developer. Finally, the gel was simultaneously
fixed and stained (40% methanol, 10% acetic acid, 0.05% Coomassie blue). Pictures were taken of the gel.
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Size-exclusion Chromatographic Analysis
Weakly and strongly active Mono Q TGRase samples were analyzed by fast protein liquid
chromatography (FPLC) on Pharmacia’s Superose-6 high resolution size exclusion column with an LKB
Bromma GT Chromatography System. Aliquots were initially separated by chromatography under native
conditions in order to determine sizes o f proteins and complexes in the sample. Approximately 800 pg of
each sample was loaded onto a pre-equilibrated 1 x 30 cm Superose-6 column and eluted with 10 mM
Tris-Cl [pH 7.5] at a flow rate o f 0.5 mL/min. Molecular weights of major peaks were compared to
standards on the basis of elution time as detected by UV monitor at 280 tun. Aliquots were then exposed to
guanidinium-HCl to induce disassociation of protein complexes and separated to identify the sizes of
protein monomers in the samples. Samples were incubated in a solution containing 4 M guanidinium-HCl
for 30 minutes at room temperature. Then, the sample was applied to the Superose-6 column and eluted
with 10 mM Tris-CI [pH 7.5] at a flow rate of 0.5 mL/min.
Computational Design and Methods
In the past decade, computational chemistry methods for structure determination have been
developed based on more and more accurate algorithms. In 1984 Harvey et al. began molecular dynamics
simulations of a tRNAphe using a very early Amber force field method (94-96). This was performed only
on “heavy atoms” and required thousands of CPU hours on either a Cray or VAX supercomputer. In 1986,
Nilsson and Karplus (97) modeled the dynamics o f the anticodon stem/loop for tRNA1*' based on an early
version of Karplus’ CHARMM software (98). This greatly decreased the CPU time required and produced
results very similar to Harvey et al.’s computationally expensive experimentation. Both sets of results have
maintained good credibility with the more recent examinations o f the tRNA by experimental methods of
temperature-jump experiments, the deciphering o f X-ray crystallographic structures, and structural
fluctuations based on multi-dimensional NMR interpretations.
In this research, Nilsson and Karplus’ methods have been adapted to a very different workstation
system and software package. However, to incorporate non-standard modified nucleotides within the
tRNA crystal structure model, full charge and geometric assessment of these nucleotides was first
performed. Semi-empirical charge assessment and geometry optimization o f nucleotides were determined
by the most current algorithm that was included with the workstation’s software utilized in this study (AMI
and PM3 algorithm in MOPAC 6.0 software). Since these algorithms are notoriously inaccurate when
assessing the geometry and charge distribution of amide linkages, an “mmok” command activating an
amide correction factor was included in the calculations.
Energy minimization and molecular dynamics simulations of a tRNA anticodon stem-loop, based
on Nilsson and Karplus’ older methods, are performed with the latest commercially available algorithms
including the current version of the Amber force field—the Kollman all-atom force field (version 6.0). All
atoms were treated in these studies and the solvent was implicitly included in the electrostatic calculations
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by use of a constant dielectric constant of 80. There are definite limitations using this new technology:
among these the limited capacity to treat large complex macromolecular structures and the mathematical
models that the experiments are based on. The computational system utilized in this study was not
powerful enough to include solvation and counterion atoms in the simulations, nor to elongate the running
time of the simulations due to limited processing speed and RAM, however the algorithms employed by
this workstation are the most powerful to date when limiting the number o f atoms explicitly treated.
Despite these limitations, these calculations provide reasonable data that have been shown (when used
appropriately) to provide accurate information about the system that is being monitored. When compared
to a very recent publication reporting molecular dynamics simulation data of a similar molecule with
counterions, solvation and much longer length of simulations (99), the results described in this treatise are
virtually identical.
Instrumentation
The computational chemistry experiments performed in this study were performed on a Silicon
Graphics Power Indigo2 workstation (MIPS R8000 processor) with 64 megabytes o f RAM (Mountain
View, CA). The modeling software was a commercially available package from Tripos and Associates,
Inc. (S t Louis, MO) and included Sybyl base (62), Dynamics, Advanced Computation, MOLCAD, and
Biopolymer modules, and MOPAC 6.0.
Nucleotide Analysis
In the initial analysis for determination of wobble base differences effecting tRNA anticodon
decoding abilities, the structure and electrical potentials o f four nucleotides were studied. Guanosine (G) is
the unmodified “traditional” base found at position 34 in the primary transcript o f the four queuosinerelated tRNAs. Guanosine remains in these tRNAs unless enzymatically replaced by queuosine synthetic
mechanisms. 7-deazaguanosine (7-deazaG) is anon-physiologically utilized guanosine analogue and was
included in the study to examine structural effects caused solely by the lack of the N7 o f guanosine which
exists as a C7 in the queuosine modification. 7-aminomethyl-7-deazaguanosine (7-am-7-deazaG) is the
first product in the prokaryotic queuosine synthetic pathway, yet only a minor physiological species. This
residue was included in the study to account for discernible effects o f the charged quaternary amine at the
end of the 7-aminomethyl side chain which also exists in queuosine. Queuosine (Q) is the fully formed
physiological modification found in prokaryotic and eukaryotic species. At physiological pH, the base
contains a charged quaternary amine in the 7-aminomethyl side-chain which terminates in a
cyclopentenediol ring.
The S'-monophosphate nucleotidyl forms G, 7-deazaG, 7-am-7-deazaG, and Q were “sketched”
and submitted to both AMI and PM3 MOPAC (semi-empirical) charge and geometry optimization
protocols using the “mmok” amide correction factor. A charged quaternary amine was utilized in the
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design of the side chains for the Q and 7-am-7-deazaG molecules based the recognized crystal structure of
the Q nucleotide (13). An electron density surface was generated for each molecule and the electrical
potential o f each molecule was mapped onto the corresponding surface.
The three G analogues mentioned above (7-deazaG, 7-am-7-deazaG, and Q) were also
incorporated into the Sybyl software’s RNA monomer dictionary (Kollman All-atom Force Field
parameters, including atom types and charges). These modified ribonudeosides were utilized for further
experimentation using site-directed mutagenesis protocols for replacement o f the G residue in position 34
of tRNA*9 anticodon stem/loop structures.
Anticodon Stem/Loop Analysis
The ability to perform optimal dynamics simulations through explicit solvation or use o f an entire
tRNA molecule is prohibitive. Therefore, a method developed by Nilsson and Karplus for investigation of
the tRNAphc anticodon stem and loop was adapted for use in this study (97). The Nilsson and Karplus
method was originally based on a protocol published by Harvey, Prabhakaran, Mao and McCammon which
studied motions o f bases and lengths o f hydrogen bonds m an intact yeast tRNAphcmolecule (94).
The Sacchromyces cerevisiae transfer RNA*9 crystal structure coordinates (2.8 A resolution) were
obtained from Brookhaven Protein Databank for this study (100,101). Two conformations o f this molecule
were identified in the crystal samples, A- and B-forms, which differ only in the DHU loop region between
two dihydrouridine residues at positions 16 and 20. Wild-type S. cerevisiae tRNAs do not contain the
queuosine modification due to the lack of any definable queuosine modification system in the host
organism (10). Therefore, the yeast crystal structure for the tRNA*9 contains a guanosine residue at
position 34, and was the basis for a software-based mutagenesis protocol to produce anticodon stem/loop
structures o f tRNA*9 containing 7-deazaG, 7-am-7-deazaG, or Q at the wobble position. With exception
of the wobble base, the resulting structures were identical to that o f the original molecule which contained
a G in position 34.
The Nilsson and Karplus method utilized tRNA1** residues 26 through 44 for model computations
which comprise the seven anticodon loop nucleotides and the six base-paired nucleosides o f the stem. In
this study, the modified and unmodified tRNA*9 anticodon stem/loop residues 26 to 44 (identical in both
A- and B-forms) were extracted in order to perform subsequent molecular dynamics simulations. Implicit
aqueous solvation (constant dielectric function of 80) was added to all calculations in order to mimic an
aqueous environment
A steepest descent energy minimization protocol of 1,000 fs was performed on each molecule to
relieve strain inherent in the crystallized structure. The resulting structures were compared with the
original tRNA*9 crystal structure which served as the reference template. The RMS differences in atomic
position varied between 0.072 and 0.092 A; therefore, it was assumed that molecular conformations were
not significantly different before the dynamics run. The dynamics simulation was begun with gentle
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warming o f the system to prevent structural distortion and artifacts. Shake constraints were set for the stem
base pairs between residues 26 to 30 and 40 to 44. The initial velocities and atomic vectors were assigned
and reassigned for each preceding step by Boltzmann distribution. Temperature steps lasting for 100 fs
beginning at 45 K and increasing to 273 K by 25 K intervals were performed and monitored at 5 fs
intervals. A final step o f 100 fs at 298 K. was performed, then a 55 ps constant temperature plateau at 300
K was monitored at 1 ps intervals with rescaling of velocities at 25 fs intervals to enhance the temperature
equilibration.
Macromolecular Complex Analysis
In order to analyze the effects o f queuosine-modified versus unmodified tRNA in interactions
with a neighboring tRNA (codon context) or cognate mRNA codon (codon bias), a model system o f the
tertiary structure for the tRNA/mRNA/tRNA complex needed to be chosen. Two possible conformations
have been described for the placement o f the tRNAs with respect to the mRNA on the ribosome: the
Sundaralingham (S-) form (102) and the Rich (R-) form (103). Lim et al. investigated both the R- and Sform models based on the rigid crystal structure of two yeast tRNA1** molecules with a flexible 6-mer
mRNA in order to study transcript phosphodiester backbone conformations between the two adjacent
aminoacyl- (A-) and peptidyl- (P-) site codons (104). It was proposed that the R-form was the most likely
arrangement on the ribosome due to relatively good agreement with cross-linkage data. MacDonald and
Rein argued that the S-form was more correct due to a design also based on fixed crystal structures o f yeast
tRNA’* ' and tRNA*5*1with a flexible mRNA transcript (105). Prabahakaran and Harvey designed a model
utilizing experimental cross-linkage data that was based on flexible anticodon loops with a fixed helical
mRNA, instead of those parameters mentioned above (106). The results also describe a conformation that
resembles the S-form, however the true ribosomally-bound configuration was suggested to be somewhere
in between the previously described S-forms and this model due to the reliance o f all of these models on
one “fixed1' component in each system.
In 1994 Easterwood, Major, Malhotra and Harvey built a model of the ternary complex
nucleotide-by-nucleotide based on the cross-linkage data and crystal structure constraints for two tRNA1* '
molecules (107). This method did not require a fixed arrangement for either the mRNA or the tRNAs
involved in the complex. The results o f the protocol (the Easterwood structure) were compared with that
of both Lim R- and S-forms for agreement with experimental fluorescent energy transfer data (108,109).
Both the Lim S-form and the Easterwood structure (also an S-form) were closest in agreement with this
information as compared with the Lim R-form. However due to the method of the model design, the
Easterwood form contained less potential conflicts. Subsequently, a three dimensional structure o f the
Escherichia coli ribosome programmed with three tRNA1*0 molecules was described at a resolution o f 18 A
( 110,111). The positions o f the A-, P-, and exit-site tRNAs were determined by high resolution cryoelectron microscopy and molecular modeling “fit” methods. This conformation was described as being
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significantly different than either Lim R- or S- models. In comparisons with the cryoelectron microscopy
structure and the aforementioned computational, the cryoelectron microscopy model and the Easterwood
model constraints were in best agreement with the experimental data. Thus, the Easterwood model was
chosen as the basis of the ternary complex conformation for analysis in this paper.
Macromolecular Complex Analysis: Interaction o f A- and P-site tRNAs (Codon Context)
The Easterwood model for the ternary complex o f A- and P-site tRNAs with 6-mer mRNA was
used to assess the likelihood o f interaction between the anticodon loops. Two o f the largest modified
nucleotides known are Q in position 34 o f tRNA"*1, tRNA”", tRNA1*, and tRNA*^ and wyebutine (Y) at
position 37 in tRNA1*" (existing in the crystal form o f tRNA1*" and utilized in the Easterwood model).
Both of these modifications have been shown to be absent in clinical cases of rapidly growing neoplastic
cells in which protein synthesis levels are increased (45). Therefore, steric interaction between these two
large anticodon modification side-chains, if positioned next to each other on adjacent codons, has been
suggested to have the potential o f effecting the stability o f the A- and P-site tRNAs in the translating
ribosomal complex resulting in altered translational efficiency via codon context effects ( 112).
The Easterwood model’s poly-uridine RNA molecule was adapted to contain a GAU codon at
either the 5’ end (the A-site) or the 3 ’ end (the P-site). The backbone and x torsions were set to mimic that
of the originally derived poly-uridine structure. Finally, a queuosine-modified tRNA”p anticodon
stem/loop structure, as described above, was superimposed to replace either the A-site tRNA1*" or the P-site
tRNA1*" of the Easterwood complex. A steepest descent energy minimization protocol of 1,000 fs was
performed on these complexes to relieve torsional strain and produce reasonable structures for the study.
Then, the two complexes were examined; A-site Q-modified tRNA”*1anticodon stem/loop with P-site Ycontaining tRNA1*", and vice versa. Distances were measured for the closest potentially interacting atoms
for the Y and Q modifications in both complexes.
Macromolecular Complex Analysis: Anticodon-Codon Association at the A-site (Codon Bias)
The ternary Easterwood structure was utilized to develop a model for anticodon/codon interaction
at the modeled A-site to assess the effects o f specific wobble nucleosides on the association of tRNA with
either of the two cognate codons. The original Easterwood 6-mer poly-uridine RNA molecule was mutated
to contain a GALJ or a GAC codon at the 5’ end o f the mRNA (the A-site) and backbone and x torsions
were set to mimic that of the original poly-uridine structure. Finally, individual modified tRNA anticodon
stem/loop structures derived from the site-directed mutagenesis protocol of the G-containing 5. cerevisiae
tRNA<sp crystal structure, as previously described, were superimposed into the A-site of the Easterwood
complex. For this portion of the study, the P-site tRNA1*" was deleted.
Four tRNA“p anticodon stem/loop structures were investigated; G-containing, 7-deazaG-modified,
7-am-7-deazaG-modified, and Q-modified molecules. Each anticodon stem/loop was complexed with
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either of two mRNA models (5’-GACUUU-3’ (GAC-mRNA) or 5’-GAUUUU-3’ (GAU-mRNA)). A
steepest descent energy minimization protocol o f 1,000 fs was performed on each o f these eight complexes
to relieve torsional strain and produce reasonable starting structures for the study. They were compared
and exhibited significant similarity as modeled starting structures (RMS differences o f0.082-0.098). Then,
each complex was subjected to a protocol of 100 fs per step ramping of 25 K increases from 48 K up to
323 K with a constant dielectric function of 80. “Actual” temperatures were monitored and levels for
kinetic energy, potential energy, and total energy were calculated at 5 fs intervals. The results for each step
were examined and when an equilibrium for the “programmed” temperature was approached, calculations
were made for average “actual” temperature, kinetic energy, potential energy, and total energy. As
expected, “actual” versus programmed temperatures averaged per step were shown to be linear with a
correlation coefficient o f0.999 and a slope of 1.000 for all complexes.
Codon Usage Analysis for Growth Control versus Housekeeping Transcripts
Coding sequences for various mammalian growth control and housekeeping genes were acquired
from published reports and manually analyzed for their content of codon triplets encoding asparagine,
aspartate, histidine, and tyrosine amino acids. Then, the ratio ofNAU versus NAC codons for each amino
acid type was determined and an overall assessment of total NAU/NAC ratio was made for each sequence.
Finally, a NAU/NAC ratio trend was determined and codon bias assessed for all transcript sequences
examined.
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CHAPTER THREE
DEFINITION OF THE QUEUOSINE MODIFICATION SYSTEM
Introduction
Prokaryotic synthesis of the queuosine modification has been well studied and is reasonably well
understood, however until recently the design o f the eukaryotic system was still relatively ambiguous. Due
to the similarities in structure of the modification in organisms o f these two Kingdoms, it was initially
assumed that the systems were evolutionally conserved, thus similar. New information concerning the
eukaryotic queuosine modification system in mammals and other classes o f organisms has shaded this with
doubt.
Based on the results of studies involving in vivo ceil culture and in vitro protein assay methods,
this document introduces a description o f the mammalian queuosine modification system. This scheme is
compared with the well characterized prokaryotic modification pathways o f Escherichia coli, and
Zymomonas mobilis. A hypothesis concerning the evolutionary relationship of prokaryotic and eukaryotic
modification systems is presented and a suggestion of the importance o f the queuosine modification in all
organisms is offered. In the end an assessment is made for the appropriate choice o f a model system to be
used for future studies of human pathology.
Definition o f the Queuosine Modification System in Prokaryotes
In prokaryotic systems, particularly the most studied organism E coli, the queuosine modification
is formed by a four-step intracellular pathway which involves enzymatic synthesis o f the unique base in
intact tRNA (Figure 3-1) (23). The first step involves the conversion of a guanosine triphosphate (GTP)
molecule to a 7-aminomethyl- or 7-cyano-7-deazaguanine derivative of the guanine base. This step is
performed by a GTP cyctohydrolase-like enzyme which involves the removal o f both the N7 and C 8 atoms
of the nucleotide base and incorporation o f some aminopropyl or cyanopropyl group, respectively, to
reform the ring. The two currently known GTP cydohydrolase enzymes (type I and II) have been ruled
out as the catalyst for this reaction. GTP cydohydrolase I is involved in pteridine biosynthesis for the
conversion of GTP into dihydroneopterin triphosphate. However, there have been no intermediates found
in this reaction which could account for possible 7-deazaguanine synthesis. GTP cydohydrolase II is
involved in riboflavin synthesis and catalyzes the formation of GTP into 2,5-diamino-6-oxy~4-(5'phosphoribosylamino) pyrimidine. A ribA mutant of £. coli deficient for this enzyme has been isolated,
but is still able to synthesize the queuosine modification. Thus, it has been proposed that there is an
undiscovered GTP cydohydrolase that catalyzes the formation of 7-aminomethyl-7-deazaguanine (preQ,)
and 7-cyano-7-deazaguanine (preQ0).
The second and third steps for the synthesis of the queuosine modification are performed by two
enzymes that have been shown to be encoded in a single operon (113). This queuine operon, as it has been
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Figure 3-1. The Prokaryotic Queuosine Modification System in Escherichia coli and Zymomonas mobilis. The prokaryotic system is a synthetic one based on a
four step process. I) Sep one is a reaction catalyzed by an unknown GTP cydohydrolase, requiring guanosine triphosphate and an unknown aminopropyl or
cyanopropyl donor to form preq, or preq0, repectively. II) Reaction two is catalyzed by tRNA'.guanine transglycosylase (from the gene tgt) which performs a
base-exchange reaction with preq, or preq„ for a transcriptionally-encoded guanine base (G) in position 34 of tRNA"", tRNA“p, tRNAhi', or tRNAl>T, The
formation of incorporated preq0 (known as preQ0) terminates the synthetic reaction, but appears to be reversible. Ill) Incorporated preQ,, however, is reacted
upon by the enzyme £-adenosylmethionine:tRNA ribosyltransferase (from the gene QueA) with the aid of s-adenosylmethionine to convert preQ, into epoxyQ.
IV) The formation of epoxyQ was only recently discovered and is reduced by an unknown mechanism with the aid of coenzyme B,2 to queuosine (Q). After the
degredation of tRNAs by non-specific RNases, the fully formed nucleoside Q is secreted by the cel) and is not reused in the prokarytic system.
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called, includes five coding regions at nine minutes on the £. coli genome. The genes are queA, tgt,yajC.
secD, and secF, in that order. The secD and Fgene products are involved in protein translocation and
export, while that ofyajC is unknown. The gene products of tgt and queA are involved in the second and
third steps o f queuosine synthesis, the expression o f this operon is regulated by the "factor of inversion
stimulation" (FIS protein) which, when bound to an upstream activation sequence, increases the
transcription of this operon (114). The FIS protein is also involved in the transcriptional activation of
several tRNA genes as well as all rRNA operons. Thus, the synthesis o f queuosine formation enzymes
appears to be directly modulated with the production o f the target substrate, the tRNA.
The product o f the tgt gene, tRNA:guanine transgiycosyiase (TGTase), is a 43 kDa zinccontaining protein consisting o f 369 residues with a pH; o f 4.6 to 4.8 (1 IS). In vivo it functions as a
monomer in a reaction requiring tRNA, guanine or guanine analogue, and magnesium ions, but does not
need adenosine triphosphate-derived energy. The TGTase enzyme appears to utilize either guanine (KM=
S.3 xlO'*M), preQ0 (Km undetermined), or preQ( (KM= 1.4 xlO**M) as substrate for incorporation into
tRNA (116). However, only the reactions with guanine and preQ0 are reversible. Due to the Km value, the
irreversibility o f the reaction, and the relative abundance o f the incorporated preQ,, it was suggested that
this compound serves as the natural substrate for this enzyme. It is noted, however, that for unknown
reasons the recombinant form of TGTase appears to often act as a multimer and in this state can reverse the
incorporation o f preQ, as well as the other substrates (117). Site-directed mutagenesis studies on the
tRNA47 substrate have indicated that the identity determinants for the association of this molecule with the
TGTase enzyme is the anticodon loop sequence U33G34U35 (118). Since the U33 is conserved in all tRNAs,
it was thus determined that only the first and second anticodon bases were factors in tRNA recognition for
this enzyme. Discovery of an E. coli TGTase mutant and subsequent site-directed mutagenesis studies on
this enzyme have provided evidence that a major catalytic residue in the function of the enzyme is a serine
residue at position 90. Sequence homology studies showed regions o f the prokaryotic TGTase in common
with the serine protease family, with the spatial orientation o f residues immediately adjacent to serine 90
(asp89-ser90-gly91-gly92) similar to those found around the catalytic serine residues in trypsin and
chymotrypsin (119). More recent evidence has shown the presence of an important aspartate residue at
position 102 in prokaryotic TGTase (120). This amino acid is proposed to serve as a critical catalytic
nucleophile in the prokaryotic queuosine synthesis reaction as suggested by the recent description of the
crystal structure of the Zymomonas mobilis TGTase.
Once the preQ, is incorporated into tRNA, it can serve as a substrate for the gene product of queA,
s-adenosylmethionine:tRNA ribosyltransferase isomerase (SAM:TGTase isomerase) (121). Although
preQ0 is often inserted into tRNA by TGTase, it is not a substrate for SAM:TGTase isomerase and has
therefore been suggested to exist only in significant amounts as a side product within an £. coli mutant
blocked in preQ! synthesis (122). The presence of the enzyme activity was discovered relatively early in
queuosine research that demonstrated E. coli and S. typhimurium cells, when starved of methionine, do not
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synthesize the queuosine modification. Only recently was it discovered that s-adenosylmethionine (SAM)
plays an unprecedented and critical role as a ribose donor for the formation o f queuosine (25,26). This
compound, usually a methlonyl or methyl group donor, serves a substrate for SAM:TGTase isomerase in
the attachment o f the cyclic ring to the end o f the 7-aminomethyl side chain of the incorporated 7deazaguanosine residue. With a weight of 39 kDa and a pH; o f 5.4, this enzyme has no sequence
homology to currently known proteins. A reaction mechanism was suggested for this reaction which
produces a 2,3-epoxy-4,5-dihydroxycyclopentyl-7-aminomethyl-7-deazaguanosine residue (epoxy-Q or
oQ).
In the final reaction of the queuosine modification system identified in both £. coli and S.
typhimurium, an unknown enzyme requiring coenzyme Bl2 performs a complete reduction o f the epoxy
group to form the final prokaryotic queuosine (Q) modified nucleoside (123). This reaction appears to be
environmentally regulated by the availability o f the B,2 vitamin nutrient, as neither prokaryotic organism
studied has the ability to synthesize this compound.
In the formation o f the prokaryotic queuosine modification the only exogenous requirement is that
o f vitamin Bu - The formation o f the modified nucleotide appears to be regulated by the availability of the
metabolic substrates (for example, GTP), FIS*induced expression of the enzymes and queuosine-associated
tRNAs, and the availability of vitamin B,2. After synthesis o f the folly-formed queuosine base, natural
tRNA-tumover events occur to renew the important participants of the protein synthetic mechanism. The
queuine base is not salvaged during degradation of the tRNA, as it is not a substrate for any o f the four
enzymes involved in queuosine synthesis, but is secreted into the environment by prokaryotes.
Definition o f the Queuosine Modification System in Eukaryotes
Many o f the mechanisms involved in the formation of the eukaryotic queuosine modification
appear to be significantly different from that o f the prokaryotic system. For example, unlike prokaryotes
eukaryotes are unable to synthesize queuosine and must rely on uptake of the free queuine base from their
diet or from secretions of symbiotic prokaryotes in gut flora. Eight week old mice that were fed specially
prepared queuine-free diets were shown to be deficient in queuosine modification levels (29,61). After
four weeks the queuosine levels in tRNA*” and tRNA11**decreased from a baseline of 85% to 15%
modified tRNA, however tRNA*sp and tRNAIyr levels were maintained at 100%. It was not until after one
year of exposure to the queuine-free diet that all queuosine modification levels in the tRNA decreased to
zero percent. Thus, it was suggested that in order to create the queuosine modification in tRNA in a
mammalian organism, queuine must be somehow taken into the system—presumably by ingestion.
The use of an in vivo uptake assay method has been used to identify and determine the kinetics of
a specific queuine transport system (74). The uptake of tritiated queuine exhibited burst kinetics over two
to four minutes o f initial exposure, then a linear import until plateauing at three to four hours showing
evidence of saturation. Lineweaver-Burke analysis indicated biphasic kinetics with a KMof 30 + 4 nM and
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a Vm„ o f 0.33 pmol queuine taken up per 106 cells for physiological concentrations of 1 to 10 nM. At
higher concentrations, 10 nM to 1,000 nM, the Km rose to 350 + 150 nM and a V„,, of 22.5 + 2.5 pmol
queuine taken up per hour per 10s cells. Treatment of the cells with guanine, 7-methyl guanine, adenine,
hypoxanthine, or 7-deazaguanine did not affect the transport rate o f queuine. However, addition o f 10 pM
dipyridamole (a generalized transport inhibitor) reduced the uptake by 50 to 70%. These results indicated
that a specific queuine transport pathway exists for physiological levels o f queuine, with additional
transport by general nucleotide transporters at higher concentrations.
The second step o f the queuosine modification system involves a queuine utilization mechanism
for the formation of this modified base in eukaryotes rather than the synthetic mechanism demonstrated in
prokaryotes. Incorporation of the base into tRNA has been studied in vivo and in vitro in many organisms,
but has not been definitively explored in any one eukaryotic organism.
In another difference from the prokaryotic queuosine modification system, eukaryotic cells have
the ability to salvage this base from tRNA turnover products to maintain queuosine modification levels
under queuine deprivation. In the early 1980s, GQndQz and Katze developed an in vivo method to study
what they suggested was evidence of a salvage capability for retrieval of queuine from tRNA turnover
products (16). They discovered that these cells had the ability to salvage queuine from degraded tRNA
molecules and reuse it to maintain queuosine levels in the absence of an exogenous supply of queuine. It
was later discovered that only queuosine-5’-monophosphate was the substrate for the queuine salvage
mechanism, as none o f the other possible tRNA degradation products (queuosine, queuosine-3'monophosphate, or mannosyl queuosine-5-monophosphate) allowed for the maintenance of queuosine
levels during queuine starvation (17).
In both prokaryotic and eukaryotic organisms, the key step for the formation o f the queuosine
modification is the only one so far studied in depth using in vitro methods. In a 1983 review of "Queuine,
the Q-containing tRNAs and the Enzymes Responsible for their Formation", Farkas describes the three
eukaryotic queuine incorporation enzymes (rabbit erythrocyte (20), rat liver (44), and wheat germ (124))
that had been purified to pseudo-homogeneity. He drew comparisons amongst these and to the well
characterized E. coli enzyme (115). The plant TGRase, isolated from wheat germ in 1983, was shown to
be a homodimer of 68 kDa subunits, and the prokaryotic monomer has been shown to be of 42.5 kDa.
Recently, published descriptions of isolations and characterizations of three additional mammalian TGRase
enzymes; bovine liver TGRase (125), rat liver TGRase (126), and rabbit TGRase (127) have been reported.
These purified mammalian proteins appear to exist as a heterodimer complex o f Mr 100 to 104. The larger
subunit o f the complex ranges from 60 to 66 kDa, with a smaller subunit o f 34 to 45 kDa.
A 1980 protocol (44) for the partial purification o f the rabbit liver TGRase by Shindo-Okada, et
al. was the basis for purification strategy developed for the isolation of mouse, rat, and human liver
samples described in this chapter. The isolation protocol used in this study involves several steps of
gravity-based liquid chromatography, differential salt precipitation, and fast protein liquid chromatography
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(FPLC). After each o f these steps an enzymatic assay was performed to assess the retention and purity of
the TGRase enzyme activity in each sample collected. The enzymatic assay for the incorporation of
queuine into tRNA was used to monitor the purification process for the isolation of the TGRase protein.
Final characterization o f the enzyme preparation involved non-denaturing and denaturing electrophoresis
and size-exciusion FPLC.
In the studies presented here, a human fibroblast cell culture model is used to gain a better picture
of the queuine uptake, incorporation, and salvage mechanisms in “normal” human tissues. The results of
the purification and characterization o f three mammalian liver queuine incorporation enzymes were used to
strengthen the description of the incorporation step o f the queuosine modification system. It is suggested
that the basic design o f the mammalian queuosine modification system is significantly different from that
described for prokaryotes. However, the evolutionary relationship between the eukaryotic and prokaryotic
systems has not yet been examined. The information gained in this research on the eukaryotic queuosine
modification system o f several mammalian organisms adds another dimension of knowledge to that of the
well characterized prokaryotic queuosine modification system. A comparison of the two systems may help
to ascertain the evolutionary development of the queuosine modification systems that have been detected in
species as diverse as prokaryotes, eukaryotic algae, many fungi, plants, insects, fish, birds and mammals.
In order to determine which model system to use for studies of human pathology, the assessment of a
physiologically similar and experimentally viable system still needs to be determined. Furthermore, the
details of how the queuosine modification system is tied into physiological metabolism within the
mammalian cell is also unknown.
Results
Characterization o f the Mammalian Queuosine Modification System via In Vivo Studies o f Normal Human
Fibroblast Cell Cultures
The results of this study with human foreskin fibroblast (HFF) cell cultures indicate that the
maximal rQT3 uptake rate occurs up to one hour, then gradually decreases until six hours at which time an
equilibrium o f uptake and export is established (Graph 3*1). Incorporation o f 100 nM iQT3 into cellular
tRNA populations occurs in these cells in a linear fashion (approximately 0.25 pmol/105cells/hour) until 12
hours, at which point the rate o f incorporation decreases to an equilibrium at 24 hours (Graph 3-1). The
initial rate o f uptake for rQT3 is ten-fold that of incorporation, and after 24 hours (at equilibrium) the
amount of intracellular rQT3 that is incorporated in tRNA remains at a constant level of approximately
30%.
Degradation o f tRNA molecules occurs as a regular process o f cellular component regeneration.
The normal turnover of tRNAs in human cells occurs between 24 to 48 hours (128). The half-life of
queuosine-modified tRNAs in the HFF cells studied was measured at 2 days by the pulse-chase salvage
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Graph 3-1. Queuine Uptake and Incorporation into the tRNA o f Human Fibroblast Cell Cultures, Culture flasks of human fibroblast cells (HFF) were grown to
near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for 24 hours, then submitted to either an in vivo queuine uptake assay (•)
or an in vivo queuine incorporation assay (■). A tritritiated analogue of queuine (rQT3) at a concentration of 100 nM was placed in the media at time zero, The
uptake of this base into the cytosolic fraction of the cells was measured in multiple parallel cultures hourly starting at time zero until 6 hours, and the
incorporation of this base into the acid-precipitable fraction of the cells (containing large proteins and nucleic acids, including tRNAs) was measured at 0 ,3 , 6,9,
12, and 24 hours. The uptake of rQT} to 24 hours was extrapolated (shown as a dashed line), this line is based on other uptake studies in HFF cells that have
been run for 24 hours. The counts per minute values obtained via liquid scintillation were normalized to the number of pmol rQT3 taken up or incorporated in
103 cells. Deviation bars indicated represent the standard deviation with n = 6 .
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method, regardless of the amount o f time that the cells were exposed to charcoal-stripped media (Graph 32). Charcoal-stripped media treatment of the cells for one day, one week, or three weeks was used to
induce queuine starvation. These cells were assessed for the ability to maintain rQT3 levels in the
incorporated state for up to 4 days. At one day o f induction by queuine-starvation, rQT3 is maintained in
the tRNA population at 100% for up to 4 days. One week of treatment appears to maximally induce the
salvage mechanism with full maintenance of rQT3 levels also for four days. After three weeks of queuinestarvation, the salvage o f rQT3 decreases to 60% after four days.
Isolation and Characterization o f Mammalian Queuine Incorporation Enzymes
In order to further characterize the queuine incorporation step, the queuine incorporation enzyme,
TGRase, was isolated from mouse, rat, and human liver samples. The conditions o f isolation for each step
are summarized and outlined in Table 3-L Samples o f each TGRase preparative step were stored at -20°C
or -70°C in two aliquots as either direct hard-freeze samples or with the addition of an equal volume of
glycerol.
During early isolation procedures for the rat liver enzyme, it was observed that the activity o f the
enzyme preparation was generally labile regardless o f storage conditions. Measurable TGRase activity in
cold stored preparations decreased rapidly to a low background level within only one to four weeks (Graph
3-3). In one instance a TGRase preparation lost activity within only three days. A preliminary test for
phosphatase activity in the TGRase preparation indicated phosphatase contamination (unpublished
observations). This was measured by the sample's ability to convert the colorless phosphatase substrate, pnitrophenylphosphate, to the yellow colored p-nitrophenoxide anion under basic conditions. Addition of
10 |iM phosphatase inhibitors sodium fluoride and sodium pyrophosphate to the homogenization buffer
served to enhance the recovery o f TGRase activity from rat liver isolates (Graph 3-4). From then on, these
general phosphatase inhibitors were added to all homogenization buffers used for the mouse, rat, and
human liver isolation procedures.
The optimized conditions (homogenization and initial centrifugation steps) indicate that this
enzyme is likely to be located in the cytoplasm, and that it may have a slight association with cytosolic
membranes. This supposition is based on the ability to increase yields o f isolations performed with 0.01%
Triton X-100 added to the homogenization buffer.
Data in Table 3-II represents a typical isolation protocol and the resulting enzymatic
characterization of the most evident TGRase-active fractions in the major steps of mouse, rat, and human
liver TGRase isolation protocols. The rQT3 incorporation percentage yield o f TGRase-active protein, unit
activity, specific activity, and purification factor o f each isolation step was compared amongst mammalian
species and exhibited similar values. The results are very similar to published results obtained for the
isolation of bovine liver TGRase by Slany and MQller (125).
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Graph 3-2. Queuine Salvage in Human Fibroblast Cell Cultures, Cultures of human fibroblast cells (HFF) were grown to near confluence in normal media, fed
with charcoal-stripped serum (lacking queuine) for 1 day, I week, or 3 weeks with regular media changes, then submitted to an in vivo queuine salvage assay. A
tritritiated analogue of queuine (rQT3) at a concentration of 100 nM was placed in the media 24 hours before the start of the assay to saturate the tRNA with the
radiolabeled base--“pulse”. In two sets of parallel cultures at time zero, extracellular rQT3 was washed away, then a media change with charcoal-stripped media
was performed. In one set of cultures unlabeled queuine (0.10 A260 units) was loaded (solid line) this represents the “chase” of the radiolabel out of the degraded
tRNA population and is an indication of the tRNA turnover rate within those cells. No queuine was added to the other set of cultures (dashed line) which
represents the ability of the cells to retain the radiolabel in the cell’s tRNA despite the degredation processes involved in normal tRNA turnover (a measure of
salvage ability). The counts per minute values obtained via liquid scintillation were normalized to the number of pmol rQT3 contained within the acidprecipitable fraction of the I05 cells that had been devoid of queuine for I day, I week or 3 weeks. Deviation bars indicated represent the standard deviation
with n =4.
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Table 3-1. Isolation Characteristics of Mammalian Liver tRNA.Guanine Ribosyltransferase in Key Steps o f the Purification Protocol

Fractionation
Step
Homogenate

Centrifuged Supernatant

DE-52 Cellulose LC

(NH4)2S0 4 Precipitant
P-ll LC

Mono Q FPLC

Superose 6 FPLC

Separation Method

Characteristic Isolation Condition
of TGRase Activity

cheesecloth filtration

soluble after homogenizing
with a tissue grinder and filtering

super- and ultra-centrifugation

soluble after 1 hour at 10,000 x g at 4°C
and 1 hour at 100,000 x g at 4°C

anion-exchange liquid chromatography:
increasing linear or step gradient
of 0 to O.S M KCI

eluted from the
diethylaminomethyl-cellulose matrix
at approximately 0.15 M KCI

salt precipitation at 35% saturation
and super-centrifugation

insoluble at 55% salt saturation
and 30 minutes at 10,000 x g at 4°C

cation-exchange liquid chromatography:
increasing linear gradient of 0 to 1 M KCI

eluted from the phosphocellulose matrix
at approximately 0.25 M Kcl

anion-exchange fast protein liquid chromatography:
increasing linear gradient of 0 to O.S M KCI

eluted from the trimethyl aminomethyl-conjugated monobeads
at approximately 0.15 M KCI

size-exclusion fast protein liquid chromatography:
isocratic elution

eluted from the cross-linked agarose beads
at approximately 34.5 kDa
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Graph 3-3. The Decay o f Two Samples o f Purified tRNA'.Guanine Ribosyltramferase Activity. The graph indicates the decay of TGRase activity in two
different rat liver Mono Q-FPLC preparations (• and ■) stored at -20°C and -70°C, respectively. Five micrograms of purified protein isolate was analyzed using
the standard TGRase activity assay to measure the ability to incorporate 3H-guanine into 0.10 Am units of yeast tRNA in one hour at 37°C. An early sample (■)
displayed residual TGRase activity of background levels after only four days, thus the activity trend after this time to 42 days is extrapolated (dashed line).
Standard deviation values are indicated for each sample with n = 4.
00
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No tRNA
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Control+NaF

Control+NaP.O.

Graph 3-4. The Recovery o f Crude tRNA.Guanine Ribosyltransferase Activity with the Addition o f Protein
Phosphatase Inhibitors to the Homogenization Buffer. The bar designated “No tRNA” indicates the non
specific binding of 3H-guanine to protein within the sample (no tRNA substrate added). The “Control” bar
shows the residual TGRase activity recovered from homogenization of a sample of rat liver tissue with no
protein phosphatase inhibitors added. The remaining bars indicate the TGRase activity recovered from the
homogenization of samples of the same rat liver tissue using homogenization buffer containing lOpM
sodium fluoride or 10 pM sodium pyrophosphate, respectively. Five micrograms o f protein isolate from
the phosphocellulose column step were used for each assay. All assays were performed using the standard
TGRase activity assay method. Standard deviation values are indicated for each sample with n = 4.
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Table 3-2. Detailed Summary of Mammalian Liver tRNA: Guanine Ribosyltransferase Purification Steps
Rat Isolate
Liver
Homogenate
Centrifuged Supernatant
DE-52 LC
(NH4)zS0 4 Precipitant
P-ll LC
MonoQ FPLC

Mouse Isolate
Liver
Homogenate
Centrifuged Supernatant
DE-52 LC
(NH4)2S0 4 Precipitant
P-ll LC
MonoQ FPLC

Human Isolate
Liver
Homogenate
Centrifuged Supernatant
DE-52 LC
(NH4)2S0 4 Precipitant
P-ll LC
MonoQ FPLC

Total Volume (mL) Unit Activity* Concentration Total Mass Percent Yield Specific Activity”
(mg/mL)
(mg)
(%)
n/a
150
100
450
60
15
1

n/a
5.3
49
99
nd
371
1480

n/a
16.6
15.4
1.42
nd
1.63
4.85

42,500
2,490
1,540
639
nd
24.4
4.85

100

5.9
3.6
1.5
nd
0.057
0.011

n/a
0.32
3.2
70
nd
228
305

Total Volume (mL) Unit Activity* Concentration Total Mass Percent Yield Specific Activity11
(mg/mL)
(%)
(mg)
n/a
250
200
500
80
25
1

n/a
5.8
58
224
nd
341
2255

n/a
12.0

9.25
2.12
nd
1.09
5.30

50,000
3,000
1,850
1,060
nd
27.2
3.74

100
6.0

3.7
2.1
nd
0.054
0.0075

n/a
0.48
6.3
106
nd
313
603

Total Volume (mL) Unit Activity* Concentration Total Mass Percent Yield Specific Activity^
(mg/mL)
(%)
(mg)
n/a
150
100
425
65
14
1

n/a
5.8
63
177
nd
520
1360

n/a
17.0
15.8
2.12
nd
1.97
3.10

43,000
2,550
1,580
901
nd
27.6
3.1

100

5.9
3.7
2.1
nd
0.064
0.0072

n/a
0.34
4.0
83
nd
264
439

Purification
_
•••
Factor
n/a
1
9.9
218
nd
712
953
Purification
Factor” ’
n/a
1
13
221
nd
652
1256
Purification
Factor*”
n/a
1
12
242
nd
776
1250

•Unit Activity: pmol 3H-G incorporated/mL sample/hour at 37°C. **Specific Activity: pmol 3H-G incorporated/mg protein/hour at 37°C. ♦♦♦Purification
Factor: enzyme activity ratio of experimental sample as a factor of the homogenate specific activity.
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Results of the phosphocellulose (P -ll) cation-exchange liquid chromatography procedure
demonstrate the first step indicating variance amongst samples. This occurs as an isolation-to-isolation
variation between species and within tissue samples, and may be due to differences in levels of
phosphorylation and possibly subunit stability in isolates. Early in the development o f the rat liver enzyme
preparations, TGRase activity assays of fractions from P-l I chromatography and succeeding steps
indicated two distinct regions o f TGRase activity, one major and one minor. Samples taken from mouse
Mono Q anion-exchange liquid chromatography preparations and those found in human P-l 1 fractions also
showed evidence o f these two regions of TGRase activity. The major TGRase active fraction was used to
determine specific activity and is the source o f the data recorded in Table 3-iI, with the second weaker
TGRase activity fraction initially ignored. Much later studies with protein kinase C phosphorylation of
these two peaks indicated that the second region o f weaker TGRase activity is dramatically increased under
phosphorylating conditions (see Chapter 4 for a more thorough explanation).
Since there was evidence of the importance of phosphorylation levels for the success of isolation
procedures, SDS-PAGE analysis and a protein kinase C catalyzed 32P-Iabeling study was performed with
isolates from a TGRase-active P-l 1 fraction and two MonoQ regions exhibiting strong and weak rat liver
TGRase activity to attempt to distinguish any differences between the highly active and weaker TGRase
fractions. 32P-labeled and unlabelled P-l 1 and Mono-Q rat TGRase fractions in a protein kinase Ccatalyzed reaction mixture were analyzed by denaturing and non-denaturing PAGE. The unlabeled
denaturing gel was stained by Coomassie stain, destained and photographed (Figure 3-2). A parallel
denaturing PAGE gel of the 32P-labeled samples was then exposed to film, and banding appeared in lanes
containing the P-l 1 concentrate and in one of the consecutive Mono-Q fractions. A band at approximately
60 kDa was observed in the P-l 1 sample and in a very weakly TGRase-active Mono-Q fraction sample. A
very faint band of potential 32P-incorporation was also observed in this region of the strongly TGRase
active Mono Q fraction. These bands matched up well with the Coomassie-stained bands in the gel (Figure
3-2). The lane containing the P-l 1 fraction does not exhibit distinguishable banding patterns with respect
to the autoradiograph, however in the lanes containing fractions o f the Mono Q step two distinct bands
fairly equal in intensity appear at approximately M, 60 and 34.5 in the fraction exhibiting weak TGRase
activity, with a strong 34.5 kDa band and a faint 60 kDa band in the strongly TGRase-active Mono Q
fraction. By comparison, a non-denaturing PAGE exhibited a very simple banding pattern in these lanes
(unpublished observations). In the strongly TGRase-active Mono-Q fraction a single band was visible and
was o f small size (between 30 and 45 kDa). This correlated well with the denaturing PAGE results.
However in the non-denaturing gel, the following Mono-Q fraction (which exhibited good 32Pincorporation, but limited TGRase-activity) exhibited a single very large molecular weight band. This
suggested possible multiple subunit involvement evidenced as banding differences under non-denaturing
vs. denaturing conditions, so a study using native and denaturing chromatography was undertaken.
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Figure 3-2. SDS-PAGE Electrophoretic and Autoradiographic Analysis o f Protein Samples During
Isolation o f the tRNA:Guanine Ribosyltransferase Enzyme, a) Two silver-stained 8% SDS-PAGE gels
were run and the important lanes are shown together above. Each lane shows the separation o f protein
isolates from various steps of the human liver tRNA:guanine ribosyltransferase (TGRase) procedure. Fifty
micrognuns of protein were applied for the first four lanes and 40 pg for the P-l 1 eluent on one gel. On a
second gel, 10 pg was applied for the MonoQ fractions. Molecular weight markers run for each gel were
used for alignment of the lanes in this graphic, and their locations are shown on the left On the right,
double-headed arrows indicate the “interesting” bands at 60 and 34.S kDa. b) A radiolabeling
phosphorylation reaction assay was performed with 10 pU o f protein kinase C (PKC) and y32P-ATP, and
either 40 pg of histone fraction IV (positive control for phosphorylation by PKC) or 40 pg of rat liver P-l I
eluent or 10 pg of rat liver MonoQ fraction sample. The reactions were quenched with the addition of
SDS-PAGE sample buffer and heating. They were then applied to an 8% SDS-PAGE gel and
electrophoresis was performed. The gel was then exposed to X-ray film at -70°C for 48 hours and
developed. Finally, bands of the gel were developed by simultaneous fixing and staining using 0.05%
coomassie blue in 40% methanol, and 10% acetic acid. Molecular weight markers were also run and their
migration positions are indicated on the left Double-tailed arrows indicating “interesting” bands at 60 kDa
and a group of four between 28 and 38 kDa (bracketed), corresponding to the positive control locations of
histones, are shown on the right.
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Comparisons were made between native Superose 6 FPLC chromatographs of the strongly
TGRase-active and ^P-incorporating, weakly TGRase-active Mono-Q fractions (Figure 3-3). Compared to
identifiable protein standards, the 32P-incorporating, weakly TGRase-active Mono-Q fraction maintains it's
major peak at approximately 100 to 110 kDa with minor peaks visible in the 55 to 65 kDa and 30 to 38
kDa ranges. Integration of the chromatograph showed 56% o f the protein in the 104 kDa range with 32%
and 12% in 60 and 34.5 kDa ranges, respectively. When this fraction was denatured by the presence o f 4
M guanidinium-Cl a definitive shift in it's peaks occurred. The 100 to 110 kDa peak virtually disappeared,
while the main peak appeared to shift to the right and plateaued between 65 and 30 kDa. The TGRaseactive Mono-Q fraction appeared to have the major peak at approximately 30 to 38 kDa, with a possible
minor peak between 55 and 65 kDa. Integration of these peaks indicated that the strongly TGRase-active
fraction contained approximately 80% o f the protein in the smaller peak with less than 10% in the mid
sized peak. The retention time overlaps for the peaks in the chromatographs are suggested to be due to the
presence o f differing complexes o f subunits. This is explained by the presence o f TGRase as a large 104
kDa complex able to dissociate into subunits o f 60 and 34.5 kDa, which corroborates the electrophoretic
data.
Discussion
Eukaryotic organisms acquire the main substrate for the formation of the queuosine modification
by either dietary ingestion o f the queuine base or absorption o f secreted queuine produced by intestinal gut
flora. The queuosine modification system in mammalian cells is shown to consist o f cellular uptake of the
queuine base, incorporation o f this nucleotide into tRNA, and salvage of the degraded transcript to recycle
the base for reuse (Figure 3-4). The characteristic uptake activity of a queuine-specific transporter in
human foreskin fibroblast cell cultures was determined using an in vivo assay method that approximates
human physiological conditions. Linear uptake of queuine occurs at a rate of 2.5 pmol/10s cells/hour until
saturation between four and six hours. The characteristic profile o f the queuine incorporation mechanism
was also assessed in the human fibroblast cells under the same conditions, with linear incorporation rates at
ten-fold less than uptake. Not until 24 hours does the incorporation rate plateau, and it appears that
approximately 30% o f intracellular queuine is maintained in the incorporated queuosine-modified tRNA
form. Finally, the ability of these cultures to salvage the incorporated queuine base and recycle was
described. A wildtype baseline salvage activity is measurable in these cells, and can be induced to
maximal activity by queuine starvation for up to one week. At three weeks and thereafter, the ability to
salvage queuine decreases with an apparent acclimation of the cells.
The incorporation step o f the queuosine modification system was studied in three mammalian
organisms in order to more fully describe this important synthetic step. All three isolated mammalian
(mouse, rat and human) liver TGRase enzymes appear to be composed of two subunits of approximately
60 and 34.5 kDa. These more recent results for the mouse and human TGRase enzymes confirm previous
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Figure 3-3. Absorbance Profiles ofSuperose 6 FPLC Separation o f Rat Liver tRNA:Guanine
Ribosyltransferase-Active MonoQ FPLC Fractions. Two MonoQ-FPLC fractions were collected. Fraction
one exhibited very high tRNArguanine ribosyltransferase (TGRase) activity, and fraction two showed very
weak activity but above the background level. An aliquot of each of these fractions were submitted to
denaturing conditions (4 M guanidinium chloride at room temperature for 30 minutes). Injections of 800
fig protein onto Pharmacia’s Superose 6 FPLC column were made for each sample and an on-line UV
monitor measured the elution absorbance at 280 nm. The first minor peak at three minutes represents the
injection peak. The first major peak indicated the void volume. Comparison’s to molecular weght
standards were made, and the three subsequent peaks were identified as being of approximately 104,66
and 34.5 kDa, respectively. The denatured fraction two sample contained an extra peak at approximately
45 minutes that represents the elution o f the guanidinium salt. The denatured fraction one profile is not
shown due to limited differences from the nondenatured fraction’s profile.
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Figure 3-4. The Proposed Eukaryotic Queuosine Modification System in Normal Human Fibroblast Cells, The eukaryotic system is based on usage of an
available resource. Queuine (q) is a nucleotidyl base that is secreted by gut flora and is digested from virtually all dietary sources. It is absorbed in the intestines
and distributed around the body in the vasculature. A specific queuine transporter is responsible for uptake of the base into the cell. In the cytosol
tRNArguanine ribosyltransferase incorporates it into tRNA**", tRNAup, tRNAhi\ or tRNAlyr via a base-exchange reaction with q for a transcriptionally-encoded
guanine base (G) located in position 34. After the degredation of tRNAs by non-specific RNases during normal tRNA turnover, the q nucleotidyl base is
salvaged by an unknown mechanism from queuosine-S’-monophosphate and reused for the incorporation step to form queuosine-modifted tRNA.
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findings regarding the rat liver enzyme (126) and are similar to that o f the bovine liver TGRase (125).
The results of this experimentation and that o f others suggest that mammalian TGRase enzymes
are a heterodimer complex of a larger subunit (60 to 66 kDa) and a smaller subunit (31 to 35 kDa). There
is speculation among laboratories both in the U.S. and in Germany about the stability o f this dimer
complex. In these studies, isolation of two regions o f TGRase activity during the isolation protocols of
both the P-l 1 cation-exchange liquid chromatographic and the Mono Q anion-exchange fast protein liquid
chromatographic steps suggest that the large salt gradient required by these methods may induce
disassociation o f the TGRase subunits. The composition o f the enzyme complex has also been suggested
to be a problem for the isolation of TGRase by phosphocellulose cation-exchange as well as tRNA-afflnity
chromatography in the isolation of bovine TGRase (125).
Characterizations o f mouse, rat, rabbit, bovine and human TGRase enzymes have shown these
isolates to be heterodimers o f very similar size (Table 3-III). However, a eukaryotic plant TGRase from
wheat germ (124) and two bacterial TGTase enzymes form £. coli (39) and Z mobilis (129) involved in the
formation of the queuosine modification have been shown to contain subunit make-ups different from that
o f mammals or plants. The plant enzyme appears to be a homodimer o f subunits similar in size to the
larger subunit o f the mammalian enzyme and utilizes queuine as it’s major substrate.
The prokaryotic systems are unique in that they are the only systems where the queuine-related
enzymes have been purified, cloned and well-characterized. The £. coli version of TGRase has been
suggested to be functional as either a monomer or as hexamer made up o f two homotrimers (130). The
monomers of both £1 coli and Z mobilis enzymes (Mr=42.5) are o f an identical size that does not appear
to correspond with either of the eukaryotic subunits. More recent studies o f these proteins indicate that
they are both likely to function in vivo as 42.5 kDa monomers, rather than oligomers (129).
Partial nucleotide and amino acid sequences for the rabbit (Genbank accession number L37420)
(I27)and bovine (125) enzymes, respectively, have been compared with known nucleotide sequences of
the prokaryotic enzymes from £ coli (Genbank accession numbers M63939 & M35286) (130)and Z
mobilis (Genbank accession number L33777) (129). There is no sequence homology between the
eukaryotic and prokaryotic species.
Metal ion requirements for the function of prokaryotic, plant and mammalian enzymes also differ.
The £. coli (131) and wheat germ (124) enzymes were suggested to require a divalent cation for activity.
More recently, the £. coli enzyme has been shown to contain a structural Zn2+-binding motif that appears to
be required for tRNA association (132,133). This region of the prokaryotic enzyme is highly conserved in
the Z mobilis nucleotide sequence which has now been resolved to 1.85 A by X-ray crystallographic
methods (134). Therefore, the Zn2+requirement for TGTase function is likely to be important in many
prokaryotic forms o f the enzyme. The bovine (125) and rat (44) liver enzymes have been shown not to
require any metal ions to function.
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Table 3-3. Comparison o f Queuine Incorporation Enzymes (tRNA:Guanine
Ribosyltransferases and tRNA:Guanine Transglycosylases) From Various Organisms

Source

Mr*

#Subunits

Nucleoside Substrate

Reference

(Mr*)
Escherichia coli

46

1(46)

preQ,

(22,130)

Zymomonas mobilis

45

1(46)

preQi

(129)

Wheat Germ

140

2(68 + 68 )

queuine

(124)

Mouse Liver

104

2(60 + 34.5)

queuine

(current work)

Rat Liver

80
104

?
2 (60 + 34.5)

queuine

(44)
(126) and
(current work)

Rabbit Erythrocyte

104

2(60 + 43)

queuine

(20 )

Bovine Liver

£100

2(66 + 31)

queuine

(125)

Human Liver

104

2 (60 +34.5)

queuine

(current work)

*Relative molecular weight (Mr) is listed in kilodalton units (kDa).
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Differences in substrate specificity between the prokaryotic and eukaryotic enzymes are also in
evidence. While both enzymes catalyze the exchange o f guanine-for-guanine in the wobble position of
tRNA, their substrates in the formation o f the queuosine modification are very different The £1 coli
enzyme utilizes 7-aminomethyl-7-deazaguanine as it’s primary substrate and does not associate with the
fully formed queuine nucleoside at all (I IS). The incorporation of both prokaryotic substrates (guanine
and 7-aminomethyl-7-deazaguanine) are reversible. Both plant (124) and animal (44,116) enzymes,
however, preferentially bind queuine for incorporation into tRNA while exhibiting 102- to I03-fold less
affinity for 7-aminomethy1-7-deazaguanine and 7-deazaguanine, respectively. Similar to the prokaryotic
enzyme, the guanine-for-guanine reaction is reversible. However the eukaryotic enzymes incorporate
queuine-for-guanine in an irreversible reaction. The removal o f queuosine’s base from the tRNA in both
prokaryotic and eukaryotic systems is only accomplished by turnover and degradation of the entire tRNA
molecule.
The results of the comparisons between these prokaryotic and eukaryotic enzymes for sequence,
complex structure, metal ion cofactor, and substrate specificity indicate significant differences in this
family of enzymes. Although historically placed under one classification (E.C. 2.4.2.29) and name (tRNAguanine transglycosylase), the prokaryotic and eukaryotic modification enzymes involved in the formation
o f queuosine appear to have arisen from distinct sources. The prokaryotic “queuine operon”, encoding at
least two enzymes involved in the formation o f the queuosine modification is not likely to be the
evolutionary source of the eukaryotic queuosine modification enzyme. It is proposed that the prokaryotic
enzyme should retain the historical name of tRNA-guanine transglycosylase, and that the eukaryotic
enzyme should attain the new E.C. name of tRNA-guanine ribosyltransferase with a new E.C. number in
sequence.
This description o f the incorporation step of the queuosine modification system provides an
important example for the differences between the prokaryotic and eukaryotic mechanisms. In addition, it
is important to point out that the existence o f the uptake and salvage steps described in the human
fibroblast cells insinuate a dramatic design difference in these two systems. Prokaryotic cells cannot utilize
the folly formed queuine base in the incorporation step and, instead of transporting a useable substrate for
the synthesis of the modification into the cell, have developed a complicated series of reactions to form the
7-aminomethyl-7-deazaguanine (preQ,) substrate for the first step of the prokaryotic queuosine synthetic
mechanism. In addition, the lack of a salvage mechanism in prokaryotes is not surprising due to the
inability of the incorporation mechanism to utilize the folly formed queuine base. The differences in the
prokaryotic and eukaryotic systems lead to the conclusion that these are not evolutionarily related, but may
be products of convergent evolution. The development of two mechanisms to form the same strange tRNA
modification also suggests that this product may have an important role in cellular function of ail
organisms, with the exception of yeast. Just what this role is, however, has not yet been determined.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

49

With the discovery of the overwhelming differences between the prokaryotic and eukaryotic
queuosine modification systems, the current focus o f basic research regarding queuine and the queuosine
modification may need to be reevaluated. Although the bulk o f the enzymatic research has been focused
on the prokaryotic queuosine incorporation enzyme for characterization, it may be necessary to concentrate
on the examination of the mammalian queuosine modification system and the TGRase enzyme for
application to human development and disease research. This research, involving the development o f a
human foreskin fibroblast cell culture model, provides a physiologically “normal” baseline for future
comparisons for modulative effects within a cell, as well as a guideline for studying apparently “abnormal”
neoplastic cells.
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CHAPTER FOUR
MODULATION OF THE MAMMALIAN
QUEUOSINE MODIFICATION SYSTEM
Introduction
The queuosine modification of tRNA is universally conserved in mature, static cells of eukaryotic
organisms from Dictyostelium discoideum to Homo sapiens. However, in rapidly dividing and
undifferentiated cells the levels o f this modification are dramatically decreased. Transfer RNA isolated
from neoplastic tissues and transformed cell lines is also hypomodified with queuosine to various degrees
(38,45,60,86). Neoplastic transformation of cells involves retrograde-differentiation events that are very
similar but reverse processes of differentiation. Both differentiation and retrograde-differentiation events
are induced and progress by the action of neighboring cell and environmental stimuli. These include such
mechanisms as cytokine-induced signaling cascades and G-protein associated secondary messenger
systems. The action of one class of experimental activators of an important intracellular signalling cascade
has been linked to both phenotypic change events in mammalian cultured cells and an alteration in tRNA
metabolism within those cells. There is some evidence that tumor promoting induction of cultured cells via
exposure to phorbol esters also has a direct effect on the queuosine modification system.
In both murine and human cell culture experiments, chemically-induced differentiation, tumor
promotion, and cellular growth potentiation have been inversely correlated with alterations in queuosine
levels. Murine erythroleukemia cells are typically queuosine-deficient. These cells can be forced to
differentiate and have been demonstrated to concurrently increase in levels of queuosine-modified tRNA
(66,67). The differentiation of these cells and the increase in queuosine-modification level was effectively
blocked by chronic treatment with the tumor promoter, 12-0-tetradecanoylphorbol-13-acetate (TPA) (66).
These observations suggest that the hypomodification o f tRNA with regard to queuosine is related to
growth enhancing or tumor promoting events. Chronic exposure o f cultured normal human fibroblasts to
phorbol-12,13-didecanoate (PDD), another classic phorbol ester, induces a large inhibition o f the
queuosine modification of tRNA (74). The decrease in queuosine content of tRNA precedes an increase in
the population density of the fibroblast cultures. Concurrent addition o f purified queuine effectively blocks
the population density increase in fibroblast cultures exposed to PDD, and maintains the queuosine level in
those cells at near normal levels. These results suggest that the queuosine modification system may be
connected to controlling the growth rate of normal human fibroblasts and is regulated by the action of
phorbol esters.
In the mid-1980s it was discovered that phorbol esters directly bind to and activate protein kinase
C (PK.C), a major player in the Ca2+signaling cascades (81,83). Not long thereafter, it was demonstrated in
in vivo cell culture studies of a few mammalian cell lines that cellular uptake of queuine is sensitive to
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phorbol esters (30,80). Thus, it was suggested that queuine uptake may be modulated by PKC (135).
Chronic exposure o f cultured cells to phorbol esters has been shown to induce a proteolytic down
regulation of PKC and its activity (84). Since a decrease in the level o f queuosine-modified tRNA was also
observed with chronic exposure o f human fibroblasts to PDD (80), it was proposed that the downregulation o f PKC activity levels in cell culture may have decreased the rate of queuine uptake needed for
the formation o f queuosine-modified tRNA.
Over the many years of attempting to isolate and purify a mammalian queuine incorporation
enzyme (tRNArguanine ribosyltransferase; TGRase), it was observed that the activity o f TGRase enzyme
preparations were generally labile regardless of storage conditions. Measurable TGRase activity in cold
stored (-20°C or -70°C) preparations would decrease rapidly to a low background level within only one to
four weeks. In one instance a TGRase preparation lost activity within only four days (see Chapter 3, Graph
3-3). Since the suspected linkage between queuosine modification levels and the level o f phosphorylation
in cell culture studies appeared to be plausible, preliminary tests for phosphatase activity in the mammalian
TGRase preparations were undertaken to see if this was the cause o f the loss of TGRase activity. Tests
indicated that there was significant protein phosphatase contamination in the samples. In addition, the
addition of general protein phosphatase inhibitors sodium fluoride and sodium pyrophosphate to the
homogenization buffer used in the initial isolation step dramatically increased the recovery o f activity (see
Chapter 3, Graph 3-4). Thus, it was suggested that the incorporation step o f the queuosine modification
system of mammals might also be influenced by the action of phosphorylation, possibly by PKC.
A multifaceted study, described here, was performed to investigate possible phosphorylationbased post-translational modification schemes using modified forms o f both the in vivo and in vitro assay
methods used in the experiments described in Chapter 3. These were undertaken in order to assess
potential regulatory mechanisms concerning the queuosine modification system by phosphorylation. The
description of the mammalian system, as described in the previous Chapter, is also revised to incorporate
knowledge gained in these regulation control studies. Finally, the significance o f this entire modification
scheme is assessed with regards to the evolutionary relationship o f prokaryotic and eukaryotic queuosine
modification systems, to the ability o f this system to be integrated within cellular metabolism, and to an
explanation of possible deficiencies observed in many neoplastic cell-lines and tumor biopsies.
Regulation o f Cellular Metabolism by Phosphorylation and Protein Kinase C
In 1992, the Nobel Prize for Physiology or Medicine was awarded to E. H. Fischer and E. G.
Krebs for their work concerning “reversible protein phosphorylation as a biological regulatory mechanism”
(136). They discovered a reciprocal kinase/phosphatase system that had the ability to regulate intracellular
events such as mobilization of glucose from glycogen stores, prevention of organ transplant rejection, and
development o f chronic myeloic leukemia.
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The list o f protein kinases discovered since the early days of Fischer and Krebs’ work has grown
very large and has been grouped into families based on either a similar target for the enzyme (such as
creatine kinase) or by the compound that activates the kinase’s activity. Protein kinase C was discovered
as a kinase that is activated by calcium ions (hence the “C”), therefore it is exquisitely sensitive to one o f
the major second messenger systems that exists in all cells (82). The activation of voltage-gated calcium
pores as well as by the formation o f inositol-triphosphate by phosphoiipase C and it’s subsequent induction
of release of internal calcium stores both serve to activate the activity o f protein kinase C. In addition, the
list of targets for protein kinase C-catalyzed phosphorylation is very long and diverse, including
cytoskeletal targets (such as vinculin, filamin, profilin, desmin, MARCKS, troponin T and I, and the Cprotein associated with cardiac myofibrils), intracellular second messenger systems (protein kinase Mcatalytic fragment, myosin light chain, neuromodulin and neurogranin), and transcription factors (CREB,
CRE, C/EBPa, the vitamin D3 receptor, and IkB in the IkB/NFkB complex) (137) Thus, protein kinase C
has been implicated as playing a role in the regulation of the cell cycle, cellular growth rate, multidrug
resistance, and phenotypic shifts during differentiation and neoplastic transformation (85).
Protein kinase C is a key regulatory enzyme in mammalian cells, however there is evidence of a
protein kinase C-like activity in organisms from yeast to humans, and in all mammalian tissues sampled.
In addition to the connection o f abberant PKC activity with cancer, abnormal levels of protein kinase C
activity have been implicated in disorders ranging from learning disabilities (138) to diabetic retinopathy
(Mandarino, 1992) to suicidal tendencies (139). Protein kinase C control over the queuosine modification
system would provide a link between tRNA metabolism and a long list o f other metabolic shifts known to
occur during differentiation and neoplastic transformation.
In Vivo Studies o f Phosphorylation Control o f the Queuosine Modification System
Cell culture studies of human fibroblasts were used to measure the three facets o f the queuosine
modification system in normal cells (see Chapter 3). Modified in vivo uptake, incorporation, and salvage
assays were repeated in these cells to assess the effect of different modulators of cellular phosphorylation
on queuine and queuosine metabolism. The initial study involved exposure of the normal human fibroblast
cultures to activators o f three different protein kinases; cAMP-dependent protein kinase (PKA), cGMPdependent protein kinase (PKG), and PKC. The observations of cellular exposure to dibutyryl- and 8bromo- analogues o f cAMP and cGMP and two phorbol esters, TPA and PDD, on uptake and
incorporation both suggested the involvement of PKC (140,141).
In this treatise, more comprehensive experiments were performed to verify the involvement of
PKC in the regulation of queuine uptake and queuosine incorporation into tRNA. These involved exposure
of the human fibroblast cell cultures to PKC activators (TPA and PDD), PKC inhibitors (H-7,
staurosporine, sphingosine, and calphostin C), and phosphatase inhibitors (okadaic acid and calyculin A)
(Figure 4- 1). Phosphatase activators are not commercially available, thus were not used in this study.
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Figure 4-1. Structures o f Phosphorylation Modulating Agents. To ascertain if phosphorylation provides a mechanism for regulation of the queuosine
modification system, an approach was developed using kinase and phosphatase modulators to measure their effect on queuine uptake, incorporation, and
salvage rates. Several kinase and phosphatase modulators were used to identify the kinase and phosphatase families involved in the regulation scheme.
Activators for protein kinase A (butyryl-cAMP and 8-bromo-cAMP), protein kinase G (butyryl-cGMP and 8-bromo-cGMP), and protein kinase C (TPA and
PDD) were employed to identify the participating kinase family. Protein kinase C activators (TPA and PDD) and inhibitors (calphostin C, sphingosine,
staurosporine, and H-7), and phosphatase inhibitors (okadaic acid and calyculin A) were studied to determine if phosphorylation, particularly by protein kinase
C, is involved in the regulation of the queuine uptake, incorporation, and/or salvage steps of the queuosine modification system.
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Chronic exposure of cell cultures to TPA is known to induce proteolytic degradation and down-regulation
of PKC activity (84). This phenomenon was exploited to verify the results o f the short-term exposure
experiments. While the effect o f exposure to PKC and phosphatase inhibitors should not change with
prolonged exposure to the agents, long-term exposure to the PKC activator TPA should instead inhibit the
enzyme. In preliminary studies for the experimentation involving phosphatase inhibitors, concentration
ranges were performed for exposure o f agents to the cultures. This enabled the determination of IC50
values which were compared to published standards of these compounds in order to suggest the family of
phosphatases involved in the inhibition o f the queuosine modification system at any o f the uptake,
incorporation, and/or salvage steps.
In Vitro Studies o f Phosphorylation Control ofthe Incorporation Step ofthe Queuosine Modification
System
Purification strategies for the isolation o f mammalian TGRases were modified to assess the
likelihood that direct phosphorylation o f the enzyme helps to maintain their activity levels. Addition of 10
pM phosphatase inhibitors sodium fluoride and sodium pyrophosphate to a homogenization buffer used in
the early stages o f purification served to enhance the recovery of TGRase activity from rat liver isolates
(see Chapter 3, Graph 3-4). Thereafter, when native in vitro TGRase incorporation assays showed minimal
activity, PKC was added during a duplication o f the assay. Through this procedural addition, it was
possible to trace the purification o f the enzyme through subsequent isolation steps. These efforts were able
to eventually produce a homogeneous TGRase isolate.
To confirm direct phosphorylation and activation by PKC with regard to the TGRase enzyme, as
was suggested by in vivo cell culture studies, additional experiments were performed with the addition of
commercial PKC to the reaction assays. Control reactions were performed to assess the effect of PKC
modulators directly on TGRase activity, and their effect on TGRase activity in the presence of PKC.
Finally, reciprocal control o f TGRase activity by a classical kinase/phosphatase regulatory mechanism was
studied with the sequential addition o f PKC and alkaline phosphatase to a single TGRase assay reaction.
Results
Regulation o f Cellular Queuine Uptake
Cultured human fibroblasts (passages 3-5) were exposed to the phosphorylation modulators to
discern influences on rQT, uptake after a three hour incubation (Graph 4-1). The agents that are reported
to stimulate the cAMP or cGMP dependent kinase systems had no effect on the rate of rQT3 uptake.
However, activators of PKC increased the rate o f rQT3 uptake by fifty percent when compared to untreated
controls. By contrast, cellular exposure to inhibitors of PKC all decreased the rate of rQT3 uptake.
Additional fibroblast cultures were exposed to the protein phosphatase inhibitors in order to maintain
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Graph 4-1. The Effect o f Protein Kinase and Protein Phosphatase Modulators on Queuine Uptake in Human Fibroblasts. Each bar represents rQT3 uptake in
cultures exposed to various kinase and phosphatase modulators for three hours. The cultures were treated with modulators at the following concentrations: 10
pM dibutyryl-cGMP, 8-bromo-cGMP, dibutyryl-cAMP and 8-bromo-cAMP, 20 nM TPA and PDD, and 10 nM okadaic acid, I nM calylculin A, 100 nM
calphostin C, 20 pM sphingosine, 100 nM staurosporine and 10 pM H-7. The uptake of the radiolabelled queuine in all cultures (4 x I05 cells) was measured
after a three hour incubation with 100 nM rQT3 and modulators at 37°C. These values were normalized to the number of pmol rQT3 taken up by I05 cells, and
converted to percentage uptake with the control culture value (5.5 ± 0.3 pmol/109cells) serving as 100%. The value and standard deviation of the control culture
is indicated as the line at the y-axis value 100% and in the shading surrounding this line. Deviation bars indicated represent the standard deviation with n ~6.
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higher protein phosphorylation levels within the cell. These cultures showed a similar increase in queuine
uptake when compared to those treated with PKC activators, further suggesting that phosphorylation is
involved in the regulation of queuine transport.
Parallel time-course studies of rQT3 uptake with short-term exposure to staurosporine, calphostin
C, TPA, calyculin A, and okadaic acid were performed and compared to the rQT3 uptake rate in control
cells at hourly intervals over four hours (Graph 4-2). Treatment o f the cells with the PKC inhibitors
resulted in a decrease in the uptake rate for rQT3 as compared to untreated control fibroblast cultures. The
PKC activator (TPA) nearly doubled the rate of rQT3 uptake, while the protein phosphatase inhibitors also
stimulated the rQT3 uptake rate. This further indicates that queuine uptake efficiency is linked to protein
phosphorylation levels.
Fibroblast cultures were pre-treated for 7 days with TPA, staurosporine, and okadaic acid in order
to measure effects of long-term exposure to these modulators on queuine uptake (Graph 4-3). This is
particularly revealing since chronic exposure to TPA results in proteolytic down-regulation of PKC activity
(84). As expected, exposures to the PKC inhibitor significantly decreased the uptake of queuine at 3 hours
of exposure to rQT3, while treatment with low levels o f the phosphatase inhibitor induced a two-fold
increase in rQT3 uptake. Furthermore, chronic exposure to TPA resulted in an inhibition o f rQT3 uptake
rate when compared with untreated control cultures. This is a reversal of the effect observed with short
term exposure to TPA, and supports the PKC modulation scheme for queuine uptake based on the
idiosyncrasy o f differential effects on PKC with short-term vs. long-term exposure to phorbol esters.
The relatively high concentrations of the protein phosphatase inhibitors used in the short-term
exposure study was cause for concern given their reported toxicity levels (142-144). A range of
concentrations o f calyculin A and okadaic acid were studied to analyze their effects on the 3 hour time
point for rQT3 uptake relative to untreated control fibroblast cultures (Graph 4-4). These studies were
performed for both short-term (simultaneous exposure to inhibitor and rQT3) and for chronic exposure to
the inhibitors (pre-treatment: 7 days prior to addition o f rQT3).
Concentrations o f okadaic acid in excess o f 100 nM proved to be cytotoxic for the 3 hour short
term exposure studies. However, increasing concentrations of okadaic acid from 5 to 100 nM
demonstrated progressively increasing rQT3 uptake. Similar trends were observed in studies of chronic
exposure to this phosphatase inhibitor. Increasing concentrations o f okadaic acid from I to 10 nM
demonstrated progressively increasing rQT3 uptake rates, while concentrations over 10 nM were cytotoxic
to the fibroblast cultures. Comparable results were seen with studies using the protein phosphatase
inhibitor calyculin A. However, the fibroblast cultures were much more sensitive to this compound.
Exposure for 3 hours to 1 nM calyculin A effectively increased the rate of rQT3 uptake. For chronic
exposures (7 day pre-treatment), 0.2 nM calyculin A demonstrated equivalent maximal induction of rQT3
uptake rate. Concentrations above these levels were cytotoxic in both short-term and chronic exposure
studies, respectively.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

,.n
.< >

cb
1

a

:
e

Time (hours)

Time (hours)

Graph 4-2. The Effect o f Short-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators on Queuine Uptake in Human Fibroblasts, The graph
on the left displays the uptake of rQTj during short-term exposure to a protein kinase C activator and protein phosphatase inhibitors. The bottom line ( + )
represents rQTj uptake in untreated control cultures, with the upper lines representing cultures treated with 10 nM okadaic acid ( <* ), 0.2 nM calyculin A ( O )
and 20 nM TPA (□ ), respectively. The graph on the right illustrates the uptake of rQTj during short-term exposure to protein kinase C inhibitors. The top line
( + ) represents rQT, uptake in untreated control cultures, with the lower lines representing cultures exposed to 100 nM staurosporine ( ■ ) and 100 nM
calphostin C ( • ), respectively. In these short-term exposure studies, modulators were added to the cultures at time 0. The uptake of the radiolabeled queuine
in all cultures was measured after a 37°C incubation with 100 nM rQTj at 0, 1,2,3, and 4 hours. These values were then normalized to the number of pmol
rQT} taken up by 10s cells. Deviation bars indicated represent the standard deviation with n =4.
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Graph 4-3. The Effect o f Long-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators
on Queuine Uptake in Human Fibroblasts. This graph displays the uptake of rQT3 after a week of
exposure to a protein kinase C activator and inhibitor, and a protein phosphatase inhibitor. The solid line
( + ) represents rQT3 uptake in untreated control cultures, with the other lines representing cultures treated
with 20 nM TPA ( □ ), I nM okadaic acid ( v ), and 100 nM staurosporine ( ■ ), respectively. In these
long-term exposure studies, cultures were pre-incubated with the modulators for 7 days before the initiation
of the uptake assay with the addition of the rQT3 at time 0. The uptake o f the radiolabeled queuine in all
cultures was measured after a 37°C incubation with 100 nM rQT3 at 0, 1,2,3, and 4 hours. These values
were then normalized to the number of pmol rQT3 taken up by 105 cells. Deviation bars indicated
represent the standard deviation with n =4.
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Graph 4-4. The Effect o f Short-Term and Long-Term Exposure to Protein Phosphatase Inhibitors on Queuine Uptake in Human Fibroblasts, These bar graphs
represent the effects of exposure of varying concentrations of okadaic acid (top graphs) and calyculin A (bottom graphs) on rQT3 uptake in cultures. Short-term
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uptake of the radiolabeled queuine in all cultures (4 x I0} cells) was measured alter a three hour incubation with 100 nM rQTj at 37 °C. These values were
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It has been reported that calyculin A l s a more effective inhibitor of protein phosphatase I than
okadaic acid. In one study, IC*, values o f approximately SO nM for okadaic acid and 03 nM for calyculin
A were reported for muscle phosphatase I in studies of long-term exposure to the agents (142). Based on
the reported sensitivity of protein phosphatases type I and II to okadaic acid and calyculin A with pre
treatment exposure (142-144), the strong similarity o f the data obtained in this study (Graph 4-4) to this
reported characteristic suggests that protein phosphatases of the type I group are participating in the
modulation of rQT3 uptake in human fibroblasts.
Regulation o f Queuine Incorporation into tRNA
Although the rate of uptake can be modulated, it was observed that maximal uptake of the queuine
base to a saturating level occurs in six hours. After this point, uptake and efflux are balanced (30). It is
suggested that the modulation o f the uptake mechanism might not be solely responsible for the dramatic
queuosine-modification deficiency seen in neoplastic transformation and progression o f cancer ceils to
metastasis. Thus, the queuine incorporation mechanism (TGRase) was studied to determine if PKC acts in
a dual role in modulating both components o f the queuine modification system.
First, cultured human fibroblasts (passages 3-5) were exposed to dibutyryl and 8-bromo analogs
of cAMP and cGMP, as well as TPA, PDD, calphostin C, sphingosine, staurosporine, H-7, okadaic acid or
calyculin A for 8 hours in order to determine effects on the incorporation o f rQT3 into tRNA by TGRase
(Graph 4-5). The queuine incorporation rates o f cells exposed to these modulators were compared to an
untreated control culture and three additional control (positive and negative) cultures. These additional
control fibroblast cultures were utilized to establish both the maximum and minimum incorporation limits
for comparison to the experimental samples. Queuosine-deficient tRNA cultures (cells treated with
charcoal-stripped media for three passages) were used as substrate targets for demonstrating the maximal
incorporation rate o f rQT3 into tRNA by TGRase (positive control). These cells demonstrated a nearly
two-fold increase in rQT3 incorporation rate when compared to normal serum-supplemented controls. The
slower rate o f incorporation in serum-supplemented control cells is likely due to partial queuosinemodification of the existing tRNA population in the cell. Two negative control cultures were grown in
10% serum-supplemented media. One culture was treated with additional 100 nM queuine and the other
was treated with 10 pM 7-methylguanine. Addition o f excess queuine completely and irreversibly saturates
the cell's tRNA with queuosine and eliminates the cell’s tRNA as a substrate for rQT3 incorporation. 7methylguanine is a competitive inhibitor of TGRase and blocks the ability o f TGRase to incorporate rQT3
into tRNA at concentrations used here (76). These two cultures represent the background levels of non
specific rQT3 association to the acid precipitable fraction o f solubilized cell cultures, which is expected in
the absence o f TGRase activity.
Cell cultures treated with agents that increase the activity o f cAMP and cGMP dependent kinases
appear to have no effect on the incorporation rate of rQT3 (Graph 4-5). However, PKC activators and
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phosphatase inhibitors increase the incorporation of rQT3 toward levels observed in totally queuosinedeficient cells, while cells treated with inhibitors of PKC reduce the incorporation of rQT3 to a base-line
level just above that o f the negative control cultures. These results demonstrate that PKC-catalyzed
phosphorylation is important in regulation of TGRase activity, thus the formation o f the queuosine
modification o f tRNA.
A 12 hour thne-course for rQT3 incorporation into tRNA of queuosine-deficient tRNA fibroblast
cultures was the performed in cells grown for three passages in 10% charcoal-stripped serum (queuinefree) supplemented media (Graph 4-6). In short-term exposure studies, rQT3 and various modulating
agents (staurosporine, sphingosine, calphostin C, TPA, okadaic acid and calyculin A) were simultaneously
added to parallel cultures. Then, these were analyzed for rQT3 incorporation into tRNA at four-hour
intervals for 12 hours. Inhibitors of PKC decreased the rate o f rQT3 incorporation into tRNA to a base-line
level as compared to untreated controls. The protein kinase activator and phosphatase inhibitors, when
added to cell cultures at the same time as rQT3, both increased the rQT3 incorporation rates when compared
to untreated control cells.
In long-term exposure studies, queuosine-deficient cells pre-treated with various agents for 7 days
were studied for rQT3 incorporation rates into tRNA over a 12 hour time-course (Graph 4-7). Chronic
exposure to TPA, which induces a proteolytic down-regulation of PKC (84), resulted in a decrease in rQT3
incorporation into tRNA. However, treatment with staurosporine was more effective at inhibiting the rate
of rQT3 incorporation in cell cultures. It is both possible and likely that residual PKC activity may still be
present in the cells chronically exposed to TPA. In addition, chronic pre-treatment o f these cells for 7 days
with okadaic acid showed rQT3 incorporation levels lower than that of the control. Since this treatment
maintains the phosphorylation level in the cell, the activity o f TGRase should be enhanced during this
preparative step and TGRase would effectively recycle queuine from tRNA turnover and incorporate it into
new transcripts o f tRNA. At the time of the rQT3 addition, the cognate tRNA would be saturated with the
queuosine modification and would no longer be used as a substrate for incoming rQT3 due to the
irreversible nature of the queuine incorporation reaction. Therefore, chronic exposure to okadaic acid
should decrease the rate of (QT3 incorporation into tRNA as compared to control cultures, and this is
indeed the case.
Regulation o f Queuosine Salvage
The final step of the queuosine modification system, salvage of the queuine base from queuosineS’-monophosphate (Q5P), was studied with regard to it’s ability to be modulated by PKC. The in vivo
salvage assay method, described in Chapters 2 and 3, was modified to integrate phosphorylation modulator
treatment into the standard assay much as was done for the in vivo uptake and incorporation assays (Graph
4-8). Cells were grown to near confluence, then a media change to charcoal-stripped (queuine free) media
for one day or two weeks was performed to induce any queuine salvage mechanism prior to the beginning
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Graph 4-5. The Effect o f Protein Kinase and Protein Phosphatase Modulators on Queuine Incorporation into tRNA in Human Fibroblasts, Each bar represents
rQTj incorporation into the tRNA of cultures exposed to various kinase andphosphatase modulators for eight hours at concentrations of 10 pM dibutyryl-cGMP,
8-bromo-cGMP, dibutyryl-cAMP and 8-bromo-cAMP, 20 nM TPA and PDD, and 10 nM okadaic acid, 0.2 nM calylculin A, 100 nM calphostin C, 20 pM
sphingosine, 100 nM staurosporine and 10 pM H-7. The incorporation of the radiolabelled queuine into the tRNA of all cultures (4 x 10 cells) was measured
after an eight hour incubation with 100 nM rQT} and modulators at 37°C. These values were normalized to the number of pmol rQTj incorporated into the acidprecipitable fraction of 10s cells. An untreated control represents rQT} incorporation into tRNA of untreated "normal’’ cultures (measured at 3.0 ± 0.2 pmol/10s
cells), and was the basis for the normalization of experimental cultures’ values to percentage uptake with the untreated control culture value serving as 100%,
The value and standard deviation of the control culture is indicated as the line at the y-axis value 100% and in the shading surrounding this line. In addition,
negative control cultures for rQTj incorporation in cells treated with 10 pM 7-methylguanine, a competitive inhibitor for the queuine incorporation enzyme, and
cultures of queuine-saturated cells (preincubated with 0.10 A2i0 queuine for three passages) enabled the minimum amount of rQTj for a null incorporation
baseline, which measure at 9 ± 3 % and 5 ± 2 %, respectively. These are shown in the line and shading at the y-axis value near zero. Finally, a sample of
queuine-deflcient cells that were preincubated with charcoal-stripped media for three passages established the maximum amount of rQTj able to be incorporated
measured at 190 ± 10 % (data not shown). Deviation bars indicated represent the standard deviation with n = 6.
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Graph 4-6. The Effect o f Short-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators on Queuine Incorporation into tRNA o f Human
Fibroblasts. The graph on the left displays the incorporation of rQTj into acid-precipitable fractions of cultures during short-term exposure to a protein kinase C
activator and protein phosphatase inhibitors. The bottom line ( + ) represents rQT} incorporation in untreated control cultures, with the upper lines representing
cultures treated with 10 nM okadaic acid (< “■), 20 nM TPA ( □ ) and 0.2 nM calyculin A ( O ), respectively. The graph on the right illustrates the
incorporation of rQTj into acid-precipitable fractions of cultures during short-term exposure to protein kinase C inhibitors. The top line ( + ) represents rQTj
incorporation in untreated control cultures, with the lower lines representing cultures exposed to 100 nM calphostin C ( • ), 100 nM staurosporine ( ■ ), and
20 pM sphingosine ( ♦ ), respectively. In these short-term exposure studies, modulators were added to the cultures at time 0. The incorporation of the
radiolabeled queuine into tRNA in all cultures was measured after a 37°C incubation with 100 nM rQT3 at 0 ,3 , 6,9, and 12 hours. These values were then
normalized to the number of pmol rQT} incorporated into the acid-precipitable fraction of 10s cells. Deviation bars indicated represent the standard deviation
with n =4.
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Graph 4-7. The Effect o f Long-Term Exposure to Protein Kinase C and Protein Phosphatase Modulators
on Queuine Incorporation into tRNA o f Human Fibroblasts. This graph displays the incorporation of rQT3
into the acid-precipitable fraction o f cultures after a week of exposure to a protein kinase C activator and
inhibitor, and a protein phosphatase inhibitor. The solid line ( + ) represents rQT3 incorporation in
untreated control cultures, with the other lines representing cultures treated with 20 nM TPA ( □ ), 1 nM
okadaic acid ( <> ), and 100 nM staurosporine ( ■ ), respectively. In these long-term exposure studies,
cultures were pre-incubated with the modulators for 7 days before the initiation of the uptake assay with
the addition o f the rQT3 at time 0. The incorporation o f the radiolabeled queuine into the acid-precipitable
fraction o f all cultures was measured after a 37°C incubation with 100 nM rQT3 at 0 ,3 , 6,9 , and 12 hours.
These values were then normalized to the number o f pmol rQT3 incorporated into the acid-precipitable
fiaction o f 10s cells. Deviation bars indicated represent the standard deviation with n =4.
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Graph 4-8. The Effect o f Short-Term Exposure to Phosphorylation Modulators on Queuine Salvage in Human Fibroblasts. Cultures of human fibroblast cells
(HFF) were grown to near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for 1 day or 2 weeks with regular media changes,
then submitted to an in vivo queuine salvage assay with the addition of phosphorylation modulators. A tritritiated analogue of queuine (rQTj) at a concentration
of 100 nM was placed in the media 24 hours before the start of the assay to saturate the tRNA with the radiolabeled base. In two sets of parallel cultures at time
zero, extracellular rQT} was washed away, then a media change with charcoal-stripped media was performed with the addition of 20 nM TPA (a protein kinase
C stimulator), 1 nM okadaic acid (a protein phosphatase inhibitor), and 100 nM staurosporine (a protein kinase C inhibitor). In one set of cultures 0.10 A260
units of unlabeled queuine was added (black bars) indicating the tRNA turnover rate within the cells. No queuine was added to the other set of cultures (light
grey bars) which represent the ability of the cells to salvage and retain the radiolabel in the cell’s tRNA. The counts per minute values obtained via liquid
scintillation were normalized to the number of pmol rQTj contained within the acid-precipitable fraction of the 10s cells that had been devoid of queuine for I
day or 2 weeks. Deviation bars indicated represent the standard deviation with n =4.
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of the study. In short-term exposure studies, addition of TPA, staurosporine, H-7 or okadaic acid at the
start of the assay produced no dramatic effect on the maintenance of rQT, levels in the acid-precipitable
fraction of the human fibroblast cells over the four days of the study. The same was observed for both sets
of cultures that had been subjected to one day or two weeks o f queuine starvation. Thus, it is suggested
that phosphorylation by PKC is not a regulating factor in the control of the salvage step o f the queuosine
modification system.
Direct Action o f Protein Kinase C on the Queuine Incorporation Enzyme In Vitro
In order to verify the results o f the in vivo assay results with regard to the incorporation step of the
queuosine modification system, TGRase was isolated from rat liver as described in Chapter 3 and tested for
modulation o f enzymatic activity and the ability to be directly phosphorylated by PKC. Early evidence of
the influence o f PKC on TGRase activity was shown with an induction of the queuine incorporation
activity in cold-stored TGRase samples (see Chapter 3, Graph 3-3). In combined TGRase and PKC
enzyme assays on the P-l 1 phosphocellulose fraction of a rat liver preparation an increase was observed in
the activity o f cold stored TGRase (Graph 4-9). Both partially active and totally inactive TGRase samples
were restored to their original P-l 1 phosphocellulose isolate activity by exposure to activated PKC. The
greater-than-100% return o f activity seen in one isolate is suggested to reflect a loss o f TGRase activity
during the isolation protocol from the original homogenate to the phosphocellulose fraction.
Purified TGRase preparations after the Mono Q FPLC step were subjected to a PKC
phosphorylation assays to determine the ability of the TGRase enzyme to serve as a substrate for PKCcatalyzed phosphorylation. The PKC was able to incorporate n P from yn P-ATP into the acid precipitable
component of the TGRase preparation derived from Mono-Q column, and at levels greater than that for
histones in the positive control sample (Graph 4-10). The phosphorylation of TGRase by PKC is
corroborated by the SDS-PAGE/autoradiograph discussed in Chapter 3 (Figure 3-3), where the larger of
the two subunits (approximately 60 kDa) appeared to be radiolabeled with 32P by PKC.
In control experiments, the direct effect of PKC modulators on TGRase activity, PKC
phosphorylation of TGRase, and TGRase activity in the presence o f PKC were tested. TGRase
preparations were assayed for 3H-guanine incorporation into yeast tRNA in the presence o f PKC activators
(diacyiglycerol, phosphatidyl serine, and CaClj, as well as ATP) and PKC inhibitors (H-7, sphingosine, or
staurosporine). None of these agents directly effected the TGRase activity (Graph 4-11). The methylated
purine, 7-methylguanine, a known competitive inhibitor of TGRase demonstrated strong inhibitory effects
and served as the inhibited control for this assay. Direct phosphorylation of TGRase by PKC was
measured in the presence of PKC activators and PKC inhibitors. As expected, the phosphorylation of
TGRase by PKC was induced by the presence of PKC activators (diacyiglycerol, phosphatidyl serine and
calcium) and dramatically inhibited by H-7, sphingosine and staurosporine (Graph 4-12). This inhibition
was observed even in the presence of the activators. The PKC preparations demonstrated no evidence of
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Graph 4-9. The Decay o f Two Samples o f Purified tRNA .Guanine Ribosyltransferase Activity and Reactivation by Protein Kinase C. These graphs indicate the
decay of residual TGRase activity in two different rat liver Mono Q-FPLC preparations and recovery of activity with the addition of protein kinase C. Five
micrograms of purified protein isolate were analyzed using the standard TGRase activity assay to measure the ability to incorporate 3H-guanine into 0.10 A260
units of yeast tRNA in one hour at 37°C (solid bars). Assay of these same samples by the combined TGRase and PKC activity assay was also performed under
the same reaction conditions (hashed bars). Standard deviation values are indicated for each sample with n =4.
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Graph 4-10. The Phosphorylation o f Histones and tRNA:Guanine Ribosyllransferase by Protein Kinase C, The control bars of histones and tRNA;guanine
ribosyltransferase (TGRase) only indicate the non-specific binding of (y- JP]ATP and any contaminating kinase activity in 5.0 pg histone fraction IV and
TGRase samples, respectively. The protein kinase C (PKC) bar indicates the background levels of (y-wP]ATP binding to 10 pll PKC with no histone or TGRase
substrate added. The remaining bars indicate the levels of 10 pU PKC-catalyzed phosphorylation of 5.0 pg histone and TGRase, respectively. All assays were
performed by the combined TGRase and PKC activity assay method. Standard deviation values are indicated for each sample with n =4.
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Graph 4-11. The Effect o f Protein Kinase C Modulators on the Activity o f lRNA:Guanine Ribosyllransferase, The bar representing “no tRNA" indicates
background levels of 3H-guanine adhering to protein within the tRNA:guanine ribosyltransferase (TGRase) sample (no tRNA substrate added). “TGRase only"
indicates the TGRase activity level of the S.O pg protein sample with the addition of 0.10 A260 units yeast tRNA substrate. Another negative control for the
TGRase activity is shown in the “TGRase + 7mG" bar, with the TGRase activity in the presence of 10 pM 7-methylguanosine (7mG), a competitive inhibitor for
TGRase. “TGRase + PKC act.” indicates the TGRase activity in the presence of traditional protein kinase C (PKC) activators activators (1 mM calcium chloride,
S.O pg diacyiglycerol, and S.O pg phosphatidyl serine). Adenosine triphosphate (ATP), an important substrate for PKC, is also required for catalytic function of
the phosphorylating enzyme PKC. So, the activity of TGRase in the presence of 10 pM ATP, and with PKC activators and ATP was assessed. Finally, the
activity of TGRase in the presence of three different PKC inhibitors (50 pM H-7, 100 nM staurosporine and 25 pM sphingosine) was measured in the presence
of calcium chloride, diacyiglycerol, phosphatidyl serine and ATP. All assays were performed using the standard TGRase activity assay method. Standard
deviation values are indicated for each sample with n =4.
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Graph 4-12. The Effect o f Protein Kinase C Modulators on the Phosphorylation o f tRNA:Guanine Ribosyltransferase by Protein Kinase C. The “PKC only"
bar indicates the background level of [y-32PJATP adherence to 10 pU protein kinase C (PKC) sample with no substrate added, but including the traditional PKC
activators I mM calcium chloride, S.O pg diacyiglycerol, and S.O pg phosphatidyl serine. The “TGRase only” bar indicates the presence of contaminating kinase
activity in the tRNA:guanine ribosyltransferase (TGRase) sample, by assaying the TGRase sample without the presence of PKC. The “PKC + TGRase”
indicates the incorporation of the radiolabeled phosphate into S.O pg TGRase by 10 pi) PKC. The remaining bars indicate the ability of PKC to phosphorylate
TGRase with the addition of three PKC inhibitors (SO pM H-7, 100 nM staurosporine and 2S pM sphingosine). All assays were performed using the standard
TGRase activity assay method. Standard deviation values are indicated for each sample with n =4.
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latent TGRase activity and the TGRase preparations exhibited no evidence of PKC activity. Finally, in
assays that measured the effect o f the presence of PKC on TGRase activity, 3H-guanine incorporation was
increased when exposed to activated PKC as seen before (Graph 4-13). However, inhibitors o f TGRase (7methylguanine—negative control) and PKC (H-7, staurosporine, and sphingosine) all appeared to reduce
the activity o f PKC-activated TGRase to background. Thus, the effect of the PKC on ^-guanine
incorporation into tRNA is suggested to be due to direct phosphorylation causing activation o f the TGRase
enzyme.
Combined assays were run with TGRase, PKC and alkaline phosphatase (AP) (Graph 4-14). The
results of TGRase activity assays with the presence of PKC and an antagonist phosphatase (AP) verify the
phosphorylation-modulation that has been suggested so far. Again, the TGRase activity was greatly
enhanced by the presence o f PKC. This induction was reversed upon the addition o f AP. In fact, baseline
TGRase activity was decreased by the presence of the phosphatase enzyme. This suggests that during the
isolation procedures there is some basal level o f phosphorylation maintained in the isolated TGRase-active
fractions.
3ZP-Iabeled and unlabelled P-l 1 and Mono-Q TGRase fractions were analyzed by denaturing and

non-denaturing PAGE as described in Chapter 3. To summarize, the mammalian liver TGRase enzyme is
likely a dimer with a 60 kDa subunit that appears to be phosphorylated at a serine residue by PKC and a
34.5 kDa subunit that appears to contain the active site for the enzyme. Superose 6 FPLC analysis of
weakly TGRase-active and strongly TGRase-active Mono Q fractions verified the composition suggested
by SDS- and native-PAGE. TGRase assays were performed on the rat liver Mono Q fractions with and
without the addition o f PKC to assess the effect of the kinase on the dimer versus the active subunit
monomer form o f the TGRase enzyme (Figure 4-2). The fraction containing primarily the 34.5 kDa
subunit exhibited almost three-fold greater TGRase activity than the dimer fraction without the addition of
PKC, and did not appeared to be effected by it’s addition. The weak TGRase-active fraction, containing
primarily the dimer form o f the enzyme, showed a near tripling of it’s TGRase activity with the addition of
PKC which increased it’s specific activity to that of the other fraction and both within the ballpark of that
reported in the isolation protocols for the purified rat liver TGRase enzyme.
Discussion
The uptake of queuine into “normal” cultured human fibroblasts appears to be modulated by
phosphorylation. Activators of cAMP and cGMP dependent kinases have no effect on rQT3 uptake, while
increasing PKC activity with phorbol ester treatment elevates the rate of rQT3 uptake. Conversely, chronic
exposure of TPA to fibroblast cultures, which is known to down-regulate PKC activity, decreases rQT3
uptake. A spectrum o f protein kinase inhibitors, with various specificities to PKC, all inhibit rQT3 uptake
into fibroblast cultures in concentration ranges reported to be most specific for PKC. These results make a
strong case for the role of PKC in enhancing the uptake rate of queuine into fibroblast cultures.
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Graph 4-13. The Effect o f Protein Kinase C Modulators on tRNA:Guanine Ribosyltransferase Activity in the Presence o f Protein Kinase C, The “no tRNA" bar
indicates background levels of *H-guanine that adheres to protein in a combined tRNA:guanine ribosyltransferase (5.0 pg TGRase) and protein kinase C (10 pU
PKC) reaction mixture with no tRNA substrate added. The “TGRase only" bar indicates the TGRase activity level of the TGRase sample (S.O pg) in the
presence of 10 pU PKC, but without the addition of PKC activators (1 mM calcium chloride, 5.0 pg diacyiglycerol, 5.0 pg phosphatidyl serine, and 10 pM
ATP). “PKC only” represents a negative control for TGRase activity in the reaction mixture containing 10 pU PKC, PKC activators and TGRase assay reagents,
but without the TGRase sample. The “TGRase + PKC” bar indicates the TGRase activity of the sample in the presence of PKC and PKC activators. Another
negative control shows the “TGRase + PKC” reaction mixture’s activity in the presence of 10 pM 7-methylguanine, a competitive inhibitor for TGRase. The
remaining bars represent the activity of TGRase in the presence of both PKC, PKC activators, and three PKC inhibitors H-7 (50 pM), staurosporine (100 nM)
and sphingosine (25 pM), respectively. All assays were performed using the standard TGRase activity assay method. Standard deviation values are indicated
for each sample with n =4.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

No tRNA
TGRase only
TGRase*AP
TGRase+PKC
TGRase+PKC+AP
i

30
3H-G Incorporation (pmol/A 160tRNA/hour)

40

Graph 4-14. The Modulation o f Purified tRNA:Guanine Ribosyltransferase Activity by Phosphorylation. The “no tRNA" bar indicates the non-specific binding
of }H-guanine to protein within the 5.0 pg tRNA:guanine ribosyltransferase (TGRase) sample (no tRNA was added). The bar identified as TGRase only
indicates the residua) TGRase activity in this sample. “TGRase + AP” indicates the TGRase activity with the addition of 0.40 mil alkaline phosphatase (AP), a
general phosphatase. “TGRase + PKC” indicates the sample’s TGRase activity with the addition of 10 pi) protein kinase (PKC). The remaining bar indicates
the TG R ase activity present w ith the addition o f com peting PKC (10 pU ) and A P (0.40 m il) enzym es.
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Figure 4-2. Superose 6 FPLC Absorbance Profiles and Results o f Assays Measuring MonoQ FPLC Fractions' tRNA.Guanine Ribosyltransferase Activity With
and Without Exposure to Protein Kinase C, The two MonoQ-FPLC fractions, corresponding to the Superose 6 FPLC profiles shown in Figure 3-3, were
examined for tRNA:guanine ribosyltransferase (TGRase) activity. Parallel assays were run using either the traditional in vitro TGRase assay method with or
without the addition of 10 pU protein kinase C (PKC) and it’s activators (1 mM calcium chloride, S.O pg diacyiglycerol and 5.0 pg phosphatidyl serine).
Negative controls for TGRase activity in the PKC and the PKC activator samples indicated no contaminating activity (data not shown). 'Specific activity for
each protein sample was calculated based on the number of pmol }H-guanine incorporated into 0.10 A260 units yeast tRNA per mg protein per hour at 37°C. The
star on the FPLC profile over the peak, estimated at 66 kDa, indicates the corresponding size subunit identified by autoradiograph (Figure 3-2) as containing the
phosphorylation site for PKC attachment of a phosphate.
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The inhibition of protein phosphatases by both okadaic acid and calyculin A also induces an
increase in the uptake of rQT3. These results indicate that maintenance o f protein phosphorylation is
important to maximize the rate o f queuine uptake. Due to the concentrations of the two phosphatase
inhibitors involved, it is suggested that protein phosphatases of type I are down-regulating queuine uptake
activity by removing a phosphate group from the queuine-specific membrane transporter. This analysis is
based on reported sensitivity o f protein phosphatases type I and II to okadaic acid and calyculin A (142144).
The incorporation o f queuine into tRNA in cultured human fibroblasts also appears to be
modulated by PKC and protein phosphatase activity. Activators o f cAMP and cGMP dependent kinases
have no effect on rQT3 incorporation. However, activators of PKC and inhibitors of protein phosphatase
both increase TGRase incorporation rates above a base-line incorporation level, while inhibitors of PKC
decrease incorporation rates o f rQT3 to the base-line level. Chronic exposure to TPA, which is known to
induce a proteolytic down-regulation o f PKC, also decreases rQT3 incorporation into fibroblast tRNA when
compared to untreated controls. These results make a strong case for the role of PKC in enhancing the
incorporation rate o f queuine into tRNA in fibroblast cultures.
The TGRase enzyme, which is responsible for the production o f the queuosine modification, has
been under scrutiny since its discovery in 1973. However, most published reports document only partial
purifications o f the enzyme and limited storage half-lives (44,115). Over the past thirteen years, TGRase
isolated from rat, rabbit, and human tissues has always shown instability and loss of assayable activity with
short term storage (three days to four weeks). The results of these in vitro studies suggest that PKC activity
is essential in maintaining the activity of TGRase in addition to activation of the cellular uptake mechanism
for it's substrate, queuine. Several stored TGRase preparations isolated from rat liver with low levels of
activity all have been shown to be fully reactivated upon exposure to PKC. Inactivation o f PKC in
combined TGRase and PKC assays with H-7, staurosporine or sphingosine resulted in a large decrease in
the activity level o f TGRase as compared with the PKC activated control. Neither the PKC inhibitors nor
the PKC activators exerted effects on TGRase directly. In addition, several 32P incorporation assays were
run demonstrating that PKC appears to be directly phosphorylating TGRase.
It is proposed that the TGRase enzyme exists as a heterodimer o f approximately 104 kDa, with a
PKC-substrate regulatory subunit o f 60 kDa and a catalytic subunit o f 34.5 kDa. The subunit composition
of the fully active TGRase protein is still under debate. The 34.5 kDa subunit has been shown to contain
significant TGRase activity, but it is not activated by PKC. A preparation containing primarily the dimer
form exhibits very weak TGRase activity which is dramatically increased by the addition o f functional
PKC. It has been suggested that PKC phosphorylates the large subunit which induces dissociation of the
dimer and releases the 34.5 kDa catalytic subunit which would then be free to perform it’s apparent
queuine-insertion activity into tRNA (126). However, Slany and Langgut have suggested that the dimer
form is the active form an that phosphorylation just alters the conformation of the dimer to induce it’s
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activity (125).
Despite the strong circumstantial evidence that both queuine uptake and incorporation are
regulated by PKC, the mechanism catalyzing the salvage of intracellular queuine does not appear to be
effected by PKC.
Revised Description o f the Mammalian Queuosine Modification System
It is proposed that PKC and protein phosphatase are important modulators o f both queuine uptake
and incorporation into tRNA in “normal” mammalian cells. These are likely to be independently regulated
sites for PKC due to 1) the ability o f the uptake mechanism to fully saturate the cell with queuine in six
hours despite down-regulation by dephosphorylation, 2) the observation o f the modulation o f TGRase
activity up to 24 hours in cultured cells, and 3) in vitro evidence that shows direct phosphorylation and
regulation of rat liver TGRase activity by PKC.
When fully integrated into the description o f the queuosine modification system in “normal”
mammalian cells, the ability to be regulated by PKC adds another layer o f functionality to the “big picture”
of queuine metabolism (Figure 4-3). This regulatory enzyme is strongly connected to many other cellular
and extracellular processes that serve to dramatically shape the metabolism and eventually the function o f a
cell. Any agent or treatment regiment that could lead to a down-regulation in PKC activity, such as
chronic exposure to phorbol-ester tumor promoters, would have an inhibitory effect on both TGRase
activity and queuine uptake into the cell leading to queuine-hypomodified tRNA.
In vivo cell culture experiments with human fibroblasts and in vitro assays with purified rat liver
TGRase suggest that control of TGRase activity by phosphorylation may be a universal mammalian
phenomenon. Due to organismal structure (multicellular and differentiated nature o f eukaryotic
organisms), different regulatory design schemes have been evolutionarily developed for eukaryotes and
prokaryotes. In the well known £. coli (prokaryotic) model, the formation of queuosine is transcriptionally
regulated by the FIS protein (114). There is no known PKC-like activity in prokaryotes and only vaguely
similar PKC-like activities in yeast which are early evolutionarily transitional eukaryotes.
Additionally, as mentioned in Chapter 3, the TGRase and TGTase enzymes are composed of
widely divergent physical compositions. It is reasonable to suggest that these two enzymes developed from
different origins, with different substrates (preQ, for the prokaryotic system and Q for the eukaryotic
system). Thus, the TGRase and TGTase enzymes are very likely derived from different genes and may
have only a superficial connection through the production of what is a universally conserved highly
modified nucleoside. Even the design of the two systems is based on different processes, the prokaryotic
version is a synthetic mechanism that builds Q from intracellular compounds while the eukaryotic version
is a utilization mechanism that imports and salvages an exogenous compound. The evolutionary
development of two independent but convergent systems seems to indicate that the queuosine modification
has great physiological importance for it’s existence, in that both the prokaryotic and eukaryotic kingdoms

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

,011

oil

HN

OH

.Oil

OH

“OH

uptake*

HjN,

IRNA0(j 4)

HN

HN

PKC

degredation

PKC
-OH

OH

salvage
HjO

HN

Figure 4-3. The Revised Eukaryotic Queuosine Modification System in Normal Human Fibroblast Cells, The eukaryotic system is based on usage of an
available resource as described in Figure 3-4. It involves an uptake step facilitated by a specific queuine transmembrane transporter, tRNA'.guanine
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system.
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have independently developed mechanisms for creating this nucleoside.
Cellular and Clinical Ramifications o f Protein Kinase C Regulation ofthe Queuosine Modification System
Protein kinase-protein phosphatase reciprocal control systems are important components o f the
cell's signal transduction system, and are known to be critical components involved with differentiation,
control of cell growth and neoplastic transformation (see Chapter 1). The results of the queuosine
modification system modulation studies tie an important signal transduction network to mechanisms
responsible for tRNA modification with queuine. Alterations in the signal transduction system can effect
both the availability o f queuine base and the activity o f TGRase which can potentially lead to the
queuosine-hypomodification of tRNA commonly observed in neoplastically transformed and
undifferentiated cells. In addition to the effect that the shift in tRNA modification might on it’s function in
protein translation, queuosine deficiencies could be used as an indication o f cellular metabolic changes that
often lead toward neoplastic transformation and progression toward metastatic cancer.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

79

CHAPTER FIVE
DEFICIENCIES OF THE QUEUOSINE MODIFICATION SYSTEM
Introduction
In normal adult human cells the tRNA population is known to be fully saturated with the
queuosine modification (60). However, neoplastic cell-lines derived from human biopsies exhibit
profound deficiencies in the levels of queuosine. The deficiencies vary in their degree of
hypomodification, as seen in such cell-lines as T-84 colon carcinoma (17% deficient), MCF-7 breast
adenocarcinoma (SO to 60% deficient), HL-60 promyelocytic leukemia (60 to 80% deficient), and HxGC3
colon adenocarcinoma (100% deficient) (45,87). The extent o f this hypomodification may be exaggerated
in successive passages by the conditions of tissue culturing, however this appears not to be an artifact of
the method due to similar observed deficiencies in primary tissue biopsies.
There have been several published reports utilizing human biopsied tissue in order to determine
the extent of the queuosine deficiency in tumors. In one study, breast adenocarcinomas were tested at 3%
deficiency in intraductal and invasive cancer, progressing to 8% deficiency in metastatic invasive tumors,
to 20% deficiency in a metastasis to the neck (87). Examination of ovarian tumors demonstrated an even
greater decline in queuosine levels; 12% deficiencies is stage I cancers, progressing to 37% in stage III, and
finally to 63% queuosine hypomodification in stage IV and metastatic ovarian cancer (42). Additionally,
brain tumor biopsies were tested for their queuosine modification levels and demonstrated a similar trend
of292% deficiency in meningiomas progressing to 66.9% in metastatic astrocytomas (43). While
diagnostic procedures have been developed based on queuosine deficiencies in Ieukemias and lymphomas
(40), lung cancers (41), and ovarian tumors (42), it is still not known if the breakdown o f a single
component or multiple steps o f the queuosine modification system are the cause o f the deficiencies. In
fact, only one published report regarding the examination of the incorporation step in a neoplastic human
cell-line has yet come to light
Studies characterizing the queuosine modification system have been performed in “normal”
human cell culture experiments and with enzymes isolated from “normal” mammalian liver tissues.
Chapter 3 of this treatise describes the three components of the queuosine modification system;
transmembrane uptake o f the queuine base, cytoplasmic incorporation of this base into tRNA to form the
queuosine modification, and salvage of the base from the tRNA turnover product queuosine-5’monophosphate (QSP). Chapter 4 provides evidence in “normal” cells that the rates o f both the uptake and
incorporation steps of the queuosine modification system are increased by protein kinase C (PKC)cataiyzed phosphorylation, while it appears that salvage is only minimally effected by PKC, if at all. Thus,
the mammalian queuosine modification system has been relatively well described in “normal” fibroblast
cells and other mammalian tissues, however the individual components of this system have yet to be
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substantially studied in abnormal cells.
The studies presented in this chapter attempt to identify the malfunctioning sites o f the queuosine
modification system in two human adenocarcinoma cell-lines. As with many cancers, the human colon
adenocarcinoma (HxGC3) and human breast adenocarcinoma (MCF-7) cell-lines are both significantly
deficient in queuosine modification levels. The HxGC, cell-line is completely unmodified with respect to
this particular modification, while the MCF-7 cell-line is greatly diminished in it’s population of
queuosine-modified tRNAs (SO to 60% deficient). Parallel in vivo uptake, incorporation, salvage, and
modulation assays were performed on the colon and breast adenocarcinoma cell-lines and with human
foreskin fibroblasts (HFF) as a “normal” reference. Comparisons between the results o f the “normal”
fibroblast cultures and those o f the cancerous cell-lines were made in an attempt to determine the site or
sites of the deficiency within the established components o f the queuosine modification system.
These results can be used to explain the observed queuosine hypomodified levels found in these
cultures. They can also be used to suggest sites for deficiencies in other known queuosine deficient tumors
and cell-lines, as well as whether a multiple-site deficiency scheme is necessary to cause the substantial
queuosine modification loss that is often seen in progressive neoplasia. Finally, results o f the in vivo assay
methods will likely give an indication if the cell culture methods utilized in this treatise are a viable and
realistic model system for future basic and clinical studies.
Description o f the HxGCj Human Colon Adenocarcinoma Cell-line
In 1978, the HxGQ cell-line was derived from a biopsy of a 61 year old male suffering from
colon polyps. The diagnosis o f this cancer was described as a poorly-differentiated adenocarcinoma o f the
transverse colon. The cells were maintained as xenografts in male immune-deprived CBA/lac mice and
eventually a cultured cell-line was established (14S). In a 1986 article describing phorbol ester modulation
of queuine uptake in diploid human fibroblasts, several transformed cell-lines, including the HxGC3 cells,
were analyzed for queuine uptake kinetics and their responsiveness to phorbol ester-induced inhibition o f
uptake (80). In experiments similar to the in vivo uptake assays described in Chapters 3 of this work, the
HxGC3 cells were shown to exhibit biphasic kinetics for their uptake mechanism in a similar pattern similar
to that observed for the “normal” fibroblast cultures. The low KMfor the HxGC3 cells was determined to
be 40 ± 2 nM which is similar to 30 ± 4 nM for the fibroblasts, while the high KMwas determined to be
440 ± 60 nM corresponding to 350 ± 150 nM for the fibroblast cultures.
In 1992, the same laboratory examined the HxGC3 cell-line for it’s ability to produce queuosinemodified tRNAs using an indirect RPC-5 medium pressure liquid chromatographic method for the
quantification of queuosine-negative and queuosine-containing tRNAs (87). It was discovered that these
cultures were dramatically deficient in queuosine-modified tRNA. However, if the cells were exposed in
vivo to a treatment of the DNA demethylating agent 5-azacytidine (5-azaC), a small peak appeared at the
same retention time as queuosine-modified tRNA. Since the uptake mechanism for queuine in the HxGC3

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

81

cells appeared to be normal, it was suggested that a defect in the incorporation or salvage components of
the queuosine modification system might be present. Additionally, it was proposed that the 5-azaC
treatment might be inducing the gene expression o f an important protein in one o f these two systems.
Activity of the HxGC3 queuine incorporation enzyme was measured after partial purification by
cell lysis, homogenization, centrifugation, separation on a DEAE-cellulose column, and simultaneous
concentration and desalting o f the active fractions with a microconcentrator (87). Finally, an in vitro assay
was performed on the concentrate in order to measure it’s ability to incorporate tritiated-dihydroqueuine
into bulk yeast tRNA. The HxGCj cell-line was not shown to contain the queuine incorporation activity,
nor did the addition of HXGC3 cell lysate to functional HL-60 TGRase preparations influence this activity.
Thus, it was inferred that the HxGCj cell-line contained no functional queuine incorporation enzyme. Any
in vitro assays that may have been performed on S-azaC treated cell homogenates were not mentioned.
The salvage mechanism for Q5P was studied in a different method from that of the queuine
incorporation enzyme. The HxGCj cells were lysed and centrifuged. The samples were added to an in
vitro assay that measured the ability o f the lysate to catalyze the formation of free tritiated dihydroqueuine
base from tritiated Q5P. There was concern that phosphatase contamination o f the lysate would produce an
inactive queuosine substrate from the QSP in a competing reaction with the salvage enzyme. Therefore,
sodium fluoride or a,P-methylene-ADP were added to the reaction mixtures to prevent dephosphorylation
o f the QSP substrate. However, this also reduced the reaction to a semi-quantitative method due to the
partial inhibition of the salvage mechanism by these compounds. After the completion of the reaction, the
mixture was separated by CIShigh pressure liquid chromatography to detect the presence of tritiated QSP,
queuosine or queuine. A mouse liver homogenate was prepared to serve as a salvage standard and the
results of the HXGC3 lysate reaction were determined as a percentage of the mouse liver salvage. The
HxGC3 cell-line was significantly deficient in both tRNA“p and tRNA1” levels and exhibited 18%
efficiency in queuine salvage.
Since this cell-line was shown to be entirely deficient in queuosine and also to contain no
observable queuine incorporation activity, it was proposed that the incorporation step of the queuosine
modification system was malfunctioning in the HxGC3 cells. The low efficiency of salvage, therefore,
would not be a major player in the low queuosine modification levels because the maintenance o f
intracellular queuine concentrations would not be able to induce the queuosine synthesis to occur without
the presence o f a functional queuine incorporation enzyme. Since in vivo 5-azaC treatment of the cells
produced measurable queuosine-modified tRNA levels, it was also suggested that the incorporation was the
component likely effected by S-azaC induced DNA demethylation and induction o f gene expression.
These studies, with the exception o f the HXGC3 in vivo uptake assays, were not utilizing methods
developed to measure the queuosine modification system components under near physiological conditions.
The assay methods described in this treatise in chapters 2 and 3 may be a better model to examine these
mechanisms. The in vivo techniques for assaying uptake, incorporation, salvage, and the PKC-modulated
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steps are used to verify that the uptake mechanism is similar to that of “normal” fibroblasts. Additionally,
these methods will be used to demonstrate that the incorporation mechanism is compromised in the HxGC3
cells and is the mechanism that is directly effected by the 5-azaC treatment. In vivo salvage assays were
not performed in these cells. This decision was made based on the futility of the in vivo method for
measuring the salvage efficiency of cells which cannot create the modification, nor modify the tRNA at
easily measurable levels even when induced by 5-azaC treatment.
Description o f the MCF-7 Human Breast Adenocarcinoma Cell-line
The MCF-7 cell-line was derived from a pleural effusion excised from a 72 year old female that
had previously undergone a radical mastectomy for malignant mammary adenocarcinoma (146). The cells
were cultured into a stable cell-line and retained several differentiated characteristics o f the mammary
epithelium including the ability to express the cytoplasmic estrogen receptor and the capability o f forming
domes. The cell-line, at passage 138, was donated to the American Type Culture Collection by C.M.
McGrath in April 1982. Since this time, the MCF-7 cell-line has become a well established standard for in
vivo studies of estrogen receptor function and multidrug resistance development. Thus, while existing in
many labs it has also been utilized for other studies as an example o f a human transformed cell-line, and
more specifically as an estrogen-dependent human breast adenocarcinoma model.
No known queuosine modification system studies have yet been performed using the MCF-7 cellline. Since it is a well known and well studied example of neoplasia, it was selected for study as another
transformed cell-line for contrast to or comparison with the HxGC3 cell-line. The in vivo techniques for
assaying uptake, incorporation, salvage, and PKC-modulated activity o f the first two steps are utilized to
describe and assess the three components o f the queuosine modification system in these cells. The MCF-7
cell-line has been determined to be 50% to 60% undermodified with respect to queuosine (data not shown).
The results of experimentation, described in this chapter, will be used to decipher the source of this
deficiency as compared with results of “normal” human fibroblast cultured cells.
Results
Uptake o f Queuine
The HxGC3 and MCF-7 cell-lines exhibit rQT3 uptake rates and levels that are comparable to that
observed in normal HFF cells (Graph 5-1). Both neoplastic cultures tested demonstrate linear uptake of the
radiolabeled queuine analogue through 60 minutes and plateau at approximately 120 minutes. In addition,
the maximal quantities of rQT3 taken up by the three cell-lines are all very close in range (7.4 to 7.8
pmol/10s cells). 5-azaC-treated HxGC, cells were also assayed for the ability to take up the rQT3 and were
shown to exhibit the same uptake profile as the untreated HxGC3 cell cultures. This culture set was studied
to ensure that any incorporation differences observed in this cell-line were due solely to the incorporation
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step and not due to uptake insufficiencies.
Incorporation o f Queuine into tRNA
It has been reported the HxGC3 cell-line is deficient in the levels o f queuosine-modified tRNA due
to transcriptional deactivation of a component of the queuosine modification system (87). In these in vivo
studies, despite the proper functioning o f the queuine uptake step, direct tune-course incorporation assays
show only background levels of incorporated rQT3 in HXGC3 cells even after 24 hours of exposure to this
queuine analogue (Graph 5-2). Treatment o f these cells with the DNA methylase inhibitor and
transcriptional activator 5-azaC does not appear to effect the uptake o f rQT3, however incorporation of
rQT3 into tRNA is distinguishable above the background as early as six hours after exposure to the rQT3.
The level of tQT3-modified tRNA elevates to 4.5-fold background levels at 12 hours, and continues to rise
through 24 hours. This pattern is in contrast to the HFF cell-line’s incorporation profile which is linear
through nine hours and plateaus at twelve. The level o f queuosine modification in the HxGC3 cultures is 5fold lower than the incorporation levels in the HFF cells at 24 hours, nonetheless it remains significantly
above that of the background.
In contrast to the HxGC3 cell-line, MCF-7 cultures exhibited no deficiency in queuine
incorporation activity. Incorporation of rQT3 in MCF-7 cells is linear to 6 hours and plateaus at 12 hours.
This is very similar to the profile of HFF culture incorporation assay. Maximal incorporation levels of
rQT3 in these two cell-lines are also similar.
Modulation o f Uptake and Incorporation by PKC-catatyzed Phosphorylation
In the rQT3 uptake studies both neoplastic cell-lines exhibited sensitivity to modulators o f PKC
activity and inhibitors of protein phosphatase activity and to a similar extent as the “normal” HFF cells
(Graph 5-3). However, exposure to phosphorylation modulators produced results for the rQT3
incorporation step that were comparable in only MCF-7 and HFF cell-lines. Even after 5-azaC-induction
of the queuine incorporation system in the HxGCj cell-line, the incorporation of rQT3 does not appear to be
effected by exposure to the PKC or phosphatase modulators (Graph 5-4). It is proposed that the absence of
regulation is due to the 5-azaC-induced synthesis of only the smaller catalytic subunit and not the larger
regulatory subunit that makes up the “normal” tRNArguanine ribosyltransferase dimer.
Queuine Salvage
The queuine salvage mechanism of the HxGC3 cell-line was not studied due to the requirement of
the cell culture assay method to measure the salvage of queuine via maintenance o f the level of
incorporated nucleotidyl base. Previous reports, however, suggest that the queuosine-deficient HxGC3
cells maintain a poor queuine salvage efficiency of 18% (17,31).
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Graph 5-1. Time-Courses o f Queuine Uptake in Human Foreskin Fibroblast (HFF), Colon
AdenocarcinomafHxGCi), 5-azaCytidine-TreatedHxGCp and Breast Adenocarcinoma(MCF-7) CellLines. These cell-lines were grown to near confluence, then 100 nM rQT3(a tri-tritiatedqueuine
analogue) was added at time 0, and uptake assays performed. The amount of radioactivity taken up into
the cells was measured at 0,0.5,1,1.5,2,2.5,3, and 6 hours. The values were normalized to the
number of picomoles of rQT3 per 10s cells. Deviation bars indicated representthe standard deviation
with n =6.
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Graph 5-2. Time-CoursesofQueuine Incorporation into tRNA o f Human Foreskin Fibroblast (HFF), Colon
Adenocarcinoma (HxGC]), 5-azaCytidine-TreatedHxGCj, and BreastAdenocarcinoma(MCF-7) Cell-Lines.
These ceil-lines were grown to near confluence, then 100 nM rQT3 (a tri-tritiatedqueuine analogue) was
added at time 0, and incorporation assays performed. The amount of radioactivity inserted into tRNA was
measured at 0 ,3 , 6,9 ,1 2 and 24 hours. The values were normalized to the number of picomolesof rQT3 per
I05 cells. Deviationbars indicated represent the standard deviation with n =6 .
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Graph 5-3. The Effect o f Exposure to a Protein Kinase C Activator (TPA), Inhibitor (Staurosporine), and
Phosphatase Inhibitor (Okadaic Acid) as Comparedto UntreatedCultures on Queuine Uptake in Human
Foreskin Fibroblast (HFF), Colon Adenocarcinoma (HxGCi), S-azaCytidine-TreatedHxGCj, and Breast
Adenocarcinoma(MCF-7) Cell-Lines. These cell-lines were grown according to methods. Then, rQT3(a tritritiated queuine analogue) was added at time 0, and uptake assays performed. Uptake assays were measured
at 3 hours. The amount of radioactivity taken up into ceils was measured by liquid scintillation. The values
were normalized to the number o f picomoles of rQT3 per 105 cells. Deviationbars indicate the standard
deviation with n = 6 .
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Graph 5-4. The Effect o f Exposure to a Protein Kinase C Activator (TPA), Inhibitor (Staurosporine), and
Phosphatase Inhibitor (Okadaic Acid) as Comparedto UntreatedCultures on Queuine Incorporation into
tRNA o f Human Foreskin Fibroblast (HFF), Colon Adenocarcinoma(HxGCj), 5-azaCytidine-TreatedHxGCp
and Breast Adenocarcinoma(MCF~7) Cell-Lines. These cell-lines were grown according to methods. Then,
rQT] (a tri-tritiatedqueuine analogue) was added at time 0, and incorporationassays performed. The
incorporation assays were stopped at 8 hours. The amount of radioactivity inserted into tRNA was measured
by liquid scintillation. The values were normalized to the number of picomoles of rQT3 per 10s cells.
Deviation bars indicate the standard deviation with n = 6.
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tRNA-tumover baselines measured for MCF-7 and HFF cells showed slightly faster degradation
rates for the tRNA of the neoplastic cell-line, and the MCF-7 cell-line was observed to have a slightly
faster growth rate over the four days o f the experimentation. However, the values are still reasonably close
(Graph 5-5). In these studies the HFF cells are able to retain nearly 100% of incorporated rQT3 for up to
four days with one day to over a week o f queuine starvation, with only a small decline in rQT3 retention
after three weeks of starvation. In contrast to queuine salvage in the “normal” cells, the MCF-7 cell-line
exhibits virtually no latent salvage capability. At only one day of queuine starvation, these cells show a
similar turnover pattern o f rQT3-modified tRNA retention with and without a non-radioactive queuine
chaser. After one week o f queuine starvation approximately 50% salvage of rQT3 is evident Three week
queuine starvation dropped rQT3 maintenance levels to that of just above background.
Discussion
Due to the multistep process o f the queuosine modification system, this research attempts to
investigate four critical aspects to it’s proper functioning. Studies were undertaken to address whether the
malfunctions of the queuosine modification system in HxGC3 and MCF-7 neoplastic cell-lines were due to
lack o f adequate uptake, incorporation ability, salvage capability or to aberrant PKC-catalyzed modulation
of uptake or incorporation. Experiments involved experimental and control cultures o f each cell-line in
order to diffuse arguments regarding the modification differences of varying cell types (fibroblasts, and
colon and breast adenocarcinomas). Comparisons of “normal” (HFF cells) and neoplastic (HXGC3 and
MCF-7 cell-lines) cells were performed verifying that the characteristic hypomodification observed in
cancer cells (45) occurs in these cultures. Additionally, an investigation of each step o f the queuosine
modification system was executed to determine the site or sites for malfunction of this system in the two
representative tumor cell-lines.
There appears to be no abnormality in the uptake mechanisms of either o f the two neoplastic celllines which could create the queuosine deficiency observed in the cultures.
Results of the HxGC3 cell-line incorporation studies directly support the hypothesis that there is
no incorporation of queuine into tRNA in these cells, and confirms that this is due to the lack of a cellular
TGRase activity. This result verifies the presence of 5-azaC-induced incorporation o f queuine in the
HxGC3 cell-line that had been previously seen only indirectly by RPC-5 liquid chromatography and is
much stronger evidence for the theory that the HxGCj cell-line is deficient in the queuosine modification
due to a null mutation in the functional alleles for the TGRase protein. Malfunction o f the incorporation
step in the queuosine modification system is not the cause for the observed MCF-7 queuosine deficiency.
“Normal” HFF cells have been shown to contain a dual-modulation scheme for both the uptake
and incorporation of queuine (Chapter 4, (126,147)). These two components of the queuosine modification
system have been shown to be directly activated by PKC. In contrast, protein phosphatases are able to
reverse this process by removing the phosphate group and thereby inhibiting both systems. Purified
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Graph 5-5. Comparison o f Queuine Salvage in "Normal" Human Fibroblasts and Mammary Adenocarcinoma Cell Cultures, Cultures of human fibroblast
(HFF) or breast adenocarcinoma (MCF-7) cells were grown to near confluence in normal media, fed with charcoal-stripped serum (lacking queuine) for I day, I
week, or 3 weeks with regular media changes, then submitted to an in vivo queuine salvage assay. A dose of 100 nM tritritiated analogue of queuine (rQT3) was
placed in the media 24 hours before the start of the assay to saturate the tRNA with the radiolabeled base. For each cell-type, two sets of parallel cultures were
established. At time zero extracellular rQT3 was washed away, then a media change with charcoal-stripped media was performed. One set of cultures was
exposed to 0.10 A26o units of unlabeled queuine (solid line) to provide an indication of the tRNA turnover rate within those cells. No queuine was added to the
other set of cultures (dashed line) which represents the ability of the cells to retain the radiolabel in the cell’s tRNA despite the degredation processes involved in
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mammalian queuine incorporation enzymes from mouse, rat, cow, and human liver tissues have been
isolated and shown to exist in a dimeric form with a regulatory and a catalytic subunit (Chapter 3
(125,126)). In order to determine if similar regulation schemes are functional in the neoplastic cell-lines, in
vivo uptake and incorporation assays were performed with cells exposed to a PKC activator (TPA), a PKC
inhibitor (staurosporine), and a protein phosphatase inhibitor (okadaic acid) in concentrations most specific
for modulation o f these cellular PKC and phosphatase enzymes. The response o f the queuine uptake
mechanisms in both HxGC] and MCF-7 cell-lines when exposed to these modulators was comparable to
that of the “normal” HFF cultures. In studies of the incorporation step of 5-azaC-treated o f HxGC] cells,
however, the induced queuine incorporation activity effected by exposure to PKC or phosphatase
modulators. This may be due to the transcriptional activation o f only the mRNA for the active subunit of
the enzyme. The MCF-7 cell-line, however, exhibited a comparable response to the “normal” HFF cellline upon exposure to phosphorylation modulators.
While it was reported that the HxGCj cell-line maintains a level of only 18% salvage activity
(17,31), it was not possible to measure the levels using the in vivo assay method employed in these studies.
However, queuine salvage studies demonstrated a distinct deficiency in the salvage ability of the MCF-7
cell-line. With no latent salvage activity to only mildly inducible salvage activity available to the cells, a
deficiency in the concentration o f the queuine substrate for the incorporation step could arise. If either a
decrease in the availability o f dietary queuine or an increase in cell division rate were to occur, these cells
would not be able to sustain high levels of queuosine-modified tRNA by salvage o f the queuine base alone.
The lack of an efficient salvage mechanism in the MCF-7 cell-line could help to explain the relatively
moderate level of queuosine deficiency (50 to 60%) exhibited as compared with the HxGC] cells (100%)
which exhibit no queuine incorporation activity.
The results o f this research suggest that the deficiencies o f the queuosine-modified tRNA
population found in cancer cells, such as the HxGC] and MCF-7 ceils used in this study, may arise from
the malfunction o f any o f a number o f steps. Due to the known importance of PKC in tumor biology and
existence o f defects o f this enzyme in several neoplastic systems (85), it is also likely that ineffective
phosphorylation-based modulation o f the uptake and incorporation systems of other tumor cell-lines might
also be a cause for observed queuosine hypomodification levels. However, two specific and distinct sites
for queuosine modification system breakdown have been identified in this study. The HxGC3 cell-line is
an example of a cell-type containing a transcriptional inability to produce the queuine incorporation
enzyme that is required to create this modification (Figure 5-1), while the MCF-7 cell-line is an example of
the disruptive effect o f an inefficient queuine salvage mechanism (Figure 5-2).
In addition to the identification of the multifocal nature of the queuosine modification system and
it’s malfunction, the identification o f the etiology for queuosine deficiency has suggested three potential
benefits for this knowledge. First, biopsied tumors that are identified as containing contrasting sites for
queuosine modification system deficiency may be ruled out as a metastatic byproduct of a primary mass.
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In addition, sites for potential chemotherapeutic treatments concerning queuine (if developed) can be more
explicitly targeted to the specific neoplastic cells o f a patient. Finally, a human cell-line with a null genetic
mutation for a major component o f the queuosine modification system has been found-the HxGC3 cellline. This appears to mimic the situation seen in only the yeast organism where the queuosine modification
does not exist (10). The discovery o f a mammalian cell-line that does not contain a functional queuine
incorporation enzyme provides a good subject for gene expression studies that allow for the experimental
investigation of the effect of the queuosine modification on cells in general, and especially in determining
the importance o f the observed queuosine hypomodification in human neoplastic cells.
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Figure 5-1. The Eukaryotic Queuosine Modification System in HxGCj Human Colon Adenocarcinoma Cells. The eukaryotic system is based on usage of an
available resource and is regulated by the direct action of protein kinase C (PKC) on both uptake and incorporation steps as described in Figure 4-3. In HxGCj
cells, which contain no queuosine in their tRNA, the incorporation step appears to be entirely deficient. Despite a very weak ability to salvage incorporated
queuine from degraded tRNA, these cells lack the ability to synthesize the modified nucleoside in any capacity. Treatment with the DNA methylase inhibitor 5azacytidine for 24 hours induces a weak but measurable induction of tRNAiguanine ribosyltransferase (TGRase) activity in these cells and provides evidence of
the formation of queuosine-modified tRNAs. This induced activity, however, is not susceptible to stimulation by PKC. Thus, it is suggested that at least one
allele of the catalytic subunit of TGRase is inactivated by the methylation of the promoter region of it’s gene in these cells.
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Figure 5-2. The Eukaryotic Queuosine Modification System in MCF-7 Human Breast Adenocarcinoma Cells. The eukaryotic system is based on usage of an
available resource and is regulated by the direct action of protein kinase C (PKC) on both uptake and incorporation steps as described in Figure 4-3. In MCF-7
cells, which contain a significant deficiency of 50-60% queuosine in their tRNA, the salvage step appears to be deficient. Despite the ability to take up queuine
from the surrounding environment and incorporate it into tRNA, these cells show a pronounced inability to salvage the modified nucleoside. Latent salvage
activity does not occur in these cells with only one day of queuine starvation. In addition, strong induction of the salvage mechanism by queuine starvation for
one week, which is seen in “normal” human fibroblasts, appears to be compromised in these cells (approximately 50% effective). After three weeks of queuine
starvation the ability to salvage queuine from tRNA is completely lacking. Thus, despite the ability to take up exogenous queuine and incorporate it into tRNA,
reduced salvage efficiency predisposes these cells to significant queuosine deficiencies in a shortage of exogenous supply or under fast growing conditions.
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CHAPTER SIX
EFFECTS OF THE QUEUOSINE MODIFICATION SYSTEM
ON THE STRUCTURE AND FUNCTION OF tRNA
Introduction
Queuosine is a modified nucleoside found in position 34 (the wobble position) o f the anticodon
hairpin loop o f tRNA“p, tRNA*” , tRNA1” , and tRNA^in every organism yet studied with the sole
exception of yeast (10,11). Chapters 3 and 4 o f this treatise folly describe the mechanism and regulation of
the queuosine modification system in human systems. The control o f this system by protein kinase Ccatalyzed phosphorylation allows the formation o f queuosine to be coordinated with other cellular
processes that control the life cycle o f a cell. The aberrant functioning of the queuosine modification
system is directly correlated with neoplastic transformation and metastatic progression o f abnormal cell
lines. Chapter S describes a series of assays used to determine the exact point at which the system failure
occurred in two cancer cell-lines. However, despite the understanding o f the normal cellular dynamics of
the queuosine modification, there is still relatively little subcellular knowledge regarding the function of
this modified nucleoside within a tRNA.
Modifications of RNAs have been shown to have a strong influence on the alteration o f steric and
electrostatic properties of these important molecules. Aspects o f RNA structural stabilization and of
anticodon hydrogen bonding potentials are crucial components for tRNA function. Weiss proposed that a
mispairing of the anticodon wobble base could dramatically effect the binding kinetics o f the tRNA to it’s
mRNA codon—which, he suggested, has the potential to regulate the rate of translation (148). Grosjean,
Houssier & Cedregen have demonstrated the presence of different conformers o f anticodon regions (i.e.
flexibility) in temperature-jump relaxation experiments due to the presence of altered binding kinetics for
queuosine versus guanosine-containing tRNAs (149). It was further proposed that the formation of the
queuosine nucleoside is involved in “a mechanism of translational control (coordinated modulation)
relying on the interdependence o f metabolic pathways, modified nucleotide synthesis and codon usage...”.
The crystal structure of the S’-monophosphoryl-queuosine nucleotide indicates the likely presence
of a hydrogen bond between the aminomethyl group of the modification’s side-chain and the 0 6 of the
purine ring structure (13). This intramolecular association may have a role in altering the hydrogen bond
accepting ability of this position in tRNA. Additionally, the anticodon loop is the most flexible region of
the tRNA molecule, with the most variable configuration adjacent to the site of the queuosine-modification
at the phosphoryl linkage between residues 33 and 34 (ISO). Thus, it is likely that the effect o f a modified
wobble base (position 34) on the function of tRNA would be influenced by alteration o f either electrostatic
or steric properties of the anticodon based on the mobility of residues in the anticodon loop. In view of the
extended multi-fonctional group structure of queuosine and its location in the wobble position of tRNA, it
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is likely that this modified nucleoside plays a significant role in the decoding properties of tRNA through
adjustment of the molecular dynamics of the anticodon or anticodon loop structures.
The structural stability o f RNA loops have been shown to be influenced by changes in the
nucleoside sequence o f the molecule. Singh and (tollman have recendy studied the relative mobility of
RNA hairpin loop residues based on thermodynamic properties o f a molecule before and after the
introduction of a point mutation (151). Their calculations indicated that a simple C to U point mutation in
the RNA loop was capable o f dramatically increasing the flexibility of the loop by dissolution o f an
intramolecular (cross-loop) hydrogen bond.
The alteration of nucleosides by modification in tRNA also plays a significant role in the
structural dynamics o f RNA stem/loop structures. Due to steric hindrance o f functional groups, 2’0 ribose
methylation and base thiolation o f non-anticodon residues have been shown to cause the shift o f ribose
puckering toward the C3’-endo conformation which stabilizes base stacking interactions throughout
neighboring residues (152). These modifications enhance the structural stabilization of the anticodon while
influencing proper codon recognition and preventing misreading of non-cognate codons (152). Recently,
an alternative ribose puckering conformation (C2’-endo) was shown to be induced by the presence of
dihydrouracil (153). In addition to this modified base’s non-aromatic nature, the promotion o f the different
ribose configuration caused a disruption of base-stacking interactions within the RNA molecule. This
causes increased regional flexibility which is important in the hinge region o f the tRNA molecule.
An increase in the strength o f base-stacking interactions (154) and the formation of extended
hydrogen bonding networks was shown to be promoted by the presence o f the anticodon loop
pseudouridine nucleotide (155). Both of these factors caused an increase in the rigidity of the entire
anticodon. Thus, modification o f RNA primary transcripts has been shown to be involved with the overall
structural dynamics of the molecule through the modulation of hairpin loop stability. Due to the extended
multi-functional group structure o f the queuosine modification, this wobble base may play a role in RNA
loop stabilization based on potential extended intra-anticodon loop interactions.
It has been suggested, due to the size of a few large modified nucleosides in the anticodon loops
of various tRNA molecules, that some modified bases have the potential to sterically interact with a
neighboring tRNA anticodon loop in aminoacyl-/peptidyl-site tRNA interactions (112). The lack of the
normal wyebutine modification at position 37 of tRNA1** molecules, a tricyclic purine analogue with a
large branched side-cbain, has been suggested to increase the speed of translation around UUU and UUC
phenylalanine codons, while the folly modified tRNA exerts unspecified restrictive codon context effects
(156). Experimental evidence supporting context effects exerted by the queuosine modification has been
reported in studies demonstrating the ability of unmodified (guanosine-containing) form of tRNA1*7to
read-through UAG stop codons (157,158). Queuosine-modified tRNA'5'1do not appear to possess this
amber suppression capability. Additional codon context effects have been proposed for both queuosinemodified tRNA*“ and wyebutine-modified tRNAphein frameshifting events essential to the translation of
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gag-pol gene products of human immunodeficiency virus (HIV), human T-cell leukemia virus (type I)
(HTLV-l), and bovine leukemia virus (BLV) (159). It was demonstrated that absence of the queuosine
modification in tRNA*” enhanced the ribosomal frameshiftmg around an AAC codon at the shift signal in
HTLV-l and BLV. Wyebutine-deficiency in tRNAphcenhanced frameshiftmg at a UUU codon
fiameshifting signal in HIV. These fiameshifting events are essential to the production of gag-pol products
for these viruses, and codon context effects exerted by these two modified nucleotides appear to have
important modulating effects in the efficiency o f the fiameshifting mechanism. Since neighboring tRNA
loop interactions are plausible in the framework of adjacent ribosomal aminoacyl- and peptidyl-sites, and
since bulky tRNA modifications, such as wyebutine and queuosine, could be positioned in immediate
proximity with sequential UUPy and GAPy codons, it is conceivable that steric interference at these codon
pairs (restrictive codon context) could be significant Thus, codon context-based steric restriction o f tRNA
association by anticodon loop modified nucleosides could effect the translation efficiency of mRNAs for
proteins based on the existence of specific codon pairs and the levels of modified-tRNAs.
The function of queuosine in the wobble position of the anticodon has also been investigated with
regard to its decoding properties. Results of experimentation, which included the injection of drosophila
tRNA1” and turnip yellow mosaic coat protein mRNA into Xenopus oocytes, demonstrated that guanosinecontaining tRNA111*has a strong preference for codon sequences o f CAC over CAU. However, queuosinemodified tRNA1"* does not exhibit a preference for either histidine codon, indicating that queuosine
eliminates codon bias between histidine codons in this system (160). Another study examined the effects
of rabbit reticulocyte queuosine-modified tRNA1* on the decoding properties for histidine codons found in
rabbit globin mRNA using a reticulocyte lysate translation system (161). The authors also demonstrated
that the queuosine-modified tRNA1* has no preference for either U or C in the third position of the
histidine codons. Grosjean, Houssier and Cedregen utilized temperature-jump relaxation experiments and
verified that while guanosine-containing and queuosine-modified tRNAs are equally stable in complexes
with NAU codons (162), guanosine-containing tRNAs are significantly more stable in complexation with
NAC codons (149,163,164). Thus, it is suggested that the queuosine modification serves to alter the codon
binding properties of tRNAs by reducing the C over U codon bias apparent with guanosine-containing
tRNAs.
This study was initiated to explore the effects of queuosine on the decoding properties of the
tRNA using computational chemistry approaches of molecular modeling, including molecular dynamics
simulations. The experimentation was designed to study the intramolecular effects of the modification on
the electrostatic and steric structure of the tRNA anticodon loop, as well as the effects of the modification
on the complexation of tRNAs with a neighboring tRNA (codon context effects) or mRNA (codon bias
effects).
Initially, nucleotide analysis was performed to assess the electrical potential of the hydrogenbonding regions for guanosine and modified guanosine analogues, including queuosine. The method
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involved semi-empirical charge assignment and geometry optimization algorithms, with visualization of an
electrical potential map on the electron density surface for each molecule. In addition, anticodon stem/loop
analysis was performed on tRNA“p anticodon stem/loop structures modified or unmodified at position 34
(the wobble position) in order to determine the effect of guanosine and guanosine analogues, particularly
the queuosine modification, on the configuration and flexibility o f the anticodon loop. This method
involved the use o f energy minimization techniques and extended molecular dynamics simulations.
Accordingly, macromolecular complex analysis was performed on a tertiary organization of
tRNA“p anticodon stem/loop molecules, whole tRNA1** molecules, and a mRNA transcript in a
configuration consistent with that associated at the aminoacyl- and peptidyl-sites o f a translating ribosome
(107). Evidence of potential interaction between aminoacyl- and peptidyl-site tRNAs at the queuosine and
wyebutine modifications o f the anticodon loop were visually analyzed in order to determine the presence
of a potential codon context phenomenon based on steric interaction. In addition, the A-site tRNA and
mRNA association was analyzed to explore potential differences between queuosine-modified and
guanosine-containing tRNA“panticodon stem/loop structures with cognate GAC and GAU mRNA codons.
Energy minimization and molecular dynamics simulations and energy calculation algorithms were used to
determine relative tRNA anticodon/mRNA complex stabilities and evidence o f preferred (biased) pairings.
Results and Discussion
Nucleotide analysis
Initially, structural analysis of guanosine (G) and the guanosine nucleoside analogues 7deazaguanosine (7-deazaG), 7-aminomethy1-7-deazaguanosine (7-am-7-deazaG), and queuosine (Q)
(Figure 6-1) was studied using semi-empirical methods. AMI and PM3 charge assessment with geometry
optimization was performed. Both MOPAC algorithms provided essentially the same values for
electrostatic potential and for geometric arrangement of atoms. Since the PM3 method is more recent and
appears to be more accurate when applied to nucleic acids with significant hydrogen bonding potential
(165), the results of these calculations were used for further modeling.
Conformational search via simulated annealing was employed to determine reasonable
conformations and differences in intermolecular associations and in the hydrogen bonding abilities of the
three functional groups for nucleoside base-pairing of purine residues. After an extensive search, the
quaternary amines of both the Q and 7-am-7-deazaG molecules appeared to be in reasonable positions for
hydrogen bonding interactions with respective carbonyl oxygens at the C6 position (Figure 6-2). A
hydrogen bond prediction algorithm built into the Sybyl software, which takes into account both distance
and bond angle parameters, verified the likely presence of this interaction. This corroborates preliminary
molecular dynamics simulations of the bases under gas phase, and under implicit and explicit solvation
conditions, which indicated greater than 60% o f the structures observed during the simulation were likely
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Figure 6*1. Modified Nucleoside Bases Studied in this Treatise. Guanine is the traditional base found at
position 34 (wobble position) of tRNA*” , tRNA*sp, tRNA1*, and tRNA1^. Queuine, a guanine analogue, is
a physiological modified nucleoside that replaces guanine in these sites in “normal” mature cells o f every
prokaryotic and eukaryotic organism with the exception o f yeast (10). 7-deazaguanine and 7aminomethyl-7-deazaguanine are intermediates in the formation of queuosine in prokarytoes. The three
major structural differences between guanine and queuine involve position 7 o f the base, the charged
quartemary amine of the aminomethyl side-chain, and the cydopentenediol ring o f the side chain. In these
studies, the intermediates were included to serve as a control for the effects of each of these differences.
Arrows indicate the position of n-giycosidic linkages to ribose.
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Figure 6-2. Skeletal Structures o f Guanosine a n d Us Analogues. Models are shown o f guanosine (upper right), 7-deazaguanosine (upper left), 7-aminomethyl-7deazaguanosine (lower right), and queuosine (lower left) after M OPAC 6,0 semi-empirical energy minimzation and geometry optimization, The orange arrows
indicate the sites for internal hydrogen bonding from the quaternary amine o f the side chain to the 0 6 o f the base's carbonyl in 7-aminomethyl-7-deazaguanosine
and queuosine,
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to contain parameters consistent with the presence of this hydrogen bond.
A study of the three sites for base pairing complexation (06, N1, and N2) was performed to assess
the effect of the hydrogen bond between the 0 6 and the quaternary amine of the aminomethyl side chain.
The MOLCAD-generated electron density surface plots of G and 7-deazaG exhibited identical electrical
potential maps, with strong hydrogen donor sites at the N1 and N2 positions and a moderate hydrogen
accepting site at the 0 6 (Figure 6-3). However, as a result of the intramolecular hydrogen bonding, the 0 6
was observed to possess diminished electronegative character comparably in the Q and 7-am-7-deazaG
molecules. This suggests a compromise of their Watson-Crick type hydrogen bond accepting status.
Additionally, the relative strength o f the electronegativity at the traditional hydrogen donating sites of the
N 1 and N2 in both these nucleotides appears to be reduced.
The results of the structural and charge studies performed for these molecules indicate the
importance of the interaction between the quaternary amine and the 0 6 in the two molecules with the
aminomethyl side chains. It appears that this intramolecular hydrogen bond alters the hydrogen
donating/accepting profile o f the base. Whereas the G and 7-deazaG appear to have a traditional (WatsonCrick type) ADD hydrogen bonding pattern, Q and 7-am-7-deazaG are suggested to have a DD pattern
which may even be weaker in strength than the imino form of an adenosine. Of course, in biochemical and
chemical systems, interactions such as hydrogen bonding are freely reversible. Therefore, both guanosine
like and adenosine-like interactions are likely to be possible with Q and 7-am-7-deazaG.
The quaternary amine o f the aminomethyl side chain, existing in both Q and 7-am-7-deazaG,
provides an electrostatic difference manifesting itself in hydrogen bonding potential differences between
these two nucleosides and G or 7-deazaG. However, the aminomethyl side chain is not likely to have any
steric effect on the codon-anticodon interaction, since the configuration of the nucleotide appears to
position this extension away from the site for base-pair hydrogen bonding-confirming results seen in the
original crystal structure o f the Q nucleotide (13). Thus, the a possible codon bias effect is suggested based
on differential electrical potential o f tRNAs for wobble bases with and without the aminomethyl sidechain.
Anticodon Stem/Loop Analysis
Transfer RNA anticodon stem/loop structures with modifications of the wobble residue were
analyzed using molecular dynamics simulation to determine differential intramolecular associations caused
by the 7-deazaG, 7-am-7-deazaG, and Q bases. Unfortunately, due to computational limitations the
addition of counterions and solvation to the system was not possible. In addition, a reasonably long length
of simulation (up to ms) was also not possible. However, these preliminary studies were performed based
on a qualitative method developed by Nilsson and Karplus on very different software and hardware
computer systems for the anticodon stem-loop of tRNAphe (97). The data generated was validated by the
duplication of the original study and a favorable comparison between the original and duplicated results for
tRNAphc and the present study of tRNA*sp.
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Figure 6-3. Electrical Potential Surface Studies o f Guanosine and its Analogues, Electron density surfaces were generated for each nucleotide in
observed in (Figure 6-2). An electrical potential map for each was generated and is displayed on the surfaces with a red color representing the
strongest positive charge proton donor capacity and purple indicating the strongest negative charge (proton acceptor capacity).
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Using molecular dynamics simulations, molecular rigidity was assessed to determine queuosine’s
effects on the overall flexibility of the anticodon loop: a region critical for the tRNA’s function as an
adaptor for the mRNA codon. At 10 ps into the temperature plateau the RMS fluctuations o f kinetic versus
total energy were calculated for the three modified and the G-containing stem/loop structures and were
determined to be less than 2%. This indicated a stable simulation for data collection and analysis. Transfer
RNA“P anticodon stem/loop molecules mutated to contain 7-am-7-deazaG and 7-deazaG produced
minimization and dynamics results that were essentially identical to that observed for the G-containing
tRNA. However, residue mobility and molecular flexibility differences were observed in the loop region
of these molecules as compared with the Q-modified RNA loop.
The stem o f the tRNA molecule from residue 26 through 3 1 and 39 through 44 maintains its basepairing and A-helix structure throughout the simulation. The radius of gyration remains fairly constant,
fluctuating from 9.85 to 1020 A for G-containing, 7-deazaG-modified, and 7-am-7-deazaG-modified
tRNAasp molecules and 9.70 to 10.10 A for Q-modified tRNA*sp during the 15 ps to 55 ps time frame over
the course of the simulation plateau, as compared to 10.6 to 10.9 A for tRNA1** in the original study (97).
The helix does appear to condense slightly over the length o f the run and corresponds well to Nilsson and
Karplus’ tRNA1** anticodon stem/loop data. The RMS deviation from starting positions over the
simulation was 0.54 to 0.70 A on average for all G-containing, 7-deazaG-modified, and 7-am-7-deazaG
tRNA*sp stem atoms, while 0.64 to 0.75 A for all Q-modified tRNA“p stem atoms. This parameter could
not be compared with Nilsson and Karplus’ data because of the differences in available reference structures
(initial dynamics structures (97) versus X-ray crystal coordinates) due to the limitations of the number of
programmable steps in the software utilized. Overall, the stem structures of the molecules were well
maintained with the only significant structural deviation at the ends (residues 26 and 44, and to a limited
degree 27 and 43). This “end-effect” artifact was brought about by the artificial termination of the
structure and was described by Nilsson and Karplus in the original work with the tRNA1** anticodon
stem/loop (97). This artifact is a necessary but unfortunate side-effect of the structural truncation required
for minimizing the computation time required for these complex calculations.
The resulting RMS differences in atomic positions o f the G-containing, 7-deazaG-modified, and
7-am-7-deazaG-modified tRNAup anticodon stem/loop structures closely mimic that o f truncated tRNA1**
model (97) in comparisons of data at 5, 10 and 40 ps timepoints (data not shown). However, in the
calculations of the Q-modified tRNA“p, the resulting RMS difference values are dramatically different in
the movement o f specific loop residues (residues 32 through 37). The variance in these nucleoside
positions are far lower in intensity than that observed in either the G-containing, 7-deazaG-modified, or 7am-7-deazaG-modified tRNA“por the tRNA1** anticodon stem/loop structures (97). This suggests possible
structural and electrostatic influences on intramolecular mobility in the anticodon loop caused by the
queuosine residue.
During the molecular dynamics simulation, it was observed that the greatest fluctuation of residue
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positions o f all tRNAup anticodon stem/loop molecules exists at residues 34 and 35 (Graph 6-1). The great
flexibility at the wobble position and that o f the middle anticodon residue (position 35) are important for
the association o f the anticodon/codon triplet interaction. The movement o f each o f the anticodon bases is
known to be influenced through direct covalent linkages as well as base-stacking interactions. In addition,
the slowly decreasing mobility o f residues through the anticodon bases (34,35, & 36), as compared with
those of residues 33 and 32 at the 5’ side o f the anticodon, corroborates the long-held assumption
concerning the role o f base-stacking interactions in the global motility o f the 3’ side o f the anticodon loop.
However, it was observed that distinct differences exist in the mobility o f several Q-modiffed loop residues
as compared with those in the G-containing, 7-deazaG, or 7-am-7-deazaG-modified loops.
The magnitude o f RMS fluctuation o f the residue at the wobble position (34) is greatest in the
case of G-containing, 7-deazaG-modified, and 7-am~7-deazaG-modified loops, but in the Q-modified loop
this falls to a level below that o f residue 35 (Graph 6-1). The extent of fluctuation for residue 35 appears to
be unchanged between the two anticodon stem/loop molecules, however the decrease in RMS fluctuations
over the anticodon bases is terminated much more quickly in the Q-modified loop, indicating a great
decline in mobility after residue 36 and before the queuosine wobble residue. Additionally, the sharp
decrease of RMS fluctuations on the 5’ side of the wobble base at residues 33 and 32 is more dramatic in
Q-modified tRNA with virtual immobility o f base 32. These observations of differences in residue
fluctuations and mobility can be explained by intramolecular hydrogen bond associations observed during
the molecular dynamics simulation.
Visual inspection o f the anticodon loop residues over the molecular dynamics simulation suggests
that several potential intramolecular hydrogen bonding interactions influence the traditional base-stacking
interactions of the anticodon nucleotides. In both G-containing and Q-modified anticodon loops, a
hydrogen bond was observed between the N3 position o f the uridine residue at position 33 (U33) and the
backbone phosphate of the cytidine residue at 36 (C36) during the molecular dynamics simulation (Figure
6-4). Confirmation o f this cross-loop hydrogen bond in the anticodon loop of guanosine-containing
tRNA*sp was published after the completion o f this research in a solvated system with counterions, and for
a simulation running roughly 10-fold longer than this simulation by Auffinger and Westhof (99).
Interestingly, the number of timepoints exhibiting the cross-loop U33 to C36 hydrogen bond in the Qcontaining loop was 68%, while its presence in G-containing-, 7-deazaG-modified, and 7-am-7-deazaGmodified loops was less than 36%. The increased frequency of intramolecular hydrogen bonding
interaction between these residues in the Q-modified anticodon loop may explain the decreased mobility
(decline in slope) of the 3’ side o f the loop (residues 37 and 38), as well as the previously discussed 5' side
of the loop (residues 33 and 32).
On closer examination o f the Q-modified tRNA<spanticodon loop, it was observed that the
hydroxyl groups of the cyclopentenediol ring were maintained in close proximity to the 3*0 and 2’OH of
the backbone ribose of U33, as well as the phosphate o f the Q residue at 34 (Q34). Further analysis
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Graph 6- 1. Fluctuations o f Anticodon Loop Residue Positions During the MolecularDynamics Simulations. The root mean square (RMS) fluctuation of the
position of each nucleotide in the anticodon stem loop structure was determined using a molecular dynamics simulation. A tRNA“p anticodon loop containing
guanosine in position 34 is represented by the graph on the left. A queuosine modified loop (position 34) is represented in the graph on the right. The
flexibility of the entire anticodon region is greater in the guanosine-containing model than in the queuosine-modified anlicodon model, with positions 32, 34,
and 37 showing the greatest difference in flexibility.
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Figure 6*4. Queuosine Induced Stabilization o fAnticodon Flexibility Through Hydrogen Bonding Networks. Representation of ribbon backbones with ball and
stick nucleoside bases for anticodon residues 34,33, and 36 as well as the backbones of residues 33 and 36, a) The structure on the left depicts the queuosine
modified tRNAasp anticodon loop (green), Queuosine (green base and orange side-chain) engages in several stabilizing hydrogen bonded interactions between
its cyclopentendio) hydroxyl groups and the phosphoribosyl backbone of U33 (indicated by solid yellow arrows), These interactions promote the stability of the
additional cross loop U33 to C36 hydrogen bond interaction (indicated by yellow arrow outline), b) The structure on the right depicts the guanosine-containing
tRNAasp anticodon loop (blue). In this anticodon loop, there is no additional hydrogen bonding network observed due to the lack of the wobble base's
cyclopentenediol ring on the side-chain. As a result the U33 to C36 cross loop hydrogen bond is less frequently observed during the molecular dynamics
simulations, thus appears to be much weaker in strength than the corresponding bond in the queuosine-modified complex.
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revealed that allowable hydrogen bonding parameters exist between the hydroxyl groups of the queuosine
cyclopentenediol ring to the 3’0 during approximately 55% o f the 55 ps simulation run and to the 2’OH
for approximately 35% of the simulation run. Though it was initially proposed that these hydroxyl groups
could interact with the phosphate group (13), in these studies the 3’0/2’0H associations were observed
even more frequently than interactions with the phosphate group. In several instances, two or three of
these hydrogen bonding associations (networks) formed simultaneously which would increase the stability
of each interaction. In one example, the one hydroxyl group o f the cyclopentenediol ring was close enough
to interact with both the 3’0 and the O o f the phosphate simultaneously, with the other hydroxyl group
interacting with the 2 ’OH. The presence of this hydrogen bonding network would explain the decreases in
RMS fluctuation for the residues from 32 to 36, as these intramolecular bonds would greatly restrict the
movement o f these nucleotides.
The full structure o f the Q modification appears to have great intramolecular influence on the
flexibility of the andcodon loop. The intraresidue hydrogen bond between the quaternary amine and the
06 o f queuosine, in addition to the potential electrostatic influences on base-pairing ability, appears to
position the cyclopentenediol ring near the backbone o f the anticodon loop between Q34 and U33. The
presence of the dihydroxyl groups of the cyclopentenediol ring appears to be the major cause of this
restriction of anticodon loop flexibility. Neither the 7-am-7-deazaG nor 7-deazaG residues contain the
cyclopentenediol moiety nor comparable hydroxyl groups, and the modified anticodon loop forms of these
bases show RMS fluctuation profiles virtually identical to that o f G-containing tRNA. The two hydroxyl
groups of Q’s cyclopentenediol ring are then able to interact with the 3’0 and 2’OH of the U33 residue,
and the O of the backbone phosphate of residue Q34. This effectively locks the flexibility of the 5’ side of
the anticodon loop which is suggested to position the U33 in a more favorable conformation for it’s
association with the backbone phosphate o f C36. Thus, a proposed hydrogen bonding network is
suggested to be stabilized by the queuosine modification; initially forming on the 5’ side of the anticodon
between Q34 and U33, and across the loop with the interaction between U33 and C36 on the 3’ side of the
loop. This network would likely produce the decreases in overall anticodon loop flexibility seen in these
molecular dynamics simulations.
Since the completion of this work a report has been published of a significantly longer molecular
dynamics simulation of the flexibility of the anticodon stem-loop of tRNA*9 containing guanosine in
position 34 of the anticodon (99). In addition, the system was solvated and contained sodium counterions
for the charges present in the phosphodiester backbone. The calculations were performed using the
CHARMM force field (98) on a different computer system with different simulation software. However,
the anticodon stem-loop structures, flexibility, and predicted presence of the cross-loop hydrogen bond
were virtually identical to those shown here. The necessary design weaknesses o f the computational
methods used in this experimentation (namely the length of simulation and lack o f solvent and counterions)
are acknowledged, but the results obtained are validated by this published report.
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Macromolecular Complex Analysis: Interaction o f A- and P-site tRNAs (Codon Context)
In an initial study o f macromolecular associations, a 5’-GACUUU-3’ transcript was modeled with
either an A-site Q-modified tRNA“p anticodon stem/loop region o f tRNA*5**and P-site tRNA1*6 or A-site
tRNAphe and A-site Q-modified tRNA*9 anticodon stem/loop region of tRNA*9 . This was performed to
assess any possible steric or electrostatic interaction between the anticodon loops and stems o f side-by-side
tRNAs on a translating mRNA (codon context). These tRNAs were chosen because they contain two o f
the largest RNA nucleosides currently known—queuosine (Q) in tRNA“p and wyebutine (Y) in tRNApbe
(Figure 6-5).
Observation of the two complexes indicates that there is no interaction between the anticodon
stems of either o f the two orientations of tRNAs. As for possible anticodon loop interaction, with Qmodified tRNAasp in the A-site and Y-tRNAphe in the P-site, the terminal methyl o f the side-chain acetyl of
wyebutine comes closest to the hydrogen of the N2 amine of queuosine at approximately 6.9 A (Figure 66). This is too great a distance to suggest that steric hindrance might be exerted between these two tRNAs.

With a relatively uncharged methyl group being a participant in any possible interaction, 6.9 A is also too
great a distance to support any electrostatic interaction. A recent cryoelectron microscopic model o f the
ribosome (110,111) suggests that the sites for the placement of the A- and P-site tRNAs are “buried” within
a fairly tight cavern, this is likely to exclude a great deal of water for hydration of even charged atoms.
Finally, with the tRNAs in reversed orientation, Y-modified tRNAphe in the A-site and Q-modified tRNA“p
in the P-site, the modified nucleotides are on opposite sides of the complex (Figure 6-6). This
conformational model suggests that there is no potential for anticodon loop interaction in this
configuration. These findings effectively eliminate the possibility of sterically or electrostatically-based
restrictive codon context in A- and P-site:Q-Y interacting anticodon loop pahs.
A caveat must be included here, however. That we did not see anticodon stem or loop interaction
in this computational modeling study does not preclude the fact that the interactions may occur in the
“real” world. Our study is based on the best three dimensional model known at this time and our findings
appear to be correct based on the predicted “kink” in the mRNA between the A- and P-site codons. This
was predicted by Fuller and Hodgson in 1969 (166) and has been recently confirmed by the cryoelectron
microscopy studies of Agrawai et al. (111). The mechanism for predicted codon context effects may then
be answered by the possibility o f interactions based on the proximity of aminoacyl acceptor ends, DHU
loops, or even specific variable loops (167) o f A- and P-site tRNAs. Additionally, recent cross-linking
studies with ribosomal components have suggested a strong potential for rRNA interactions to influence
the stability of tRNA/mRNA complexes by direct interaction with the wobble base of A-site tRNA (168).
Thus, the previous codon context observations may be explained by rRNA/tRNA interactions which were
not under investigation in this study.
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Figure 6-5. Structures o f Hypermodified Nucleotidyl Bases: Queuosine and Wybutine. These two
modified nucleosides are currently the largest ones that have been identified in any nucleic acid. The
wybutine base (often designated Y) is found in all organisms next to the anticodon o f tRNAphc in position
37. The queuine base (Q) is found in the wobble position (34) of tRNA*” , tRNA*sp, tRNAh“, and tRNA1^
in all organisms except for yeast.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

/

(

4

Figure 6-5. Interaction Between Anlicodon Loops Complexed with mRNA on Ribosomes, a) Shows the ternary complex o f queuosine-modified (Q34) tRNA*5'1
(green) in the A-site adjacent to a wyebutine-modified (Y37) tRNAPhe (blue) in the P-site o f a ribosome complexed to apair o f cognate codons in a hexameric
mRNA (red), b) Shows the reverse orientation o f wyebutine-modified (Y37) tRNAi*® (blue) in the A-site adjacent to a queuosine-modified (Q34) tRNA"P
(green) in the P-site o f a ribosomal complex. The highly modified Q and Y bases are drawn in yellow. T he models are consistent with the structural parameters
established by Easterwood and Harvey for tRNA-mRNA-ribosomal interactions. Results indicate that a bend occuring in the mRNA between the A- and P-sites
o f the ribosome prevents the queuosine and wyebutine modifications from sterically interfering with each other.
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Macromolecular Complex Analysis: Anticodon-Codon Association at the A-site (Codon Bias)
In an additional study of macromolecular associations, the G-containing and three modified
anticodon stem/loops of tRNA“p were modeled onto the A-site o f either a 5’-GACUUU-3’ (GAC-mRNA)
or 5’-GAUUUU-3’ (GAU-tnRNA) transcript to form eight possible tRNA/mRNA complexes. The
strength of association o f each o f these complexes was assessed by temperature-ramping molecular
dynamics simulations to determine the effects o f the unmodified and modified wobble bases on anticodoncodon interactions. Visual and computational examinations o f G-containing, 7-deazaG-modified, 7-am7deazaG- modified, and Q-modified tRNA"*’ complexes were performed.
Our results suggest that the G-tRNA/GAC-mRNA, 7-deazaG-tRNA/GAC-mRNA, and 7-am-7deazaG-tRNA/GAC-mRNA complexes were tightly associated through all three anticodon-codon bases
from 48 K through 323 K. Through a ramping protocol for increasing temperatures, the GAU-tnRNA
complexes and both Q-tRNA/GAC-mRNA and Q-tRNA/GAU-mRNA complexes were observed to
“retract’' the S’ end of their anticodon loops away from the codon beginning at the wobble (34) position.
This indicated that G-, 7-deazaG-, and 7-am-7-deazaG-containing anticodon stem/loops associated in a
more stable complex with the GAC- over that o f GAU-programmed mRNAs. In contrast, the Q-containing
anticodon stem/loop did not appear to have a preference for association with either GAC- or GAUprogrammed mRNAs.
Total, potential, and kinetic energies for each system were determined during the simulations
(Graph 6-2). The total energy o f each complex was observed to increase with the temperature ramp.
However, there are distinct differences in the energetics patterns of complexes involving the G-containing,
7-deazaG-modified, and 7-am-7-deazaG-modified tRNAs as compared with the Q-modified tRNA
complexes. With the rise in temperature during the simulation, those complexes involving a G/C or
modified-G/C interaction (traditional Watson-Crick base-pairing) at the wobble position exhibited a more
gradual increase in kinetic and potential energies than that observed for queuosine-containing complexes.
The rate of increase in total energy for the G-tRNA/GAC-mRNA, 7-deazaG-tRNA/GAC-mRNA, and 7am-7-deazaG-tRNA/GAC-mRNA complexes was approximately half that of the G-tRNA/GAU-mRNA, 7deazaG-tRNA/GAU-mRNA, 7-am-7-deazaG-tRNA/GAU-mRNA, and both Q-tRNA complexes with GAC
or GAU-mRNAs. The slow rise of energy levels for the second grouping of complexes indicates that the
initial geometry assumed for all complexes is less favorable for the non-traditional Watson-Crick pairing
structures. Each tRNA associates with either o f it’s cognate codons by exploiting the flexibility of the
anticodon region. In comparing the energy patterns for the four nucleosides studied, we suggest that the
reason for the difference in kinetic, potential and total energy pattern of the queuosine-containing complex
is not due to the replacement of the guanosine base’s N7 atom with a carbon atom, since the G-tRNA and
7-deazaG-tRNA complexes exhibit identical energetics patterns. The effects observed are also unlikely to
be due to the charged aminomethyl side chain o f the queuosine modification, since the 7-am-7-deazaG-
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Graph 6-2. Energetics Analysis o f Eight Complexes During Temperature Ramping Studies. The grey lines show the efficiency of the temperature steps during
the molecular dynamics simulation. The red line ( • ) indicates the rise in kinetic energy, the blue line (O) represents the rise in potential energy and tlic purple
line (+) indicates the rise in total energy during the simulations's increases in temperature (❖), These were calculated by a programmed algorithm within the
Sybyl software (Advanced compulation module). Each temperature step was examined for equilibration time (generally within 10 fs) and the remaining data
points for each of S fs intervals during the 100 fs step were averaged. Note the similarities in all lines for the complexes involving a guanosinc-, 7dcazaguanosinc-, or 7-aminomethyl-7-dcazaguanosinc-containing tRNA and the traditional Watson-Crick partner for the rnRNA’s codon, cytosine. Also note
the similarities in those complexes with the wobble pairing of the mRNA’s codon containing uridine with both queuosine-modiffed tRNA complexes involving
cytosine or uridine in the third position.

112

tRNA energetics patterns also duplicate that observed for G-tRNA and 7-deazaG-tRNA. Instead, the
differences detected for complex stability o f the G-, 7-deazaG-, and 7-am-7-deazaG-tRNAs versus the QtRNA systems are suggested to be caused by the presence o f the cyclopentenediol ring moiety that exists
only in the queuosine modification.
These results demonstrate that tRNA*sp/mRNA complexes containing the queuosine modification
and all those with GAU-programmed codons exist in a higher energy state than those with the more
traditional Watson-Crick type interaction. Additionally, we have shown that the modification of tRNA
with Q greatly increases structural rigidity o f the anticodon loop which is suggested to cause the observed
destabilization o f the anticodon/codon interaction. These computational modeling studies provide similar
results to published experimental data (149,163,164) which indicate that the queuosine modification
eliminates the G-containing tRNA’s strong codon bias for codons ending in cytidine over uridine. Thus,
alterations in RNA structure, represented by these sequence variations, appear to have a significant impact
on the ability o f the tRNA to efficiently associate with (decode) the sequence of the mRNA transcripts.
The results of this study provides evidence o f differences in the hydrogen bonding potential o f the
Q-modified versus G-containing anticodon triplet in addition to differential rigidity o f anticodon loops of
Q-modified and G-containing forms of tRNAasp. Either or both effects o f the queuosine modification are
suggested to have the potential to restrict the “wobbling ability” o f the queuosine base and the anticodon
when compared to the G-containing form.
Codon context effects by A- and P-site anticodon loop interactions do not appear to be a factor in
systems containing queuosine-modified tRNA anticodon stem and loop structures due to the modeled
“kink” in the mRNA between these two sites used in this study. The axes o f A- and P-site tRNA molecules
sharply angle away from each other which prevents even highly modified nucleosides on adjacent tRNAs,
such as that seen for queuosine and wyebutine, from interacting.
Potential coding biases, however, do appear to exist between G-containing and Q-modified
tRNA“p anticodon stem/loop structures for the cognate and pseudo-cognate codons. G-containing tRNA“p
demonstrates a much more stable and energetically favored association with the traditional Watson-Crick
type codon GAC, than with the wobble codon GAU. However, Q-modified tRNA*9 molecules exhibit no
difference in complex stability with either o f mRNA codons GAC or GAU. In addition, both Q-modified
tRNA<sp complexes exhibit virtually identical structural and energetic associations as the G-containing
tRNA“p/GALJ complex. The bias difference between guanosine- and queuosine-containing systems
appears to be primarily due to the inflexibility o f the Q-modified anticodon loop and its inability to
accommodate the proper positioning required o f tight Watson-Crick type associations. The presence o f
altered electrostatic potential surface (hydrogen bonding) characteristics of the wobble base appears to be
subordinate to the strong differences observed in loop flexibility for realistic effects on overall function of
Q-modified anticodon loops but may play a synergistic role in the overall function of queuosine-modified
tRNA.
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In 1982, Yarus proposed an “extended anticodon hypothesis” whereby many of the nucleosides in
the anticodon loop are likely to have influence over the structure and the function o f the anticodon,
particularly in regard to anticodon/codon interaction at the A-site o f the ribosome (169). In the following
years, his proposition has been verified and extended to the functions of modified nucleosides in stabilizing
or destabilizing the anticodon loop dynamics o f tRNA (149). Thus, the efficiency and accuracy of
translation is not solely limited to the participation o f the three anticodon nucleosides. Moreover,
modifications o f nucleosides in and around the anticodon appear to be important factors effecting the
coding potential and efficiency o f tRNAs (170).
The results of this research suggest that the queuosine modification is involved with the regulation
of gene expression rates in cells via a codon bias mechanism in tRNA-mRNA associations on the
ribosome. The proposed mechanism is based on the decreased flexibility of the anticodon produced by the
queuosine-induced extended intramolecular hydrogen bonding network of the anticodon loop. This
appears to restrict the modified anticodon loop’s ability to accommodate proper positioning for tight
Watson-Crick type associations with cognate codons, thereby limiting wobbling capabilities for queuosinemodified tRNA. In eukaryotic tRNA“p and tRNAlyr, the cyclopentenediol ring o f the queuosine
modification is often modified with one or several mannose or galactose moieties, respectively (14,18,19).
Individual oligosaccharides or chains of these glycosidic additions may have the potential to establish
supplementary hydrogen bond interactions through the loop and up along the groove of the A-type RNA
helix of the anticodon stem. If this proves to be true, it would undoubtedly further enhance the structural
stabilization o f the anticodon loop providing a significantly decreased bias in the coding potential of
tRNA** and tRNAtyr molecules.
The cellular level o f Q-modified tRNA appears to have strong implications with regard to
translational control of gene expression for “biased” genes involved in cellular differentiation, stress
response and neoplastic transformation. These events are tightly regulated by the production levels of
specific growth control, differentiation inducing and stress response proteins. It is doubtful that the
queuosine modification alone is responsible for the dramatic effects needed for phenotypic alterations of
cells. However, it is likely that the costly and complex enzymatic formation o f this modification has a
measurable effect on global cellular physiology, particularly in collaboration with well known mechanisms
for transcriptional regulation of specific growth control gene products.
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CHAPTER SEVEN
THE EFFECT OF Q ON TERRAN LIFE-FORMS
The research discussed in this document has produced a description o f the mammalian queuosine
modification system which has been largely based on that found in human cells. This system is
dramatically different from the well understood prokaryotic version. For many years it has been assumed
that the production of the queuosine modification m tRNA o f all organisms was by the same or a similar
mechanism.
Since 1973 the transglycosylase enzyme that incorporates the modified base into tRNA has been
designated as tRNArguanine transglycosylase in both Escherichia coli and rabbit reticulocytes where it was
first found to reversibly exchange a guanine-for-guanine in position 34 of asparagine*, aspartate-, histidineand tyrosine-encoding tRNAs (60). The first indications that the eukaryotic and prokaryotic queuosine
modification systems are different were published in 1976 with evidence o f glycosylation o f the queuosine
residues of tRNA19 and tRNA11* in rabbit reticulocyte lysates (14). In 1978 the substrate o f the base-forbase exchange leading to the synthesis o f queuosine in E coli was determined to be pret^ and not Q (24),
while in 1980 it became evident that mammals required the fully-formed Q base for incorporation (11,61).
A comprehensive description of the prokaryotic queuosine modification system has been
published (23) and is explained in depth in the introduction o f Chapter 3 o f this document It is a synthetic
mechanism which uses readily available substrates within the cell to build the modification on intact tRNA.
The mammalian system, discussed in Chapters 3 and 4 o f this treatise, is based on a utilization scheme
which incorporates a specific transport mechanism for the queuine base, an incorporation enzyme that
places it directly into position 34 o f the involved tRNAs, and a salvage mechanism which can recycle the
queuine base from tRNA turnover products for reuse by the incorporation enzyme (Figure 7-1). Even the
generalized structures of the incorporation enzymes, which may catalyze a similar reaction with the two
different substrates, are dramatically different
Control of both the prokaryotic and eukaryotic queuosine modification systems is also dissimilar.
The modulation of the prokaryotic system is based on transcriptional regulation of the operon which
contains two of the four enzymes required for queuosine synthesis. The FIS (factor of inversion
stimulation) serves to activate the gene expression for both the “queuine operon” and operons containing
sequences for the four substrate tRNAs (114) The mammalian system is shown to be regulated by a posttranslational phosphorylation-based mechanism in Chapter 4 o f this document Two of the three
components are activated by protein kinase C-catalyzed phosphorylation while deactivated by the action of
a protein phosphatase. The kinase-phosphatase reciprocal scheme is a common paradigm observed for the
control of important metabolic events in virtually all eukaryotic systems, with protein kinase C a key
regulatory switch for cellular growth and differentiation mechanisms.
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Figure 7-1. The Cellular Design fo r the Eukaryotic Queuosine Modification System. This depiction of the eukaryotic system is based on the three step
mechanism with modulation described in chapters three and four of this document; It involves an uptake step facilitated by a specific queuine transmcmbranc
transporter (shown in blue) which is activated by the pohosphorylation of protein kinase C (PKC) (shown in green). Once inside the cell, tRNAiguaninc
ribosyltransfcrasc (TGRasc) catalyzes the incorporation reaction of the queuine base (Q) into tRNA"", tRNA"1’, tRNA1"1, or lRNA,yr with concomitant release of
guanine (G). The TGRasc enzyme is a hctcrodimcr made up of a larger regulatory subunit (shown in black) which is the target for phosphorylation by PKC,
and a smaller catalytic subunit (shown in red). This enzyme is shown as being loosely associated with the membrane since the addition of detergents to the
homogenization buffer during protein purification increases the yield of the isolate dramatically. The stoichiometry of phosphorylation and the functional slate
of the enzyme (dimcrizcd or dissociated, associated with the membrane or soluble in the cytosol) is still in doubt. So a range of possibilities are shown here.
Finally, the last step of the queuosine modification system is a salvage step (catalyzed by an unknown mechanism represented in orange) which recycles free
queuine base for the incorporation step from qucuosinc-S’-monophosphate.
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Malfunctions o f various steps o f the queuosine modification system have been found to correlate
with drastic phenotypic changes in cellular appearance and behavior. These include the inability to survive
environmental stresses and to undergo developmental differentiation. In addition, queuosine deficiencies
have been strongly correlated with increased growth rate, retrograde differentiation, and neoplastic
transformation and metastatic progression o f mammalian cells. In Chapter 5 o f this document, two
different human adenocarcinoma cell-Iines (colon and breast), both strongly deficient in queuosine levels,
were determined to contain lesions o f the incorporation and salvage steps, respectively. The in vivo
methods developed in this research could be used to screen many other cell-lines and biopsies and
determine sites o f queuosine insufficiency in their queuosine modification systems. In addition, along with
the in vitro assay methods, these techniques could be used to fully characterize a biopsy’s pathological
phenotype for neoplastic grading as has been previously suggested (40-43).
Despite this new understanding o f the queuosine modification system in eukaryotes and
prokaryotes, a realistic physiochemical mechanism for queuosine’s effect on cellular metabolism has still
not been developed in either set o f organisms. In order to discover the purpose and biological function o f
the queuosine modification of tRNA and explain queuosine’s connection to the control o f cellular
maintenance, differentiation and growth, it is important to determine the most logical place for the greatest
influence o f this molecule in the cell. There has been some discussion of the queuine base as an activator
for tyrosine kinases(l5,171), however this has not been pursued as a significant function o f the nucleotidyl
base and would not account for the correlations o f queuosine level fluctuations with such a wide variety o f
phenotypic alterations that have been observed.
Transfer RNA molecules are involved in many minor cellular functions, including serving as
cofactors in retroviral priming, RNA polymerase priming, ATP-dependent ubiquitin-directed proteolysis,
sequestration o f the glucocorticoid receptor, chloroplast synthesis ofS-aminolevuIinic acid and
chlorophyll, synthesis of heme and vitamin BI2>and prokaryotic cell wall biosynthesis (172). However, in
situ the tRNA molecule’s major role is in protein synthesis. Thus, the most logical site for the global effect
of queuosine-modified tRNAs in areas as diverse as development, differentiation, stress-management, and
neoplastic transformation is in the control o f the translation stage o f gene expression.
There are a few defined reactions of the tRNA which might be influenced by the presence or
absence of modified bases. Transfer RNAs are involved with both initiation and elongation phases of
protein translation, however those molecules involved with the queuosine modification (asparaginyl-,
aspartyl-, histidyl-, and tyrosyl-tRNAs) are only utilized during elongation. The tRNA is complexed with
several macromolecules during the elongation phase o f translation: the cognate aminoacyi synthetase; the
transport-specific elongation factor; and the ribosomal complex which includes the mRNA, aminoacyi
(A-) site, peptidyl (P-) site, and exit (E-) site tRNAs, rRNAs and rRNPs.
In translation, the first major reaction for tRNA is it’s association with a cognate tRNA synthetase.
Several researchers have shown that a key identity determinant for proper association of the tRNA with it’s
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cognate aminoacyi synthetase is in the anticodon (173). However, many tRNAs are identified based on
specialized base presence in the DHU or PFC loop and especially (even in the case of the aspartyl-tRNA)
in the aminoacyi acceptor arm (174). Kinetics studies of guanosine-containing versus queuosine-modified
tRNAs show no significant difference in aminoacylation rates by cognate aminoacyi synthetases (175).
Aminoacylated tRNAs are then required to associate with the ribosome, the site for the translation
process. Movement through the ribosome is facilitated by translational elongation factors (EFs).
Prokaryotic EF-Tu and eukaryotic E F -la appear to have the same function in cells. They transport all
aminoacyl-tRNAs to the ribosome for association with the ribosomal complex. The EFs do not
discriminate when binding to any tRNA family member or isoacceptor. Recently, EF-tRNA complexes
have been crystallized and are shown to bind solely to the aminoacyi acceptor arm of the tRNA (176).
Therefore, it can be inferred that the presence or absence o f a modified base in the anticodon should not
have an effect on the association or transport o f tRNAs by EFs.
The association o f the tRNA with the ribosome is currently a focus o f a great amount o f research.
£ coli ribosomal complexes have been the predominant subject for cross-linkage, nuclease protection, and
tRNA binding studies (168), with their global structure recently clarified by high resolution cryoelectron
microscopy (111). tRNA association with the translation platform appears to be due to the interactions of
the EF and aminoacyi acceptor stem o f the tRNA with the 23S rRNA, and the tRNA-anticodon with the
mRNA (177). Cross-linkage studies have strongly suggested the presence o f a ternary interaction between
the tRNA-anticodon, the mRNA-codon and the C1400 residue of the 16S rRNA at the wobble position,
which may be a stabilizing influence on the complex (168). No evidence of direct rRNP-tRNA interactions
have yet been reported.
After the association of the tRNA with the A-site of the ribosome, the formation of the peptide
bond (transpeptidation) and translocation of the tRNA to the P-site and then to the E-site takes place at a
relatively steady state rate (177). Transpeptidation appears to be catalyzed by the 23S rRNA in the
aminoacyi acceptor stem region of the A- and P-site tRNAs, with the translocation of the mRNA and
associated tRNAs caused by the shifting of the tRNA molecules causing the subsequent dragging o f the
entire ribosomal complex along the mRNA transcript (178). Therefore, it is suggested that the presence of
the modified wobble base does not have an effect on the rate of transpeptidation or translocation.
Finally, the potential effect o f the wobble modification on translational rate is narrowed to either
or both the interaction o f the incoming tRNA with the P-site tRNA and the association of a tRNA with the
mRNA. These are described by well known theories of “codon context” and “codon bias”, respectively.
Interaction between neighboring tRNAs in the A- and P-sites of the ribosome have been suggested to be
due to the close proximity o f the successive codons on the mRNA and the extended nature of a couple of
modified bases located near the margins o f the anticodon loops: such as wyebutine located at position 37
of tRNA1*®and queuosine in position 34 of tRNA“", tRNA*sp, tRNA1*, and tRNA'*'(4,112,179). However,
in the case of tRNA1** and tRNA*55 with the currently accepted models of A-site tRNA/mRNA/P-site tRNA
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conformations, it is shown in Chapter 6 o f this treatise that these two bases do not interact. A very recent
report has been published indicating that the neither presence nor the absence of the queuosinemodification in tRNA** has a dramatic effect on translational frameshifting at the coraavirus frameshift
signal (180). This supports the computational model which disputes the biological function o f queuosine
in codon context effects for such events as ribosomal frameshifting.
Harvey’s group demonstrated that the anticodon loop of tRNAs are functionally and structurally
separated from the rest o f the molecule by the extended anticodon stem (94). Differences in the strength
and stability of the anticodon-codon interaction, caused by an alteration in the flexibility o f the anticodon
loop, could influence the speed of tRNA placement into the A-site o f the ribosome (169). Thus, the
flexibility of the anticodon loop may have an effect on the rate of translation in general. Since the wobble
base is often modified in tRNA, a modified nucleoside could effect the rate o f translation due to it’s ability
to associate with the codon’s corresponding base.
Modified bases have been shown to greatly effect the flexibility of the tRNA molecule by
influencing ribose puckering, base stacking, and intraloop hydrogen bonding networks (151-155,181).
These factors have been shown to greatly increase the ability of the tRNA to efficiently decode their
corresponding tRNAs (149,170,182). Results discussed in Chapter 6 o f this document show that the
presence of the queuosine modification in tRNAasp does alter both the structural flexibility of the anticodon
loop and the complex stability of the anticodon with the mRNA. In the case of tRNA*9, the addition of the
queuosine modification dramatically decreases the flexibility of the anticodon loop by establishment of an
extended cross-loop hydrogen bonding network, thereby decreasing the stability of a tRNA complex with
either the cognate or pseudo-cognate mRNA. In a ribosomally-based context, the modification of the
tRNA*5’’ with queuosine decreases the strong bias o f guanosine-containing tRNAs for the traditional
Watson-Crick pairing (cognate) over the wobble pairing (pseudo-cognate) for association with the codon
on the mRNA.
In a final study performed in this research, a preliminary analysis of codon usage for several
oncodevelopmental control and housekeeping transcript sequences was made. This was attempted in order
to assess possible effects o f the presence or absence o f the queuosine modification on protein synthesis of
these important proteins. Over time, the identity o f the tRNA wobble base (queuosine or guanosine) could
have a global effect on the metabolism and, potentially, phenotypic alteration of a cell.
Queuosine-modified tRNAs (asparaginyl-, aspartyl-, histidyl-, and tyrosyl-) translate four specific
codons ending in either the traditional Watson-Crick base cytosine (C) or wobble base uridine (U) (Table
7-1). An analysis o f the codon usage for these codons was performed for a sampling of several
housekeeping and oncodevelopmental genes. The results are shown in Table 7-II. The percent usage of
queuosine-involved from all transcript codons varies from 10 to 17 percent with no consistent trend based
on housekeeping versus oncodevelopmental status. Although this does not seem to be a large percentage
of residues, these four amino acids often play a major role in structural stabilization and function of
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Figure 7-2. The Genetic Code
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Start and stop codons are indicated. Queuosine-related codons, darkly shaded, are encoded by the letters
NAU or NAC (N indicates any nucleotide base). Tyrosine-encoding codons begin with uridine (U),
histidine-encoding codons begin with cytosine (C), asparagine-encoding codons begin with adenosine (A),
and aspartate-encoding codons begin with guanosine (G).
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proteins based on either their proton or electron transfer capabilities. An important observation of these
codon patterns, however, is that the ratio o f U (wobble base) to C (Watson-Crick base) in the wobble
position of these codons differs between the housekeeping versus oncodevelopmental transcripts. In the
overall nucleic acid sequence comparisons for the involved amino acid codons, the U to C wobble ratios
demonstrate a large gap between the housekeeping transcripts (greater than 0.71) and the
oncodevelopmental transcripts (less than 0.32) for those sequences examined. Thus, it is suggested that
there may be a bias between these two classes of gene sequences which is able to be exploited by the
guanosine-containing versus queuosine-modified tRNA translational machinery.
In developing a queuosine-associated codon bias hypothesis, normal and cancer cells would have
different protein synthetic levels for specific proteins based on the codon usage o f each mRNA sequence
and the levels o f queuosine-modified tRNA levels within the cells. Cells exhibiting normal queuosinemodified tRNA levels would produce housekeeping proteins such as ornithine decarboxylase,
phospholipase A* (3-gaIactosidase, a-actin, and a- and P-globin in similar quantities to oncodevelopmental
protein assuming a comparable number o f transcript copies. This is suggested to occur due to the lack of
preference of queuosine-modified tRNAs for either NAC or NALJ codon. In neoplastic cells, which
contain elevated levels o f guanosine-containing tRNAs, oncodevelopmental proteins such as c-fos, N-myc,
c-Jun, and c-myc would be translated much more efficiently and rapidly than “usual” due to the more
stable association o f guanosine-containing tRNA to NAC over NAU codons.
Current dogma accepts that transcriptional regulation of oncodevelopmental genes in normal ceils
greatly reduces the quantity of these transcripts when compared to housekeeping mRNAs. Dual control of
the expression o f these growth control genes through both transcriptional and translational regulation could
effectively modulate the levels o f these important gene products. Thus, fully queuosine-modified normal
cells would produce the housekeeping proteins in much larger quantities relative to the highly influential
oncodevelopmental proteins which must be maintained at very low intracellular levels.
This document proposes a codon bias-directed hypothesis explaining the effect of the queuosine
modification on cellular physiology. The organization o f the queuosine modification system in
prokaryotes and eukaryotes is now known. In addition, regulatory mechanisms for wiring the modification
systems in with cellular metabolism have been identified. Thus, the cellular dynamics o f the queuosine
modification’s formation in tRNA, as well as the molecular dynamics o f queuosine’s effect in protein
translation are regulated in a cellular physiological context This theory appears to propose a logical
mechanism for how the loss of normal queuosine levels could cause the shift of the cellular life-cyde from
stasis to retrograde-differentiation, and neoplastic transformation to tumor progression.
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T able 7-1. Wobble Base Bias o f Codons Decoded by tRNAam, tRNA**, tRNAhis and
tRNA1°'r in Selected Human Gene Transcripts

Total Number o f
Codons

Number o f Q
Codons (%)

Wobble U/C
Ratio

Ornithine Decarboxylase

461

73
(16%)

2.04

Phospholipase A2

749

126
(17%)

1.93

P-Galactosidase

677

114
(17%)

1.00

N-ras

189

32
(17%)

0.88

a-Actin

337

58
(17%)

0.81

(3-GIobin

107

24
(22%)

0.71

Fos

364

37
( 10%)

0.32

N-myc

456

53
( 12%)

0.29

Leukemia Inhibitory Factor

202

35
(17%)

0.25

JunA

331

33
( 10%)

0.14

C-myc

439

63
(14%)

0.02

Human Gene Transcript

All analyses were performed manually. The total number of codons, Q codons (those encoding for
asparagine, aspartate, hisidine, and tyrosine), and those Q codons that ended in U or in C were determined
based on visual inspection of the coding sequences for the gene transcripts. The percentage o f total codons
that involved Q and wobble U/C ratio was calculated based on these observations.
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APPENDIX
SEPARATION OF QUEUOSINE-MODIFIED tRNA ISOACCEPTOR FAMILIES
BY RPC-5 AND W-POREX C4 LIQUID CHROMATOGRAPHY
Introduction
An eariy method developed to directly measure levels o f the queuosine modification in tRNA is
based on reversed phase C-5 (RPC-5) medium pressure liquid chromatography. The protocol employs the
use of an RPC-5 column matrix composed o f 10 micron polychlorofluoroethylene particles coated with
trialkyImethylammonium chloride-containing alkyl groups ranging in length from C, to Ct0- The RPC-5
methodology has been applied to the separation of tRNA species from many sources (183,184), and is the
standard technique applied to the chromatographic analysis o f queuosine-modified tRNAs (21,91,185).
Despite its successful application, the RPC-5 methodology presents some serious limitations and
disadvantages. The RPC-5 matrix does not separate the different isoacceptor families with high efficiency.
For example, it is possible to resolve the queuosine-modified from unmodified forms of aminoacylated
tRNAs. However, the separation of tRNA"**, tRNA*” , tRNA1” , and tRNA'5'1species is not possible.
Furthermore, the RPC-5 matrix does not tolerate repeated pressurized applications with reproducible
resolution. In addition, the use of organic solvents for optimizing separations on the RPC-5 column can
lead to degradation o f the matrix, where alkyl groups are gradually stripped away from the inert support
The rate of this deterioration can be decreased by the addition o f a trace amount o f trialkylammonium
chloride (Adogen 264) to the running buffer (Farkas, pers. commun.). Ultimately, the matrix must be
removed from the column to be regenerated. This takes time and compounds problems with
reproducibility between reconditioned batches. Finally, and maybe most importantly, the RPC-5 matrix is
no longer commercially available.
An alternative high pressure liquid chromatography (HPLC) column matrix has shown promise as
a potential replacement for RPC-5 in analysis of queuosine modification levels in tRNA. The W-Porex C4
HPLC column has been successfully applied to the separation o f bulk tRNAs isolated from bovine liver
and wheat germ, as well as snRNA from L929 cells (35). The column matrix consists of an inert support
of 5 micron porous silica particles with a uniform pore size o f 30 nm. A C4 carbon chain bound to the
support provides the hydrophobic reversed phase for separation. The W-Porex C4 matrix has been
demonstrated to significantly improve separation of bulk tRNAs over that of RPC-5 (35). This column
matrix also has a high capacity for tRNA binding (1 to 20 mg), high durability, and excellent resolution
over high pressure applications (60 to 90 BAR at a flow rate o f 1 mL/min). In studies shown here, the WPorex C4 column was tested for the ability to resolve the four families of the queuosine-containing tRNAs,
and for the ability to separate individual queuosine-modified from unmodified tRNA isoacceptors.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Materials and Methods
Transfer RNA from promyelocytic leukemia (HL-60), chronic lymphocytic leukemia (CLL),
acute myelocytic leukemia (AML), and normal human foreskin fibroblast (HFF) cells were isolated using
established methods (21,91).
In vivo labelling o f queuosine-containing tRNA from HL-60 cells was performed by exposure of
the cell cultures to a radiolabeled queuine analog (iQT3; specific activity 0.19 Ci/mmol, 0.1 pCi/mL). The
cells were grown in a ISO cc culture flask to a density of 2 x 106 cells/mL, then exposed to 100 nM rQT3
for 24 hours. Finally, the tRNA was isolated as mentioned above.
Enhancement of queuosine-deficient HL-60 tRNA was performed by treatment o f cultures with 7methyiguanine, an inhibitor o f TGRase activity. Enhancement of queuosine-modified HL-60 tRNA
populations was performed by the addition o f excess queuine to the media. These tRNA populations were
used to assess shifts in the levels o f queuosine-modified versus unmodified tRNA isoacceptors when
compared to untreated HL-60 tRNA. All cells were grown in 500 mL cultures to a density o f 2 x I06
cells/mL and exposed to 10 pM 7-methylguanine or 0.10

units of queuine for 24 hours. Again, the

tRNA was isolated as above.
In vitro aminoacylation o f tRNA with 3H-aspartic acid, 3H-histidine, and 3H-tyrosine or unlabeled
amino acids was performed using isolates from 0.10 A360queuine-treated and 10 pM 7-methylguaninetreated HL-60 cells. Mouse liver aminoacyl-tRNA synthetase, isolated by established methods, was
utilized to catalyze the aminoacylation reaction. Enzyme isolation and aminoacylation reaction conditions
were performed as previously described (21,91).
Unlabelled tRNA, rQT3-labeled tRNA, and 3H-aminoacyl tRNA were analyzed by W-Porex C4
HPLC. Generation o f tRNA profiles was accomplished using a 250 x 4.6 mm i.d. W-Porex C4 column
purchased from Phenomenex (Rancho Palos Verdes, CA). A programmable LKB Ultrachrom GTi
Bioseparation system was used to develop running conditions for the column. All buffers were filtered
through 0.22 pm filter and degassed prior to column equilibration and sample analysis. The optimal
conditions for separation and analysis o f queuosine-containing tRNAs were developed at a flow rate o f 1.0
mL/min with a back pressure o f 70 to 90 BAR based on elution conditions described by Dudock (35). A
linear decreasing salt gradient was applied for separation of tRNAs consisting of 1.0 M to 0 M ammonium
sulfate in 0.10 M potassium phosphate buffer (pH 7.0) modified with 0.75% isopropanol. The column was
equilibrated in 1.0 M ammonium sulfate containing buffer at 1.0 mL/min for 10 minutes prior to analysis
of tRNA samples. A linear descending salt gradient from 1.0 M ammonium sulfate to 0.20 M ammonium
sulfate was applied for 80 minutes, then the salt concentration was reduced to 0 M over 20 minutes. The
column was rinsed an additional 10 minutes with no salt buffer, brought back to 1.0 M salt over a one
minute interval and re-equilibrated in 1.0 M ammonium sulfate containing buffer for ten minutes prior to
the next analysis. On the final run o f the day, the column was left in no salt buffer and the flow rate was
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reduced to 0.1 mL/min and allowed to run continuously overnight. The rate o f gradient change could be
altered to enhance resolution o f specific peaks either early or late in the chromatogram, but the simple
linear gradient demonstrated adequate efficiency at separating the queuosine-containing tRNA
isoacceptors.
The HPLC profiles o f tRNA from rQT3-treated HL-60 cells were used to identify the retention
times of the four rQT3-modified tRNAs. Isolated 0.10 A^o queuine-treated HL-60 tRNA samples were
radiolabeled in an aminoacylation reaction and the retention times determined. The tRNA isolated from 7methylguanine treated HL-60 cells was subjected to a radiolabeling aminoacylation reaction and analyzed.
Comparisons between differentially 3H-aminoacyIated tRNA profiles o f 0.10 A^o queuine-treated and 7methylguanine-treated HL-60 tRNAs in order to determine the isoacceptor identity of each "peak” and the
relative amounts o f queuosine-modified and unmodified tRNAs were determined based on the established
retention times for HL-60 tRNA.
Results and Discussion
Transfer RNA, isolated from several human cultured cell-lines (HL-60, AML, CLL, and HFF),
was subjected to HPLC using a W-Porex C4 column in order to determine the best running conditions for
effective resolution o f different populations of tRNA isoacceptors (Figure A-l). The ability o f this column
matrix to perform good separation o f bulk tRNA populations is a particular feature of this resin, and has
been shown to be more proficient than the RPC-5 matrix (35). The optimal running conditions for the
separation of the HL-60 tRNA isoacceptors was established at 1.0 mL/min which provided a back-pressure
of 70 to 90 Bar for the HPLC system (36). The elution is controlled using a linear decreasing ammonium
sulfate gradient from 1.0 M to 0.2 M in 0.10 M potassium phosphate buffer (pH 7.0) over 80 minutes, and
finally to 0.0 M over an additional 20 minutes (37).
Parallel tRNA samples were isolated from HL-60 and CLL cultures that were either exposed to
non-radiolabeled queuine or to a radiolabeled queuine analogue, rQT3, for 24 hours. The unlabeled control
tRNA was aminoacylated in three reaction mixtures with one of the three available tritiated amino acids
(3H-aspartate, 3H-histidine, or 3H-tyrosine). The tRNA containing the rQT3 label was aminoacylated with
non-radioactive amino acids. Each reaction mixture was applied to the W-Porex C4 HPLC system. The
profile overlays for tritiated aminoacylated (Figure A-2) or tritiated queuosine-containing tRNAs (Figure
A-3) are shown with identifying labels. Four distinct regions of radioactivity for queuosine-containing
tRNAs were detected at retention times of 6,21,55, and 70 minutes. This is suggested to be due to the
separation of the four different possible queuosine-modified tRNA isoacceptors. RPC-5 medium pressure
liquid chromatography does not have the ability to resolve tRNA isoacceptors, and can only differentiate
glycosylated from non-glycosylated forms of queuosine-modified tRNAs (87).
To verify that the four peaks detected with the in vivo rQT3 labeling experiment were due to four
distinct tRNA isoacceptors, another study was begun to detect both specific tRNA isoacceptors and
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Figure A-l. W-Porex C4 HPLC Profiles o f Transfer RNA Isolatedfrom Four Human Cell Cultures.
Purified tRNA samples (0.5 mg) from chronic lymphocytic leukemia (CLL), acute myelocytic leukemia
(AML), promyelocytic leukemia (HL-60), and normal human fibroblast (HFF) cells were separated by an
80 minute decreasing salt gradient of 1.0 M to 0.2 M (NH^SC^ in 0.10 M potassium phospate buffer (pH
7.0) modified with 0.75% isopropanol. The running buffer was then held at 0.2 M (NH^SO* for 20
minutes. The samples were eluted on a 250 x 4.6 mm Phenomenex W-Porex C4 column at 1 mL/min and
monitored by an on-line UV detector which measured the absorbance of the flow at 254 nm.
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Figure A-2. Aminoacylated Transfer RNAsfrom Chronic Lymphocytic and Promyelocytic Leukemia Cells.
Purified transfer RNAs from CLL and HL-60 cells exposed in vivo to 0.10 Am units of queuine were each
aminoacylated, in three separate reactions, with 3H-aspartate, 3H-tyrosine, or H-histidine. In each reaction
SO fig of tRNA was charged with 3H-amino acid (0.S pCi) in the presence of semi-purified mouse liver
aminoacyl-tKNA synthetase in a total volume of ISO pL. Each sample was separated by W-Porex C4
HPLC by a decreasing salt gradient of 1.0 M to 0.2 M (NH4)2S04 over 80 minutes, then held at 0.2 M
(NH4)2S0 4 for 20 minutes at a flow rate of 1 mL/min. Elution fiactions were collected at 0.S minute
intervals and analyzed by scintillation. This figure represents an overlay of the three chromatograms (one
for each }H-amino acid) for tRNA isolated derived from CLL and HL-60 cells, respectively. Backgrounds
were subtracted to normalize the baselines relative to each other.
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Figure A-3. Queuosine-Containing Transfer RNAsfrom Chronic Lymphocytic and Promyeiocytic
Leukemia Cells. Transfer RNA from CLL and HL-60 cells exposed to 100 nM rQT3 in culture was isolated
and a sample (0.5 mg) was added to a reaction mixture for aminoacylation with non-radiolabeled amino
acids. The reaction mixture was separated by a decreasing salt gradient o f 1.0 M to 0.2 M (NH^SO., over
80 minutes, then held at 0.2 M (NH^SO* for 20 minutes at a flow rate of 1 mL/min. Eluent fractions were
collected at 0.5 minute intervals and analyzed by liquid scintillation. The figure shows four major
radioactive peaks returned from each cell-type corresponding to the four queuosine-containing tRNA
species. The peaks were assigned identities by comparison to the elution patterns of ^-aminoacylated
tRNAs seen in Figure A-2. *The tRNA“" peaks were assigned by process of elimination, since no 3Hasparagine was available at the time of these studies.
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visualize each queuosine-modified and deficient forms. The HL-60 cell-line is known to be naturally 60 to
80% queuosine-deficient, so the cells were exposed in culture to two effectors o f the queuosine
modification system in order to exaggerate the queuosine-modified and queuosine-deficient populations of
tRNA. Parallel cultures o f HL-60 cells were treated for 24 hours with either an additional 0.10 A ^
queuine to induce saturation o f the queuosine-modified tRNA isoacceptors, or 10 pM 7-methylguanine
which is a competitive inhibitor (used at 10 times the Kj) of the queuine incorporation enzyme. The tRNA
fractions of these cultures were isolated and in vitro aminoacylation reactions were performed with each of
three specific radiolabeled amino acid substrates (3H-histidine, 3H-tyrosine, and ^-aspartate).
Radiolabeled asparagine, the remaining queuosine-related isoacceptor, was not commercially available at
the time of this study. Overlays of each amino acid's chromatographic profiles for both queuine-treated
and 7-methylguanine-treated tRNA samples are shown in Figure A-4.
The 3H-histidyl tRNA profiles o f queuine-saturated and queuine-deficient both exhibit three peaks
of identical retention times. The 6 minute peak is likely to be the flow-through o f excess radiolabeled
amino acid remaining from the aminoacylation reaction. The peaks at 37 and 67 minutes correspond to
tRNA1" isoacceptors. Integration o f the two peaks indicates that the 0.10 A260 queuine-treated sample
contains a 62 to 38% ratio o f area from the first to the second peak, while the 7-methylguanine-treated
sample has a ratio o f 48 to 52% area. Therefore, the 37 minute peak corresponds to the queuosinemodified tRNA1" isoacceptor, with the unmodified tRNA1" eluting at 67 minutes. The incomplete
saturation of the modification as seen in these percentages of shift was not unexpected given unpublished
observations in this laboratory. However, the limited extent of the shift is somewhat disconcerting, since
these conditions have been published as being effective concentrations of effectors o f the queuosine
modification system and utilized in many cell culture studies (116).
The 3H-tyrosyl tRNA profiles o f queuine-saturated and queuine-deficient samples both exhibit
three peaks o f identical retention times. The 7 minute peak is the flow through o f excess radiolabeled
amino acid remaining from the aminoacylation reaction. The peaks at 18 and 25 minutes correspond to
tRNA1^ isoacceptors. Integration o f the two peaks indicates that the 0.10 A^o queuine-treated sample
contains a 82 to 18% ratio o f area from the first to the second peak, while the 7-methylguanine-treated
sample has a ratio o f 47 to 33% area. It is concluded that the 18 minute peak corresponds to the queuosinemodified tRNA1^ isoacceptor, with the unmodified tRNA1*1eluting at 25 minutes. As seen with the histidyl
tRNA profiles, incomplete saturation and inhibition of the queuosine modification system is in evidence
with this aminoacyl tRNA also, although not quite to the same extent as with tRNA1" .
The 3H-aspartyl tRNA profiles o f queuine-saturated and queuine-deficient samples both exhibit
two peaks of identical retention times. The 5 minute peak may be due to either the flow through of excess
radiolabeled amino acid remaining from the aminoacylation reaction, or it may also be a significant peak
with a second peak eluting at a retention time o f 8 minutes. Assuming (for sake o f argument) that the first
peak is due entirely to one form o f tRNA*sp isoacceptor, integration of the two peaks indicates that the 0.10
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queuine-treated sample contains a 99 to 1% ratio o f area from the first to the second peak, while the 7methylguanine-treated sample has a very similar ratio of 98 to 2% area. This suggests that the 5 minute
peak corresponds to the queuosine-modified tRNA*5’’ isoacceptor, with the unmodified tRNA“p eluting at 8
minutes. As seen with both the histidyl and tyrosyl tRNA profiles, incomplete inhibition of the queuosine
modification system is in evidence with this isoacceptor. Therefore, years o f unpublished observations in
this laboratory and elsewhere (29) regarding a non-uniform and preferential loss o f the queuosine
modification by certain isoacceptors are corroborated by the lack of complete inhibition of the queuine
incorporation enzyme expected at these published concentrations for 7-methylguanine (76). In addition,
the inhibition o f queuosine modification for aminoacyl tRNA isoacceptors is not a global effect but occurs
in a specific order with the tRNA“p and tRNA'5'1 isoacceptors exhibiting the greatest resistance to queuosine
decreases.
A final comparison o f all three profiles and table o f values (Table A-I) suggests that one combined
aminoacylation reaction (3H-histidyl, 3H-tyrosyl, and 3H-aspartyl labeled tRNA) mixture run on the WPorex C4 HPLC system can separate both the tRNA isoacceptors and the queuosine-modified from
unmodified forms. An experiment reacting the rQT3 labeled tRNA population with individually labeled
amino acids and a mixed reaction o f all four amino acids is currendy underway. However, the results of
this preliminary study also suggests that, were radiolabeled asparagine available, a combined reaction assay
of all four aminoacyl tRNAs would resolve all four possible isoacceptors and their queuosine-modified and
unmodified forms. This contention is based on the resolution o f four distinct regions o f rQT3 incorporated
tRNAs from in vivo studies. The results o f the W-Porex C4 HPLC method is in direct contrast with
chromatographs from established RPC-5 protocols which separate queuosine-modified from unmodified
forms but do show acceptable resolution between isoacceptors. The RPC-5 methodology can, however,
identify glycosylated from unglycosylated queuosine-containing tRNAs, while the W-Porex C4 HPLC
system does not appear to be able to do this.
The W-Porex C4 HPLC method is, therefore, a very effective method for the separation and
quantification of queuosine-modified tRNAs. Although it does not resolve glycosylated from
unglycosylated modifications, it does have the advantage over RPC-5 medium pressure liquid
chromatography o f the ability to simultaneously detect the four tRNA isoacceptors and each queuosinemodified from unmodified form. This is important due to the current limitations of the RPC-5
methodology which is no longer commercially available and has several other drawbacks including rapid
deterioration o f the matrix by both solvent exposure and pressurized running conditions. Both liquid
chromatographic procedures require rather large amounts of sample to analyze. Although the
chromatographs shown in this chapter were run on the W-Porex C4 column with sample sizes of as little as
23 |ig tRNA, most protocols would require > to 10 mg tRNA for efficient resolution. Therefore, it is
important to note that this suggested sample size can limit the type of applications that could utilize this
technology.
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Figure A-4. Aminoacylated Transfer RNAsfrom Queuosine-Modified and Queuosine-Deficient
Promyelocytic Leukemia Cells. The shift o f 3H-aminoacyIated tRNA peaks was analyzed for tRNA
isolated from HL-60 cells exposed to 0.10 A26o units of unlabeled queuine to help produce a fully
queuosine-modified compliment of tRNAs (solid lines) and those who were pre-exposed for 24 hours to 10
pM 7-methylguanine, a competitive inhibitor for the queuine incorporation enzyme (dashed lines). HL-60
tRNA samples (50 pg) were placed in aminoacylation reactions with partially-purified mouse liver
aminoacyl-tRNA synthetase in three separate reactions with either 3H-aspartate, 3H-tyrosine, or 3Hhistidine (0.5 pCi each). The samples were seperated by W-Porex C-4 HPLC by a decreasing salt gradient
of 1.0 M to 0.2 M (NH4)2S04 over 80 minutes, then held at 0.2 M (NH^SO., for 20 minutes at a flow rate
of 1.0 mL/min. Elution fractions were collected at 0.5 minute intervals and analyzed by liquid scintillation.
Backgrounds were subtracted to normalize the baselines relative to each other.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

[40

Table A-l. Retention Times and Percent Compositions o f Major Peaks in HL-60 tRNA
Samples.

Queuine-treated HL-60
tRNA Isolates

7-methylGuanine-treated
HL-60 tRNA Isolates

R,= 5 minutes
99%

R,= 8 minutes

1%

R»=5 minutes
98%

R,= 8 minutes
2%

3H-tyrosyl peaks

R,= IS minutes
82%

R,=25 minutes
18%

R*= 18 minutes
47%

R ,= 25 minutes
53%

3H -histidyl peaks

R,= 57 minutes
62%

R,=67 minutes
38%

R,=57 minutes
48%

R ,= 67 minutes
52%

3H-aspartyl peaks

The retention times (RJ for each of the three aminoacylated HL-60 tRNA isoacceptor pairs were based on
the results depicted in Figures A-3 and A-4. The first peak suggested to contain queuosine-modified tRNA
and the second the unmodified guanosine-containing form. The tRNA populations were purified samples
from parallel HL-60 cultures, that had been exposed for 24 hours ro either 0.10 A260 units of exogenous
queuine (to attempt to fully saturate the tRNA) or 10 pM 7-methylguanine (a strong competitive inhibitor
for the queuine incorporation enzyme responsible for the formation o f queuosine). Percent composition
was ascertained from integration of the chromatographic profile shown in Figure A-4. Despite the
assumption that the queuine-saturated and 7-methylguanine-treated cells should contain homogenous
populations of queuosine-modified or queuosine-deficient tRNAs, this was not observed. A shift in the
peak areas, however, was determined and exhibited the expected trend.
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